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1. SUMMARY 
 
Several studies investigated preferences of retroviral integration site selection on the 
molecular level of the linear genome. The three-dimensional nuclear organization, 
large-scale chromatin structure and possible dynamics of retroviral integration sites, 
however, have received little attention. The nucleus of a eukaryotic cell is a highly 
organized organelle. Retroviruses, to complete their life cycle, have to integrate their 
genomes into the host cell nucleus. Hence, the question arises if and how integration 
of foreign material changes the existing nuclear order. 
 This study investigated the consequences of stably integrated retroviral 
sequences for nuclear architecture in two independent experimental systems: in HIV 
infected human astrocytes, HeLa cells and T-lymphocytes as well as in the mouse 
hematopoietic precursor cell line cloneB transduced with a gamma-retroviral gene 
transfer vector. In HIV infected cells, integration sites were first mapped via LM-PCR 
(linker mediated PCR), whereas integration sites in the mouse cell line were 
previously known. BACs (bacterial artificial chromosomes) covering each integration 
site were tested and used as probes for fluorescence in situ hybridization (FISH).  
Difficulties in visualizing the rather small nuclear HIV and gene transfer vector 
integrations were solved by modifications of FISH protocols, which allowed proper 
visualization of fluorescence signals deriving from <10 kb target sequences. 
Structurally preserved FISH preparations were evaluated by confocal microscopy and 
digital 3D image analysis. The nuclear 3D radial distribution of the integration loci 
was determined and compared to the homologous host loci without integration. In 
both, human and mouse cells, changes in large-scale chromatin structure upon 
retroviral sequence integration were observed. 
Of the nine gene transfer vector integration loci in the mouse hematopoietic 
precursor cell line cloneB, two were significantly repositioned towards more interior 
regions of the nucleus. Notably, the more repositioned of these two integration sites 
is in the immediate vicinity of the protooncogene Evi1 (ecotropic virus integration site 
1), a region with frequently observed viral and gene vector integrations. As in most 
cases upon retroviral integrations at this locus, the Evi1 gene in the cloneB cell line is 
overexpressed. This upregulation was shown to be essential for cell survival and 
immortalization of the cell line. Thus, repositioning of the locus is linked to activation 
 11
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of Evi1 and clonal viability. All other seven gene transfer vector integration loci were 
slightly but not significantly repositioned towards more interior nuclear regions 
compared to their homologous loci. 
The HIV infected HeLa cells investigated in this thesis were thought to be a 
clonal cell line, but are declared as a pool of clones here. Several HIV integration 
sites were found in different clones, whereas the clone harboring integration locus 
Xq22.1 dominated the population. 
Two of five HIV integration loci in HeLa cells, 18q22.3 and Xq22.1, were 
significantly repositioned, with a more interior nuclear location as the respective loci 
on the homologous chromosomes. In both cases repositioning was accompanied by 
microscopically detectable large-scale chromatin decondensation. Repositioning and 
decondensation were not observed in astrocytes or T-lymphocytes. Therefore, such 
effects of retroviral integration may be locus or cell type specific. In HeLa cells 
integration locus 18q22.3 was more decondensed than Xq22.1, correlating with more 
pronounced repositioning. All five investigated HIV integration sites were 
transcriptionally active, but did not differ in their location towards SC35 splicing 
speckles compared to their homolgous regions. Sodium butyrate (NaBut) treatment 
increased HIV transcription, but did not lead to changes in radial distribution of 
integration loci compared to untreated cells. 
In summary, the data show that stable retroviral integration can lead to 
alterations of nuclear chromatin organization and has the potential to modulate 
chromatin structure of the host cell. HIV is known to preferentially integrate within 
active transcription units with the advantage to ensure transcription of the provirus. 
Large-scale chromatin reorganization might provide an additional mechanism to 
increase transcriptional probability. 
INTRODUCTION 
2. INTRODUCTION 
2.1 Motivation and goals of the present work 
The nucleus is highly organized and presents the core compartment of a eukaryotic 
cell. Organizational levels range from the DNA fiber to the nuclear distribution of 
chromosome territories (see  2.3.2). The nucleus harbors most of the cellular genome 
and provides the environment for decisive and sophisticated processes like gene 
expression and replication which are indispensable for life. Even small irritations in a 
process cascade may provoke serious implications such as apoptosis or malignancy. 
 Viruses are infectious particles which lack an own metabolism and therefore 
have to rely on a host cell. Retroviruses integrate their genome within the cellular 
genome and use the host transcription machinery to complete their life cycle (Alberts, 
2011). A successful viral strategy ought to be a compromise between exploitation 
and survival of the host. The question arises whether the highly and subtle organized 
nuclear structure is irritated by the infiltration and integration of foreign material like 
retroviral genomes in any way. As described in the subsequent chapters, it is known 
that retroviral integration causes changes on the molecular and epigenetic level and 
affects host cell gene expression properties. Whether these processes lead to 
rearrangements in large-scale chromatin organization, however, has not yet been 
investigated. 
 Although retroviral and especially HIV integration sites have been investigated 
intensely on the molecular level of the linear genome, the 3D nuclear position of 
integration sites was not described before. Preferential targets for integration site 
selection of HIV are active transcription units (discussed in  2.3.3), which are 
widespread in the nucleus. Hence, the viral DNA could be integrated immediately 
after entering the nucleus or penetrating further resulting either in a more peripheral 
or internal position. But since the probability of transcription events declines from 
gene rich to gene poor regions and these regions are distinctly distributed within the 
nucleus, preferences for the HIV genome to integrate are conceivable. 
 Another consideration is repositioning of the integration site. Having integrated 
into a putative inauspicious region, relocation may be the solution. Moreover, the 
addressed alterations on the molecular and epigenetic level could lead to alterations 
in nuclear architecture and therefore benefit repositioning of the integration site. 
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 In this thesis these aspects with the focus on repositioning of the integration 
locus and changes in the affected chromatin environment were investigated. 
Experiments were performed, on the one hand, in three HIV infected cell types 
(astrocytes, HeLa cells and T-lymphocytes), on the other hand, in a mouse 
hematopoietic precursor cell line transduced with a gamma-retroviral gene transfer 
vector. Thanks to their capacity to deliver genetic material into target cells, viral gene 
vectors play an important role in the field of gene therapy. Retroviral vectors integrate 
stably into the host genome and therefore have the potential to exert enduring 
therapeutical effects (see  2.4). 
 
2.2 General aspects of HIV 
2.2.1 Taxonomy, history and genomic properties 
HIV belongs to the retrovirus family and to the genus Lentivirus (Latin: lentus = slow). 
Lentiviruses are known for long-duration illnesses with a long incubation period. Two 
types of HIV are known to date: HIV-1 and HIV-2. HIV-2 shows a much lower 
virulence as well as infectivity compared to HIV-1. Throughout this thesis the term 
HIV is always referring to HIV-1 except when stated otherwise. HIV is thought to have 
developed from SIV (simian immunodeficiency virus), the equipollent in African 
primates. In contrast to humans and HIV, monkeys adapted to SIV and do not suffer 
any illness. A current study revealed that SIV has been in monkeys for at least 
32,000 years, much longer than the previously estimated several hundred years 
(Worobey et al., 2010). SIV crossed the species barrier from monkey to human 
during the late 19th or early 20th century (Worobey et al., 2008). The most probable 
act of transmission is thought to be an accident, where a bushmeat hunter was bitten 
or cut during the butchering of a monkey and the resulting contact with infected 
simian blood. 
The HIV genome consists of two copies of positive sense single-stranded 
RNA, each ~9.2 kb in size, which encode the canonical retroviral genes gag, pol and 
env plus six additional open reading frames with regulatory genes (tat, rev, nef, vif, 
vpr, and vpu) which makes HIV a member of the complex retroviruses (Frankel and 
Young, 1998; Watts et al., 2009). 
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Figure 1: HIV genome 
Image taken from Stanford University webpage 
(http://www.stanford.edu/group/virus/retro/2005gongishmail/HIV.html) 
 
2.2.2 Life cycle 
A brief overview of the HIV life and replication cycle to describe viral behavior in host 
cells from cell entry until release of viral particles is given here. More detailed 
accounts are given by (Ciuffi and Bushman, 2006; Klimas et al., 2008; Delelis et al., 
2010). 
 
Cell entry 
HIV entry into host cells is preferentially mediated by the surface receptor CD4. 
Therefore, T-lymphocytes (T helper cells), monocytes, macrophages and dendritic 
cells, which are all cells of the immune system, come into consideration as primary 
target cells. The viral envelope fuses with the cell membrane and the HIV capsid is 
released in the cell (Suzuki and Craigie, 2007). Recent studies provide compelling 
evidence that HIV enters the cell primarily via endocytosis and not by direct fusion of 
the plasma membrane and release of the viral genome into the cytoplasm (Campbell 
and Hope, 2008; Miyauchi et al., 2009; Permanyer et al., 2010). In vitro studies 
revealed that primary fibroblast and osteoblast-like cells were also susceptible for 
HIV infection suggesting low expression of small amounts of CD4 molecules (Mellert 
et al., 1990). Furthermore CD4 independent HIV infection of central nervous system-
derived cells was described (Harouse et al., 1989; Brack-Werner et al., 1992). 
Nevertheless, infection of lymphoid cells mediated by CD4 receptor is the most 
efficient. In addition to direct infection, HIV can hijack dendritic cells and be 
transmitted to helper T-cells, a process, in which dendritic cells are thought to offer 
 15
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some kind of reservoir for HIV (Grouard and Clark, 1997; Geijtenbeek et al., 2000; 
McDonald et al., 2003). 
 
Integration and transcription  
In the cytoplasm, the pre-integration complex (PIC) consisting of viral proteins, host 
proteins and the HIV genome is formed (Miller et al., 1997). Within this complex the 
viral RNA genome is converted to dsDNA by the viral enzyme reverse transcriptase 
(reviewed in Herschhorn and Hizi, 2010) while simultaneously the RNA is degraded. 
Subsequently, the PIC together with the DNA cargo is actively transported through a 
nuclear pore into the nucleus, where the viral enzyme integrase mediates the 
integration into the host genome. The integrated viral genome is called provirus and 
is embedded between 5´ and 3´ long terminal repeat (LTR) sequences generated 
during the process of reverse transcription. Each LTR is approximately 640 bp in 
length, which results in an integrated HIV provirus genome size of ~9.7 kb (Ratner et 
al., 1985). The LTR regions contain all of the essential signals for gene expression 
such as enhancer, promoter, transcription initiation, transcription terminator and 
polyadenylation signal. 
Gene transcription itself is carried out by the host enzymes RNA polymerase 
II, poly A synthetase and guanyl transferase. The promoter within the LTR region is 
boosted by the viral protein Tat (Bannwarth and Gatignol, 2005; Brady and 
Kashanchi, 2005). The Tat protein is expressed from the small number of initial RNA 
transcripts and thereupon extensively increases the transcription of the viral genome. 
Initially the mRNA is spliced by the host splicing machinery and transported to the 
cytoplasm where it is translated into the proteins Tat and Rev. Rev allows unspliced 
RNA to exit the nucleus, promoting the production of different viral structural proteins 
and the whole viral genome. HIV was long believed to insert only one copy of its 
genome into the host nucleus. Several studies, however, disproved this assumption, 
revealing multiple infections within one nucleus (Jung et al., 2002; Dang et al., 2004). 
In this context a certain importance is assigned to the entry pathway since dendritic 
cells can capture from a few up to a few hundred virions per cell (McDonald et al., 
2003; Chen et al., 2005). 
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Figure 2: HIV life cycle 
Image taken from (Mandell et al., 2004) 
 
Assembly and release 
Under assistance of viral glycoproteins generated from the Env polyprotein, the 
budding of new virus particles (virions), containing the HIV genomic RNA from the 
cell membrane, starts. A visual summary of the HIV life cycle is given in Figure 2. 
 
2.3 Interplay of HIV and host cell chromatin 
2.3.1 Chromatin architecture on the molecular level 
Chromatin is the organized and packaged form of DNA in nuclei of eukaryotic cells. 
Chromatin can be divided into different hierarchical and organizational levels with 
increasing compaction ratio (Woodcock and Dimitrov, 2001; Woodcock and Ghosh, 
2010). Nucleosomes represent the smallest unit. Approximately 146 to 147 base 
pairs of DNA are wound around a histone octamer building the nucleosome core 
particle (NCP) which consists of two copies of each of the core histones H2A, H2B, 
H3 and H4 (Luger et al., 1997; Felsenfeld and Groudine, 2003; Richmond and 
 17
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Davey, 2003; Woodcock, 2006). Neighboring nucleosomes are connected by linker 
DNA that varies in length from 10 to 80 base pairs. When DNA is uncondensed this 
structure is referred to as “beads on a string” under the electron microscope. The 
linker DNA is attached to the histone H1, which forms by compaction the putative 30 
nm fiber (Adkins et al., 2004; Tremethick, 2007). Further compaction leads to the 
most condensed chromatin form, the mitotic chromosome. Here, the DNA is 
compacted some 10000- to 20000-fold (Belmont, 2006).  
Chromatin in interphase nuclei is subclassified in euchromatin and 
heterochromatin. Distinct amino acids of the core histones can be modified in various 
manners such as acetylation, ubiquitylation, methylation and phosphorylation. 
Depending on the decoration either specific heterochromatic or euchromatic regions 
are characterized (Li et al., 2007; Campos and Reinberg, 2009). Heterochromatin is 
preferentially located around nucleoli and at the nuclear periphery where it is 
associated with the nuclear lamina. Compared to euchromatin, it is more condensed 
and transcriptionally less active. Methylation of histone H3 at lysine 9 and the 
heterochromatin protein HP-1 are typical markers and necessary for heterochromatin 
formation (Grewal and Jia, 2007). Constitutive heterochromatin perpetually remains 
in the compact silent form and is predominantly occuring in repetitive, gene-poor and 
late replicating DNA sequences. Regions packaged in facultative heterochromatin 
are transcriptionally silent but retain the potential to alternate between 
heterochromatin and euchromatin and therefore become transcriptionally competent. 
An example is the formation of the inactive X-chromosome (Trojer and Reinberg, 
2007). Euchromatin is less condensed with a compaction ratio supposedly below the 
30 nm fiber, more accessible and in principle transcriptionally active. 
Hyperacetylation and -methylation of lysine 4 and lysine 36 of histone H3 are typical 
indicators for transcriptionally active regions (Li et al., 2007). 
2.3.2 Nuclear architecture and inner nuclear dynamics 
Intensive research has contributed to see the nucleus as a highly organized and 
dynamic organelle (Lanctot et al., 2007). In the interphase nucleus chromosomes 
occupy distinct confined spaces termed chromosome territories which are non 
randomly distributed within the nucleus (for review see Cremer and Cremer, 2001; 
Cremer et al., 2006). Depending on the cell type the positioning was linked to size, 
gene density and morphology (Cremer and Cremer, 2010). In human lymphoblast 
nuclei, for example, gene dense chromosome territories tend to be located more 
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internal, whereas gene poor ones are more likely to be found towards the periphery 
and associated with the lamina (Boyle et al., 2001). This gene density dependent 
distribution was also found in other animals like rodents, cattle, primates and chicken 
(Habermann et al., 2001; Mayer et al., 2005; Neusser et al., 2007; Köhler et al., 
2009). On the other hand, in human fibroblasts a size dependent correlation for the 
nuclear position of chromosome territories could be shown (Sun et al., 2000; Cremer 
et al., 2001; Bolzer et al., 2005). The nuclear organization with distinct arrangements 
is also implemented on chromosomal substructures like chromosome arms (Dietzel 
et al., 1998), telomeres and centromeres (Molenaar et al., 2003; Weierich et al., 
2003). The highly organized structure and compartmentalization does not exclude 
inner nuclear dynamics. Especially for gene function a prominent role was assigned 
to dynamics of chromatin and accordingly chromosomal interactions. Studies on 
nuclear architecture applying molecular methods (3C, 4C) revealed spatial proximity 
of genes located far apart on the linear chromosomal level or even on different 
chromosomes (reviewed in de Laat, 2007; Fraser and Bickmore, 2007; Gondor and 
Ohlsson, 2009). Associations of genes have been described both in cis and trans 
upon transcriptional activation (Thompson et al., 2003; Osborne et al., 2004; Simonis 
et al., 2006; Osborne et al., 2007; Sutherland and Bickmore, 2009) even though the 
functional basis of such a gene convergence is controversially discussed. 
 Further examples for inner nuclear dynamics are genes or gene regions 
looping out from their chromosome territory. This was described for the α-globin gene 
(Brown et al., 2006) or the gene dense region 11p15.5 (Mahy et al., 2002; Albiez et 
al., 2006) Furthermore, erythroid genes located on different chromosomes 
prevalently associate with each other (Brown et al., 2008). Examples for regions 
looping out upon transcriptional activation are Hox gene loci (Chambeyron and 
Bickmore, 2004; Morey et al., 2007), genes in the major histocompatibility complex 
(MHC) (Volpi et al., 2000) or the proneural regulator gene Mash1 (Williams et al., 
2002) and several adipogenesis genes (Szczerbal et al., 2009). Protrusions and 
motions in interphase nuclei can take place both over shorter distances within a 
range of <2 µm (Abney et al., 1997; Gerlich et al., 2003) and in a long-range manner 
with movements >2 µm distances (Bornfleth et al., 1999; Chuang et al., 2006). 
The radial nuclear position of a given gene may be linked to its transcriptional 
state (Lanctot et al., 2007; Kumaran et al., 2008; Takizawa et al., 2008b; Zhao et al., 
2009). Since gene density increases when approaching the nuclear interior it might 
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be convenient for a genetic locus to increase its transcriptional potential by moving 
towards the nuclear center. Repositioning towards the nuclear interior upon 
transcriptional activation has been reported for transgenes (Tumbar and Belmont, 
2001; Dietzel et al., 2004) and several gene regions such as the different nuclear 
position of the two alleles of the monoallelically expressed GFAP gene in astrocytes 
(Takizawa et al., 2008a). The active allele generally reveals a more internal position 
compared to its inactive equivalent. Repositioning for transcriptionally activated 
genes was shown especially during cell development and differentiation. The β-
globin locus in mouse erythroid cells, for instance, departs from the nuclear periphery 
after its expression is switched on (Ragoczy et al., 2006). The already mentioned 
Mash1 gene moves away from a peripheral location upon transcriptional upregulation 
during neural differentiation (Williams et al., 2006). In cell types, where the CFTR 
gene is transcriptionally inactive, this gene locus is associated with the nuclear 
periphery and perinuclear heterochromatin.  In contrast, in cell types, where the gene 
is actively transcribed, it is embedded in euchromatin enriched areas more internal in 
the nucleus (Zink et al., 2004). The influence of a surrounding chromatin milieu was 
furthermore shown by the correlation of transcriptional silencing and repositioning to 
a putative transcriptional repressive environment. In Type 1 helper cells the Type 2 
helper cell specific transcription factors GATA-3 and c-maf are repositioned to 
centromeric heterochromatin or the nuclear periphery retaining their transcriptionally 
inactive status (Hewitt et al., 2004). 
But changes in the nuclear distribution of a gene do not necessarily have to 
alter its transcriptional state or vice versa. In murine ES cells that differentiate to 
neurons the transcription of the Mash1 gene is upregulated and its localization 
changes from a peripheral to a more internal position (Williams et al., 2006). Several 
neighboring genes are transcriptionally affected by this relocation towards the center 
and some of them remain in their inactive state. Repositioning of several genes 
during tumorigenesis independent of changes in their activity was also observed 
(Meaburn and Misteli, 2008). Moreover, results from in-vitro designed systems 
revealed discrepancies. In one approach, the transcription of a reporter gene was 
reduced after being tethered to the nuclear lamina (Reddy et al., 2008). On the other 
hand the nuclear lamina does not have to be a transcriptionally inactive region. 
Placing an inducible transgene at the periphery to interact with lamin B did not have 
an effect on its transcriptional property (Kumaran and Spector, 2008). 
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2.3.3 HIV integration and host cell chromatin 
The pre-integration complex (PIC) is a large nucleoprotein complex carrying the viral 
cDNA (see  2.2.2). Having entered the nucleus, the PIC immediately begins to interact 
with the chromosomal DNA. The ubiquitously expressed nuclear protein lens 
epithelium-derived growth factor (LEDGF)/p75 plays an important role in this process. 
LEDGF/p75 is a transcriptional regulator, which is tightly associated with chromatin. It 
contains a nuclear localization signal (NLS) and binds to the viral enzyme integrase 
in the PIC (Ciuffi and Bushman, 2006; Singh et al., 2006; Engelman and 
Cherepanov, 2008). The next step is searching an appropriate locus for integration. 
In this process LEDGF/p75 acts as a targeting factor, but it is not essential for the 
actual event of integration, which is catalyzed by the viral enzyme integrase (Ciuffi et 
al., 2005; Shun et al., 2007). A precise target sequence for HIV integration has not 
been gleaned yet although weak consensus sequences at and near the integration 
site could be identified (Holman and Coffin, 2005; Wu et al., 2005). HIV integration 
was first believed to be random (Holmes-Son et al., 2001) but finally proclivities were 
identified. The preferential but not exclusive locations for HIV to integrate into the 
host genome are active transcription units (Schröder et al., 2002; Mitchell et al., 
2004; Bushman et al., 2005). This was confirmed by investigations of epigenetic 
properties at the integration site (Wang et al., 2007). 
 Interestingly, HIV integration site location differs in adult and infant cells 
(Wellensiek et al., 2009). The frequency of integrations within transcriptionally active 
genes is higher in cord T-lymphocytes and macrophages than in adult blood cells 
suggesting a relation to the higher viremia, i.e. more viruses in the bloodstream, and 
a more rapid progress to AIDS observed in HIV infected infants. Moreover, in patients 
with low viremia, HIV integrations are predominantly found in the GC-richest 
isochors. In patients with higher viremia, on the other hand, integrations more often 
locate in GC-poor isochore regions. Patients with the highest viremia integrations into 
GC rich regions are often predominant again but not to the same extent as for low 
viremia levels (Tsyba et al., 2004). Since the GC content correlates with gene 
density, it is to be expected for the virus to integrate into gene dense and therefore 
GC rich regions. This might guarantee proper transcription. The observation at higher 
viremia levels is explained by the authors with the compositional matching of the GC 
poorness of HIV-1 called `isopycnic integration´. This was also described before for 
other viruses and is associated with stability of integration and transcription of the 
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provirus (Rynditch et al., 1998). In the study of (Wang et al., 2007) strong 
associations with distinct histone modifications like mono-, di- or trimethylated H3K4, 
acetylated H3K9/K14 and acetylated H4 which all are markers for euchromatin and 
therefore open and accessible chromatin have been shown. 
 For the integration of the double-stranded virus genome it is indispensable to 
create double-strand breaks (DSB) in the host genome. A human cell is confronted 
with about 10000 DNA lesions per day (Lindahl, 1993), resulting in the evolution of a 
sophisticated repair machinery in which Atm (ataxia telangiectasia mutated) and Atr 
(Atm and Rad-related) kinases play a pivotal role. The host cell discerns retroviral 
integration as an event of DNA damage indicated by the histone variant γ-H2AX 
(Daniel et al., 2004). Many viruses exploit the cellular damage response machinery 
(Lilley et al., 2007) and HIV is no exception. ATM is required for efficient HIV infection 
(Lau et al., 2005) and blocking Atm activity with caffeine leads to inhibition of the HIV 
replication cycle (Nunnari et al., 2005). After integration of the viral dsDNA genome, 
chromatin in the 5´LTR region is ordered by arrangement of five nucleosomes (nuc-0 
to nuc-4). Thus, viral gene expression is regulated through limited access to the 
promoter region within the 5´LTR (Easley et al., 2010). Nuc-1 is located at the 
transcription start site and has to be remodeled for initiation of transcription. This is 
managed by an interaction of the viral Tat protein with the host SWI/SNF complex. 
This complex regulates the expression of several endogenous genes by altering their 
nucleosomal position along the DNA. In vitro, Trichostatin A (TSA) or sodium byturate 
(NaB) treatment leads to histone acetylation around nuc-1 (Coull et al., 2002). One of 
the core subunits of the SWI/SNF complex, BRM, is also involved in the regulation of 
alternative splicing (Batsche et al., 2006) which is discussed in the next chapter. 
2.3.4 HIV transcription and the host splicing machinery 
HIV dependens on the host cell splicing machinery. More than 40 different mRNAs 
are created via alternative splicing from the primary RNA transcript (Tazi et al., 2010). 
For this purpose HIV-1 uses multiple splice donor and splice acceptor sites on the 
polycistronic pre-mRNA generated by the cellular RNA polymerase II. The SR 
proteins are serine/arginine rich proteins that are involved in splicing processes. 
Within the nucleus, SR proteins often localize in nuclear speckles, which occupy 
discrete regions with little or no DNA. They are dynamic structures, which vary in 
size, shape, location and number (Spector and Lamond, 2010). Especially for 
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alternative splicing, SR proteins are essential by promoting the use of nearby splice 
sites (Graveley, 2000; Lin and Fu, 2007). 
 In in vitro HIV infected cells, the distribution of integrated proviral DNA with 
respect to SC35 splicing speckles has only been investigated once with the result of 
a random distribution (Bell et al., 2001). This study was performed in a human 
osteosarcoma cell line. In cells transfected with plasmids containing the HIV genome, 
random distribution (Berthold and Maldarelli, 1996; Zhang et al., 1996; Boe et al., 
1998) but also co-localization of SC35 with HIV DNA was observed (Favaro et al., 
1998). 
2.3.5 HIV persistence and latency 
The highly active antiretroviral therapy (HAART) markedly reduces morbidity of 
patiens infected with HIV (Palella et al., 1998). Although viremia is decreased to 
undetectable levels by inhibitors of viral protease, fusion and integration, HIV can 
persist in cells in a latent state. Latently infected cells harbor per definition replication 
competent integrated HIV genomes, which are transcriptionally silent but 
reactivatable (Pace et al., 2011). Pre- and post-integration latency is distinguished. In 
pre-integration latency, resting CD4+ T cells are infected and therefore provide some 
reservoir for HIV. Reactivation of viral transcription in these cells can be induced by 
antigenic stimulation, cytokines, mitogens or phorbol esters (Bisgrove et al., 2005). In 
post-integration latency on the other hand, active CD4+ cells are infected and 
subsequently turned into a resting memory state (Dahl et al., 2010). 
 Several mechanisms and characteristics to induce and maintain viral latency 
are known. It was shown that integration into heterochromatic structures, where 
accessibility of transcription factos is hindered, promotes latency (Jordan et al., 
2003). Binding of the transcription machinery is also known to be prevented by high 
levels of CpG methylation of viral promoter sequences (Blazkova et al., 2009). 
Furthermore, the precise position of the integration site might also be crucial. The 
immediate vicinity of the LTR promoter region to nearby host promoters can result in 
transcriptional interference for example by collision of RNA polymerase complexes 
(Coiras et al., 2009). This can for example explain a latent provirus in transcriptionally 
active genes. Transcriptional repression of the HIV provirus has been shown to be 
linked up with distinct epigenetic modifications such as hypoacetylation whereas 
treatment with deacetylase inhibitors accordingly increases HIV transcription (He and 
Margolis, 2002). 
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 In (Dieudonne et al., 2009) a scenario of HIV latency with subsequent 
transcriptional activation of the provirus by phorbol ester (TPA) treatment is 
described. The investigated Jurkat cell line J-lat A1 was transduced with an HIV-1 
vector which contains a reporter gene under the control of the viral 5´LTR. Upon 
transcriptional activation the original association of the latent provirus with 
pericentromeric heterochromatin was lost. The nuclear localization of the provirus 
remained at the periphery. 
 Efficient viral transcription is regulated by the viral protein Tat (Kao et al., 
1987). Therefore, the nuclear presence of Nf-kB and especially Tat, whose activity is 
mainly regulated by the acetylation of distinct lysine residues, plays an important role 
in the latent provirus state (Coiras et al., 2009). Inefficient transportation of viral 
mRNA to the cytoplasm decreases translation of viral proteins, by which 
transcriptional efficiency is diminished through negative feedback. RNA interference 
has also been brought in association with HIV latency. Both microRNAs encoded by 
HIV genome sequences and host microRNAs can modulate viral gene expression 
(Corbeau, 2008; Kumar and Jeang, 2008). Applying that mechanism the virus can 
induce its own latency. 
 
2.4 Gene therapy vectors 
The use of retrovirally derived gene vectors to deliver genetic material to target cells 
in terms of gene therapy offers a possibility to profit from retroviruses. The first 
clinical study using gene transfer is dated to the year 1989 (Rosenberg et al., 1990) 
where a modified retroviral gene vector was used. Naked DNA and gene vectors 
based on adenoviruses or retroviruses present the three main groups for delivery of 
genetic material used in gene therapy (Figure 3). 
Retroviral gene vectors provide the advantage of a stable integration into the 
host genome and hence an enduring therapeutical effect (Kay et al., 2001; 
Mancheno-Corvo and Martin-Duque, 2006; Edelstein et al., 2007). Although the 
payload is limited to ca 10 kb, most cDNAs can be accommodated. Lentiviruses 
became attractive for vector design because of their ability to infect non-dividing cells, 
an exclusive feature among the retrovirus family. The common method to convert a 
putative pathogenic retrovirus into a useful gene transfer vector is to delete the viral 
genes and replace them by the designated expression unit. Therefore, retroviral gene 
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transfer vectors lack most retroviral protein coding sequences while retaining the viral 
packaging signal and the 5´ and 3´ terminal repeat sequences (LTRs), which are 
required for DNA integration (Thiel, 2007; Nolan, 2009). 
 A major concern using retrovirally derived gene vectors is the unpredictable 
integration site selection. This can lead to severe consequences associated with 
insertional mutagenesis by disruption of tumor suppressor genes or activation of 
nearby proto-oncogenes (Ott et al., 2006; Hacein-Bey-Abina et al., 2008; Howe et al., 
2008; Stein et al., 2010). For retroviruses, preferences in the selection of integration 
sites are known (Bushman et al., 2005), but which factors finally determine the 
definite genomic position remains to be fully elucidated. Retrovirus-derived vectors 
have preferences similar to their parental retroviruses (Mitchell et al., 2004; Baum et 
al., 2006; Daniel and Smith, 2008). The Gammaretrovirus Murine leukaemia virus 
(MLV) is the most commonly used retrovirus for generating gene transfer vectors 
(Cotrim and Baum, 2008). MLV based vectors favor the vicinity of transcription start 
sites for integration site selection. This may alter the structure of the respective host 
gene, potentially resulting in activation or disruption (Wu et al., 2003). 
The mouse hematopoietic precursor cell line cloneB, which was investigated in 
this thesis, was transduced with the MLV based vector pSF91-GFP (Modlich et al., 
2006). Transduction as a technique in molecular biology is the process of inserting 
DNA into a target cell by a virus or a viral vector (Alberts, 2011). The cloneB cell line 
was established by transduction of primary murine bone marrow cells followed by 
limiting dilution assay (Figure 4). Although gene therapy is not fully matured yet and 
unfortunately, leukemia outbreaks derived from gene transfer vector integration were 
observed, numerous clinical trials were thoroughly successful and looked promising 
(Cotrim and Baum, 2008). Nevertheless, further development and improvements still 
have to be made. 
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Figure 3: Gene therapy statistics 
A – number of gene therapy clinical trials approved worldwide (1989-2010); B – vectors used in gene 
therapy clinical trials; data from http://www.wiley.com//legacy/wileychi/genmed/clinical/ (state 04/11). 
 
 
 
 
 
Figure 4: Establishment of the cloneB cell line 
Image taken from (Modlich et al., 2006); primary bone marrow cells from mice (C57BL/6J) were 
isolated, purified using Lin- specific antibodies (Gr1, CD11b, CD45R/B220, CD3e, TER119) and 
cultivated for two days. Transduction with the pSF91-eGFP vector was performed on day four and 
repeated on day five. After two weeks of cultivation the cells were diluted and cultivated for additional 
two weeks. Randomly picked clone were characterized with genotypic and phenotypic parameters by 
which a clone with stable growth and normal cytology was chosen (cloneB). For further information 
see (Schambach et al., 2000; Modlich et al., 2006). 
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2.5 Experimental strategy 
The spatial distribution of retroviral integration sites was investigated for two 
examples: HIV integration sites in astrocytes (TH4-7-5), HeLa cells (LC5-HIV) and T-
lymphocytes (KE37/1-IIIB) (see  3.1.1,  3.1.2 and  3.1.3) and gamma-retroviral gene 
transfer vector integration sites in the mouse hematopoietic precursor cell line cloneB 
(see  3.1.4). HIV Integration sites were mapped using the LM-PCR technique (see 
 4.1.1). The gene transfer vector integration sites in the mouse cell line were mapped 
after the cell line was established in the lab of Christopher Baum (Hannover Medical 
School, Germany) (Modlich et al., 2006). Besides the five integration sites mentioned 
in the original publication, four additional ones were identified in the lab of Manuel 
Grez (Georg Speyer Haus, Frankfurt, Germany), who kindly provided the cell line (for 
overview of integration sites see  6.2.2).  
To determine possible changes in chromatin structure or repositioning upon 
retroviral integration, the integration site regions were compared to the respective 
regions on the homologous chromosome within the same nuclei. Therefore, the 
karyotype of both HIV infected cells and the mouse cell line was analysed, 
respectively the integration site harboring chromosomes were investigated on 
homology (see  4.1.4 and  4.7.1). BAC (bacterial artificial chromosomes) clones 
covering the integration site were used as probes for fluorescence in situ 
hybridization (FISH). Integration sites and respective loci on the homologous 
chromosomes were distinguished by co-localization of BAC and HIV or, respectively, 
gene vector FISH signals. To compare properties of signals originated from FISH 
probes of equal sizes, the BAC signals were used for the actual location and 
chromatin analysis. The HIV and gene vector signal was only used to discriminate 
the homologous BAC signals. 
 Nuclei for confocal microscopic recordings were selected as follows: the 
nucleus should show the average shape and morphology of the respective cell type 
population. Additionally, the HIV or gene vector signal should be visible and co-
localizing with the BAC signal used for the respective experiment. Due to the critical 
size of the HIV and gene vector target sequence (<10 kb), the distinct signal 
visualization was challanging (discussed in  5.1). Image analysis revealed the position 
of the integration sites and the homologous regions in a 3D nuclear context (see  4.3 
and  4.8.2). Changes in chromatin condensation upon retroviral integration were 
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determined by measuring and comparing the surface areas of the BAC signals (see 
 4.4 and  4.8.3). While BAC probe testing, karyotyping and chromatin compaction 
analysis of the integration site regions in the mouse hematopoietic precursor cell line 
were part of this thesis, 3D FISH experiments and evaluation were performed by 
Birgit Groß as a Diploma thesis (Groß, 2009). HIV integration sites were additionally 
investigated after sodium butyrate (NaBut) treatment, which increased the proviral 
transcription (see  4.5). Furthermore, the spatial distribution of HIV integration sites 
and HIV RNA with regard to SC35 splicing speckles was determined (see  4.6). 
MATERIALS AND METHODS 
3. MATERIALS AND METHODS 
3.1 Cell material 
All HIV infected cells were kindly provided by Ruth Brack-Werner (Helmholtz Zentrum 
München). The HIV infected astrocytes, HeLa cells and T-lymphocytes were 
characterized in advance with regard to the number of integrations per nucleus via 
LightCycler qPCR (Manja Meggendorfer, Helmholtz Zentrum München, personal 
communication). The results predicted one provirus copy per astrocyte, six copies 
per T-lymphocyte and 0.6 copies per HeLa cell nucleus. For simplicity in the further 
course of this thesis, HIV infected cells are referred to as astrocytes, HeLa cells and 
T-lymphocytes or with the respective abbreviation (Astro, HeLa, TLy). 
3.1.1 Astrocytes (TH4-7-5) 
TH4-7-5 cells derive from the human astrocytoma cell line 85HG-66, grow adherently 
and show fibroblast like morphology. HIV-1 infection of 85HG-66 cells was ensured 
by co-cultivation with chronically HIVIIIB-infected KE37/1-IIIB cells for 5 days (Brack-
Werner et al., 1992). The successful infection was monitored by indirect 
immunoperoxidase staining (IPS) using human anti-HIV-1 serum. Cells were cultured 
in RPMI medium supplemented with 10% FCS, 100 U/ml penicillin and 100 µg/ml 
streptomycin. 
3.1.2 HeLa cells (LC5-HIV) 
LC5-HIV cells were established by HIV-1 infection of the cell line L-132 (Mellert et al., 
1990), which originally was thought to be derived from embryonic lung tissue but 
subsequently was identified as a HeLa-derived cell line (ATCC number: CCL-5). HIV-
1 infection was accomplished by the same co-cultivation technique just like above. 
LC5-HIV cells grow adherently and were cultured in RPMI medium supplemented 
with 10% FCS, 100 U/ml penicillin and 100 µg/ml streptomycin. 
3.1.3 T-lymphocytes (KE37/1-IIIB) 
KE37/1-IIIB cells derive from chronically HIV-1 (HTLV-IIIB) infected human T-
lymphoma cell line KE37/1 (Popovic et al., 1984). KIII cells grow in suspension and 
were cultured in RPMI medium supplemented with 10% FCS, 100 U/ml penicillin and 
100 µg/ml streptomycin. 
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3.1.4 Mouse hematopoietic precursor cell line (CloneB) 
The mouse haematopoietic precursor cell cloneB was generated by transduction with 
the LTR-driven gamma-retroviral gene vector pSF91-GFP. The cell line was 
established in the lab of Christopher Baum (Hannover Medical School, Germany) 
(Modlich et al., 2006) and kindly provided from Manuel Grez (Georg-Speyer-Haus, 
Frankfurt, Germany). The cells grow in suspension and were cultivated in Iscove’s 
modified Dulbecco medium (IMDM) including 10 ng/ml m-IL 3 (Murine Interleukin-3), 
50 ng/ml m-SCF (Murine Stem Cell Factor), 4 mM L-Glutamin, 10 % FCS and 100 
U/ml penicillin and 100 µg/ml streptomycin. It has to be taken into account that the 
cells tend to differentiate and change their morphology upon longer cultivation (Groß, 
2009). Therefore, it is seriously recommended to apply experiments on cells being in 
early passages as it was done here. 
 
3.2 Cell culture 
3.2.1 Safety issues 
Living HIV infected cells have to be cultivated in S3 laboratories (reasonable danger 
for human or environment;(GenTG, 2010)). Only after fixation the cells can be kept in 
S1 laboratories (no danger for human or environment; (GenTG, 2010)). Hence, the 
cells had to be cultivated, seeded and fixed under S3 standards in the lab of Ruth 
Brack-Werner (Institut für Virologie, Helmholtz Zentrum München, Neuherberg, 
Germany) and then transferred on ice to the Biozentrum in Martinsried in 1xPBS for 
further treatment. 
3.2.2 Cell cultivation 
The cell cultivation of the HIV infected cells was kindly accomplished by Manja 
Meggendorfer, Stephan Kremb and Ingrid Hülsmeyer (AG Ruth Brack-Werner) until 
seeding and fixation steps. 
3.2.3 Sodium butyrate (NaBut) treatment 
NaBut treatment was performed by 24h incubation at a final concentration of 0.5 mM 
immediately prior to fixation. In case of adherently growing cells NaBut incubation 
was combined with cell attachment to coverslips in quadriperm plates. In suspension 
growing cells were incubated with NaBut in culture flasks. 
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Alterations upon NaBut treatment were determined for virus particles in the 
cell supernatant and HIV transcriptional activity, each compared to untreated cells. 
Virus production was measured with a p24-ELISA test (HIV-1 p24-Antigen Capture 
ELISA). P24 is a HIV core protein and therefore correlating with the virus particle 
count. 105 cells were placed in a 12-well plate, 24h later NaBut was added (final 
concentration 0.5mM), another 24h later the supernatant was taken and Triton was 
added at a final concentration of 0.5% (further proceedings see protocol). 
HIV transcriptional activity was determined via qPCR using the LightCycler 
480 (Roche) and the Light Cycler 480 SYBR Green I Master PCR kit. HIV RNA levels 
were compared to RNA polymerase II RNA, a house keeping gene showing constant 
transcriptional activity. Cellular RNA was extracted with the RNeasy RNA Mini Kit, 1 
µg RNA was transcribed into cDNA applying the Superscript First Strand Synthesis 
System for RT-PCR and 2 µl were used for the PCR (Primer sequences see  6.5). 
Both p24-ELISA and LightCycler qPCR were kindly performed by Manja 
Meggendorfer (Helmholtz Zentrum München). 
3.2.4 Seeding cells on coverslips 
 In suspension growing cells (T-lymphocytes, cloneB): 
The suspension should show an adequate cell density having ~80% 
confluency when seeded on coverslips subsequently (if necessary the 
suspension was centrifuged and solved in less medium, increasing the cell 
concentration). Poly-L-Lysin coated coverslips (26x76mm) were laid into 
quadriperm plates and covered with 4 ml cell suspension. After 1 h at 37°C in 
the incubator, the coverslips were rinsed in 0.3x PBS for 45 sec. directly 
followed by fixation in 4% PFA/0.3x PBS (see  3.2.5). 
 Adherently growing cells (HeLa cells, Astrocytes,): 
Cells were trypsinized and seeded on sterile coverslips (26x76mm) in a 
quadriperm plate. The cells grew over night until they showed ~80% 
confluency and then were fixed in 4% PFA/1x PBS (see  3.2.5).  
3.2.5 Cell fixation 
Adherently growing cells for DNA FISH: 
Cells on coverslips were fixed by incubating the slide in 4% PFA/1xPBS (made 
immediately before use) for 10 min. at RT followed by washing 3x 5 min. in PBST 
and stored in 1x PBS at 4°C until subsequent treatment for 3D FISH (see  3.10.1). 
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In suspension growing cells for DNA FISH: 
Cells on coverslips were fixed in 4% PFA/0.3x PBS (freshly made immediately before 
use) for 10 min. at RT. The slides were washed 3x 5 min. in PBST and stored in 1x 
PBS at 4°C until subsequent treatment for 3D FISH (see  3.10.1). 
For RNA FISH: 
Distilled water in all buffers and solutions used in RNA FISH treatment was DEPC 
(Diethylpyrocarbonate) treated inactivating RNase. 
Cells on coverslips were rinsed in 1x PBS, permeabilized 5 min. in 0.5% Triton in 
CSK buffer (incl. 10mM VRC) on ice, 45 sec. incubated in 0.3x PBS (only for in 
suspension growing cells), fixed in 4% PFA/10% acetic acid/1x PBS (or 4% PFA/10% 
acetic acid /0.3x PBS for in suspension growing cells, respectively) for 10 min., 
rinsed in 1x PBS and stored in 70% EtOH at 4°C until subsequent treatment for RNA 
FISH (see  3.10.6). In contrast to DNA FISH, where fixed cells can be stored in 
formamide for several months, it is recommended, for best results, to continue with 
the RNA FISH protocol within the next days. 
 
3.3 Metaphase spreads 
3.3.1 Fixation of in suspension growing cells for metaphase spreads: 
 Per 1 ml cell suspension 10 µl colcemide (10µg/ml) were added (to increase 
the amount of metaphases, the cells should be in a well growing state). 
 After 60 min incubation at 37°C (5%CO2) the suspension was centrifuged for 
10 min at 1000 rpm in a 50 ml falcon tube. 
 The supernatant was removed except for 3 ml in which the pellet was 
resuspended. 
 Carefully and slowly the falcon tube was filled up with pre-warmed (37°C) 
0.56% KCl solution and incubated for 16 min. in a 37°C water bath. 
 10 min. centrifugation at 1000 rpm (immediately before centrifugation a few 
drops fixative were added). 
 The supernatant was removed except for 3 ml in which the pellet was carefully 
resuspended. 
 Carefully and slowly the falcon tube was filled up with fixative solution 
(methanol : acetic acid 3:1; -20°C) and stored at -20°C for at least 1h. 
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 After 10 min centrifugation (1000 rpm) the supernatant was removed except 
for 5 ml to resuspend the pellet. 
3.3.2 Fixation of adherently growing cells for metaphase spreads: 
 Cells grew in a T75 flask until 70-80% confluency. Per 1 ml medium 10 µl 
colcemide (10µg/ml) were added. 
 After 60 min incubation at 37°C (5%CO2) less adherent cells (particularly cells 
in mitosis) were removed by thorough beats with the hand against the flask. 
 The cell suspension including the detached mitotic cells was transferred to a 
50 ml falcon tube and centrifuged 10 min. at 1000 rpm (immediately before 
centrifugation a few drops fixative were added). 
 The supernatant was removed except for 3 ml in which the pellet was carefully 
resuspended. 
 Carefully and slowly the falcon tube was filled up with fixative solution (-20°C) 
and stored at -20°C for at least 1h. 
 After 10 min centrifugation (1000 rpm) the supernatant was removed except 
for 5 ml to resuspend the pellet. 
3.3.3 Metaphases dropping 
 Microscopic slides were placed into a metal box floating in a  55°C water bath 
 The cell suspension was dropped with a Pasteur pipette on the slides (two 
drops per slide); the water bath cover was closed immediately creating a 
special humid climate which allows the metaphases to spread (takes about 40 
sec.) 
 The metaphase spreading could now be observed and judged under the 
phase contrast microscope. 
 Troubleshooting:  
o Cell density to less: cell suspension was centrifuged (10 min, 1000 
rpm), pellet was resuspended in less fixative increasing the 
concentration. 
o Too much dirt on the slide: cell suspension was centrifuged (10 min. 
1000 rpm), pellet was resuspended in fresh fixative and repeated if 
necessary (mark that a certain amount of dirt is also removed by 
subsequent pepsin treatment). 
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3.3.4 Pepsin treatment and aging 
 50 µl pepsin (10%) were mixed in 100 ml 0.01 N HCL (37°C) 
 Metaphase slides were incubated in pepsin solution for 10 min. at 37°C 
 3x 5 min. 1x PBST washing step 
 After an ascending ethanol series (70% and 90% at RT; 100% at -20°C; each 
for 5 min.) the metaphase slides were air dried. 
 1h incubation at 60°C 
 Metaphase slides were stored with desiccant in a plastic box at -20°C. 
 
3.4 Linker-mediated PCR (LM-PCR) 
3.4.1 General considerations 
Linker-mediated PCR (LM-PCR, also ligation-mediated PCR), first described in 
(Pfeifer et al., 1989), is a commonly used technique for the retrieval of a known 
sequence in an unknown genomic environment e.g. integration sites of viruses in the 
host genome (Schmidt et al., 2001; Kustikova et al., 2008). A requirement is that the 
integrated DNA sequence is known or at least its the flanking regions. Also a linker 
has to be designed. There are tons of different protocols generally based on the 
same principle with more or less variations indicated in the scheme below. 
 
Figure 5: General principle of LM-PCR 
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Step 1: Digest 
The genomic DNA isolated from a virus infected cell line is digested with a restriction 
enzyme which should fulfill several conditions: on the one hand it should cut with high 
frequency, on the other hand it should not have a recognition site in the 5´LTR since 
this is where the primer for the subsequent PCRs bind (recognition sites are 
indicated by perpendicular arrows in Figure 5). 
Step 2: One cycle PCR 
The first primer (in executed protocol ( 3.4.2) termed “Bio-LMPCR-1”) has a biotin tag 
and binds in the proviral 5´LTR with orientation outwards the provirus towards the 
genomic DNA. After one cycle of a PCR with the biotinylated primer the emerging 
DNA fragments are marked with biotin and range ideally from the primer to the 
closest restriction site. In case that the restriction enzyme also cuts within the 
provirus (right branch in Figure 5), a second DNA fragment is marked with biotin as 
5´LTR and 3´LTR have identical sequences (this fact could be used as some kind of 
positive control). 
Strep 3: paramagnetic enrichment and linker ligation 
After a paramagnetic enrichment via dynabeads a linker is ligated to the biotynilated 
DNA fragments.  
Step 4: nested PCR and sequencing 
With primers for the linker and the 5´LTR sequences, a nested PCR is accomplished. 
After a gel run of the PCR products, bands are cut out and directly sequenced. The 
sequencing result is blasted and shows ideally the host genomic region adjacent to 
the proviral 5´LTR. 
3.4.2 Executed LM-PCR protocol 
Materials: 
- 3 sequence specific primer (stock solution: 10 pmol/µl) thereof one outer 
biotinylated primer (-> primer extension) and two linker specific primers (stock 
solution: 10 pmol/µl) 
- Linker 
- Dynabeads kilobaseBINDER Kit 
- Quiageb PCR purification Kit 
- Magnetic extractor (MPC) 
- Rapid DNA Ligation Kit 
- Quiaquick Gel Extraction Kit 
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Sequences: 
Linker +: 5’-GACCCGGGAGATCTGAATTCAGTGGCACAGCAGTTAGGT -3` 
Linker -: 5’-Pho-CCTAACTGCTGTGCCACTGAATTCAGATCTCCCG - 3’ 
Linker specific primer for nested PCRs: 
LSP1 (outer): 5’ - GACCCGGGAGATCTGAATTC - 3’  
LSP2 (inner): 5’ - AGTGGCACAGCAGTTAGG - 3’ 
Provirus specific (HIV) primers: 
Bio-LMPCR-1: 5´- TAACTTCTCTGGCTCAACTGGTAC - 3´ 
LMPCR-2 (outer): 5´ - TGGCCCTGGTGTGTAGTTCTG - 3´ 
LMPCR-3 (inner): 5´- AGGATATCTTGTCTTCGTTGGGAG - 3´ 
Method: 
Linker-Annealing: 
In a tube each 25 µl 100 µM Linker+ and 100 µM Linker-, incubation for 5 min. at 
95°C, transfered to 70 °C Hotblock, switched of and let cool down to RT, 1 h at RT, 
transfered to 4°C fridge in a small Styrofoam box and incubated for 12h. Aliquots 
were stored at -20°C. Before use aliquots were slowly thawed on ice. 
Digest of genomic DNA: 
1µg DNA in 50 µl volume was digested with 5 U enzyme over night. 
Following restriction enzymes were used all provided from NEB company: 
AvrI, BamHI, BglI, DraI, EcoRI, HindIII, MseI, NheI, NlaIII, NotI, SacI, SacII, SmaI, 
SpeI, SphI, NotI, PstI, PvuII 
Digest reactions were carried out as recommended in the NEB protocol. As control 
extracted DNA which already gave a positive result in a prior LM-PCR experiment 
was digested with enzyme MseI* and treated together with the other probes as 
described below (kindly provided from Manja Meggendorfer). 
EtOH precipitation 
Per tube: 100µl EtOH 
 15µl 3M NaAC 
 1µl glycogen (=20µg) 
1h at -80°C, 30 min. centrifugation at 4°C, washed with 150 µl 70% EtOH by 
additional 15 min. centrifugation at 4°C. Pellet was air dried under the hood and 
dissolved in 37 µl ddH2O. 
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Primer-Extension: 
35.5 µl digested DNA 
0.5 µl Taq polymerase (=2.5 U) 
5 µl polymerase buffer (10x) 
5 µl MgCl2 (25mM) 
2.5 µl Bio-LMPCR-1 (0.1 pmol/µl) 
1 µl dNTPs (je 10 mM) 
PCR program: 
95°C 5 min 
58°C 30 min 
72°C 15 min 
PCR products were purified with the Qiaquick PCR purification Kit and eluted in 42 µl 
ddH2O. 
Dynabead protocol: 
20 µl Dynabeads were immobilized (see protocol). In the last step (6.) dynabeads 
were dissolved in 40 µl binding solution. 30 µl purified extension mix were added, 3 h 
incubation on shaker (750 U/min) at RT, washing steps see protocol (9.-11). 
Dissolving in 14 µl ddH2O 
Ligation: 
0.5 µl T4 Ligase (NEB) = 200U 
2 µl 10x Puffer (NEB) 
14 µl DNA (Dynabeads) 
1 µl Linker 
3 µl H2O 
 Incubation in the PCR tube at 16°C on shaker over night (alternatively, the Rapid 
DNA Ligation Kit from Roche could be used which only takes 3h of incubation). 
Washing step at MPC with 100µl dd H2O, dissolving in 10 µl ddH2O 
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PCR experiments: 
PCR1: 
Reagent Stock conc. Final conc. Vol per 50 µl 
PCR buffer 10x 1x 5 µl 
MgCl2 25 mM 2,5 mM 5 µl 
dNTP mix 10 mM 200 µM 1 µl 
LSP1 (outer) 10 µM 500 nM 2.5 µl 
LMPCR-2 (outer) 10 µM 500 nM 2.5 µl 
Template DNA (ligation) - - 2 µl 
Taq Pol 5 U/µl 0.1 U/µl 1 µl 
ddH2O - - 31 µl 
 
Number of cycles Reaction Temperature Time 
1 Initial denaturation 95°C 5 min. 
30 Denaturation 95°C 1 min. 
 Annealing 58°C 45 sec. 
 Extension 72°C 1.5 min 
1 Final extension 72°C 10 min 
PCR2: 
See PCR1, though 1 µl PCR product from PCR1, 2.5 µl 10 pmol/µl LSP2 (inner), 
2.5 µl 10 pmol/µl LMPCR-3 (inner), 33 cycles 
Separation via gel 
5 µl of each PCR result was analyzed on a 1.5% gel (see  3.5.1). The remaining 45 µl 
of the lanes with promising bands were subsequently run on a preparative gel (see 
 3.5.2). Bands were extracted with the Qiaquick Gel Extraction Kit and directly 
sequenced. 
Following integration sites were mapped with this protocol: 
Astro 18q22.1, HeLa 6p12.3, HeLa 15q21.3, HeLa 11q22.3, HeLa 18q22.3, HeLa 
Xq22.1, TLy 2q11.2 
3.4.3 Universal genome walker kit 
Another possibility for integration site mapping is using the universal genome walker 
kit (Clontech) in combination with the Advantage 2 PCR Kit (Clontech). It is also 
some kind of LM-PCR but without a biotynilated primer and accordingly no 
purification with dynabeads. The kit provides several positive such as negative 
controls and is very easy to handle. 
Following restriction enzymes were used: 
- provided in the kit: DraI, EcoRV, PvuII, StuI 
- additionally used enzymes (NEB company): BSaAI, FspI, HincII, NaeI, PshAI 
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Digest reactions were carried out as recommended in the protocol from the Kit or 
NEB company. 
The following integration sites were mapped with this Kit (some were already 
mapped with the protocol from the previous chapter and confirmed with this protocol): 
Astro 18q22.1, HeLa 16p13.3, TLy 2q11.2, TLy 2q14.2. 
 
3.5 Gel electrophoresis 
3.5.1 Analytic gel 
PCR results were visualized using 1.5% agarose gels. Therefore 1.5 g agarose were 
solved in 100 ml 1x TAE buffer by heating the solution in a microwave. After brief 
cooling the transparent solution was poured in the appropriate device forming the 
analytic gel by cooling down to room temperature. 
The gel run at 150 mA and 80 V until the lowest marker band had reached two-thirds 
of the whole distance. The gel was stained for 10 min. in EtBr solution, briefly rinsed 
in distilled water and recorded under UV light. 
3.5.2 Preparative gel 
Depending on the length of the bands to be extracted between 0.8% (to separate 
larger fragments) and 2% (to separate shorter fragments) gels were used. Due to 
larger volumes of approximately 50 µl of the probes a larger comb was used to 
ensure that the whole volume could be put in one gel pocket. The running and 
staining conditions were the same as in  3.5.1. The bands of interest were cut out 
under UV light. 
 
3.6 Sequencing of LM-PCR products and BAC clone selection 
The extracted bands from the preparative gels were purified with the Quiaquick gel 
extraction kit. The purified DNA was sent for sequencing either to Sequiserve 
(Vaterstetten, Germany) or to GATC (Konstanz, Germany). To obtain the genomic 
position of the integration sites, sequencing results were blasted on the NCBI web 
page. In case of positive blast hits appropriate BAC (bacterial artificial chromosome) 
clones were chosen, that cover the genomic region of the integration site. BAC 
clones were selected using the “cytoview” display of the genome browser on the 
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ensemble web page and ordered from BAC PAC Resources 
(http://bacpac.chori.org/). 
 
3.7 BAC clone preparation 
Delivered as E.coli LB stocks, BAC clones were isolated via the method of alkaline 
lysis (Birnboim, 1983) using the Plasmid Miniprep Kit from Peqlab. The isolated DNA 
was eluted in 100 µl ddH2O. Prior to labeling the BAC DNA was amplified using the 
illustra GenomiPhi V2 DNA amplification kit (Dean et al., 2001). This rolling cycle 
amplification method allows resulting DNA amounts of 5-7 µg from a minimum input 
of 10 ng DNA. The average amplification length of the fragments is about 10 kb. The 
use of exonuclease-resistant random hexamer primers in combination with the Phi29 
DNA polymerase with its high accuracy and processivity and its excellent strand 
displacement activity are the characteristics of this effective procedure. 
 Correct chromosomal positions of the BACs were verified in 2D FISH 
experiments on human lymphocytes or mouse erythroleukemia (MEL) cell 
metaphase spreads with the respective chromosomal paint probe. If any BAC did not 
hybridize to the expected position, the BAC was rejected and a new one was 
ordered. This was twice the case. 
 
3.8 pNL4-3 Plasmid isolation 
Detecting the nuclear HIV DNA was implemented by using the pUC-based pNL4-3 
plasmid (Adachi et al., 1986) as FISH probe. The pNL4-3 plasmid with 14833 bp in 
size contains the whole 9.7 kb HIV-1 proviral genome (plasmid map see  6.6). The 
plasmid was isolated from E.coli with the NecleoBond Kit from Macherey-Nagel. As 
probe the complete plasmid DNA was used. 
 
3.9 RNase digest 
For RNAse digest fixed cells on coverslips stored in 1x PBS were incubated in 
RNase A solution (200 µg/ml in 1xPBS) for 2h at 37°C. As control an additional 
coverslip with alike cells was incubated under same conditions in 1x PBS. The slides 
were washed 2x 5 min. in 1 x PBS and stored in it until further treatment. 
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3.10  Fluorescent in situ hybridisation (FISH) 
FISH is a commonly used technique for visualizing nuclear RNA or DNA. Depending 
on the type of probe it is possible to visualize either chromosomal subregions (e.g. 
BAC / centromeric / telomeric probes) or whole chromosomes (chromosomal paint 
probes). A distinction can be drawn between 2D FISH on metaphase spreads, 3D 
FISH on structurally preserved nuclei and RNA FISH (for further details concerning 
the FISH technique see (Cremer et al., 2008)) 
3.10.1 Cell treatment in preparation for 3D FISH 
Fixed cells on coverslips have to undergo a special treatment, amongst others 
allowing access of the FISH probe to the nuclear target DNA and preservation of the 
3D nuclear morphology (protocol adapted and modified from (Solovei et al., 2002)): 
 20 min. incubation in 0.5% Triton X-100/PBS 
 1h incubation in 20% glycerol/1x PBS (o/n incubation also possible) 
 Frozen in liquid nitrogen, thawed at RT and put back into 20% glycerol (five 
times) 
 7 min. incubation in 0.1 N HCl 
 3x 5 min. 1x PBST washing step 
 2x 3 min. 2x SSC washing step 
 Storage in 50% formamide/2x SSC at 4°C until use (at least 48h). 
3.10.2 Probe providing and labeling 
FISH probe Provided by 
pNL4-3 plasmid (HIV) AG Brack-Werner 
pSF91-GFP (gene transfer vector);  AG Grez 
BACs BAC PAC Resources 
Chromosome paints AG Cremer 
β-actin (Fitc labeled) Christian Lanctot 
 
Probes were either labeled via DOP-PCR or nick translation (protocols adapted and 
modified from (Müller et al., 2007)). 
a) Label DOP PCR 
One possibility for amplifying an unknown DNA sequence is the Degenerate 
Oligonucleotide Primed PCR (Telenius et al., 1992). In this work DOP-PCR was used 
for labeling chromosome paint probes that were prior amplified via primary/secondary 
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DOP PCR. For a master mix, the following reagents were mixed together and stored 
at -20°C: 
 
Reagent Amount Final concentration 
Cetus-II-buffer (10x) 100 µl 1x 
MgCl2 (25mM) 80 µl 2 mM 
6 MW primer (100 µM) 20 µl 2 µM 
ACG mix (2 mM each) 50 µl 100 µM 
dTTP (1 mM) 80 µl 80 µM 
Bio-/dig-/dnp-dUTP or 
TexasRed-dUTP 
20 µl or 
40 µl 
20 µM or 
40 µM 
ddH20 To 970 µl - 
 
For the labeling reaction, the following reagents are mixed together on ice in a 0.5 ml 
PCR tube: 
Material Amount 
Master Mix 48 µl 
DNA 2 µl 
Taq polymerase (5 U/µl) 0.5 µl 
 
PCR program: 
Number of 
cycles 
Reaction Temperature Time 
1 Initial 
denaturation 
94°C 3 min. 
30 Denaturation 94°C 1 min. 
 Annealing 56°C 1 min. 
 Extension 72°C 1.5 min. 
1 Final 
extension 
72°C 8 min. 
 
The size of the DNA fragments was checked with 2µl of the PCR reaction on a 1% 
agarose gel. In case of the smear not being between ~200 bp and 1.5 kb, an 
additional DNase digest as follows for 20 min. was performed. 
 
Material Amount 
DNA (Label DOP-PCR) 50 µl 
10x NT buffer 10 µl 
ddH2O 30 µl 
DNase (1:1000 in H2O) 10 µl 
 
The reaction was stopped by freezing down the tube to -20°C and stored at this 
temperature until use. 
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b) Nick translation 
Incorporation of labeled nucleotides in BAC probes and the pNL4-3 probe was 
accomplished by the use of nick translation. DNase (2000 U/ml) was diluted 1:250 in 
ice cold ddH2O and kept on ice until use. 
 
Reagent Amount Final concentration 
DNA ~ 1µg ~ 0,02 µg/µl 
NT buffer (10x) 5 µl 1x 
β-Mercaptoethanol 
(100 mM) 5 µl 10mM 
dNTP mix 
 
5 µl 
 
50 µM dATP/dCTP/dGTP each; 
10 µM dTTP 
Modified dUTP 
(1 mM) 
2.5 µl of Bio/dig/dnp-dUTP or 
5 µl of fluorochrom labeled dUTP 
50 µM of bio/dig/dnp-dUTP or 
100 µM of fluorochrom labeled dUTP
ddH2O to 48 µl  
DNase I (8 U/ml) 1 µl 0.16 U/ml 
DNA polymerase I (10 U/µl) 1 µl 0.2 U/µl 
 
The reaction mixture was incubated for 90 min. at 15°C in a water bath. A 
subsequent DNase digest was generally added since the length of the DNA 
fragments in previous nick translations had not shown the optimal range of 300-1000 
bp. For this purpose 1 µl of diluted (freshly made) DNase I was added and incubated 
for additional 30 min. at RT. 
 
Applied labeling: 
Probe Labeling 
pNL4-3 (HIV probe) Dig-dUTP 
Texas Red-dUTP 
BAC probes / CT probes Bio-dUTP 
Cy3-dUTP 
Dig-dUTP 
DNP-dUTP 
TAMRA-dUTP 
Texas Red-dUTP 
 
Generally, due to fluorescence signal quality, BAC and CT probe labeling did not 
cause major circumstances in contrast to the HIV probe (see discussion). Therefore 
HIV probe labeling was the decisive element. Having a working HIV probe the 
labeling scheme for the respective BAC and CT probes was chosen.  
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3.10.3 Hybridization mixture (HM) 
Depending on the type of probe and labeling, the table below shows the general 
composition of a 12 µl HM: 
Material Amount 
DNA (labeled) pNL4-3: 50 µl 
BAC (hapten labeled): 25 µl 
BAC (direct labeled): 50 µl 
CT* : 25 µl 
Cot1-DNA (1 µg/µL) per µl pNL4-3: 1 µl 
per µl BAC: 1 µl 
per µl CT: 0.5 µl 
Salmon sperm DNA (10 mg/mL) 2 µl 
Nick translation stop mix 1 µl 
 
* If a DNase digest was performed (see  3.10.2), 50 µl of labeled CT DNA were used 
(because of the minor DNA concentration) and accordingly 0.25 µl Cot1-DNA per µl 
CT-DNA. 
For further steps the HM is protected from light if direct labeled probes are used. 
 Components were mixed by vortexing 
 2.5 vol. of ethanol abs. were added 
 30 min. incubation at -80°C 
 30 min. centrifugation at 14000rpm (preferentially at 4°C) 
 Supernatant was discarded and the pellet was air dried in a vacuum centrifuge 
for 5-10 min. 
 6 µl of 100 % formamide were added 
 The pellet was dissolved on a heat shaker at 38°C for at least 1h 
 6 µl HM master mix were added and the HM was put back on the shaker for 
additional 10 min. 
 HM was stored at -20°C until use. 
3.10.4 2D FISH procedure 
2D FISH experiments were used on the one hand to check the correct chromosomal 
position of the BAC probes, on the other hand to confirm the mapped HIV integration 
sites. The latter was critical since the integrated HIV DNA is only about 9.7 kb in size. 
Therefore two different protocols were applied. In both cases the metaphase spreads 
stored at -20°C had to be thawed at RT. 
a) 2D FISH to verify BAC positions 
 HM was denatured 5 min. at 80°C in a water bath and briefly put on ice. 
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 2 µl of the HM were put on the metaphase spreads and covered with a 
coverslip (8x8 mm) whose edges were then sealed with fixogum. 
 Once fixogum was completely dried the slide was placed on a hot block at 
72°C for 100 sec. denaturing the genomic DNA. 
 Hybridization was ensured by incubation of the slide in a metal box floating in 
a 37°C water bath over night. 
 For stringent washing steps and antibody detection see  3.10.5. 
b) 2D FISH to confirm HIV integration sites 
 HM was denatured 7 min. at 72°C in a water bath and afterwards incubated at 
37°C for 1h allowing the ssDNA to pre anneal. 
 Meanwhile the metaphases were denatured in 70% formamide/2x SSC (pH 
7.0) at 72°C for 1.5 min. (70% formamide/2x SSC (pH 7.0) is stored at – 20°C 
and can be reused up to 4 times). 
 After an ascending ethanol series (70% and 90% at -20°C; 100% at RT; each 
for 3 min.) the metaphase slide was air dried. 
 5µl of HM were put on the metaphase spreads and covered with a coverslip 
(12x12 mm) whose edges were then sealed with fixogum. 
 Hybridization was ensured by incubation of the slide in a metal box floating in 
a 37°C water bath for 48h. 
 For stringent washing steps and antibody detection see  3.10.5. 
3.10.5 3D FISH procedure and antibody detection 
By dint of 3D FISH it was possible to visualize HIV integration sites and their 
chromosomal neighborhood in structurally preserved interphase nuclei. 
Fixed cells seeded on 76x26 mm coverslips were stored in 50% FA / 2xSSC, for 3D 
FISH an appropriate piece (app. 12x12 mm) was cut of using a diamond slicer. 
 
 HM was denatured 5 min. at 80°C in a water bath and briefly put on ice. 
 5µl of HM are put on a slide, the coverslip of app. 12x 12 mm in size (if larger 
the amount of HM had to be increased) carrying the cells was placed on it and 
the edges were sealed with fixogum. 
 Once fixogum was completely dried the slide was placed on a hot block at 
72°C for 100 sec. denaturing the genomic DNA. 
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 Hybridization was ensured by incubation of the slide in a metal box swimming 
in a 37°C water bath for 48h. 
 Having removed the fixogum with forceps the coverslip (3D FISH) / 
metaphase slide (2D FISH) was immediately put into washing buffer avoiding 
the cells to dry out.  
 Stringent washing steps: 
- 3x 3 min. 2x SSC (37°C) 
- 3x 5 min. 0.1 SSC (62°C) 
- 1 min. 4x SSC (37°C) 
 Blocking: 20min 4% BSA/4x SSC (37°C) 
 1. antibody: diluted in 4% BSA/4x SSC; incubation for 60 min. in humidified 
chamber at 37°C 
 Washing steps: 3x 5 min 4x SSC (37°C) 
 2. antibody: diluted in 4% BSA/4x SSC; incubation for 60 min. in humidified 
chamber at 37°C 
 Washing steps: 3x 5 min 4x SSC (37°C) 
 Counterstaining: DAPI (500 µg/ml) diluted 1:100 in 4x SSC (37°C) 
-> duration: 2 min. (2D FISH) or 10 min. (3D FISH) 
 2D FISH slide was subsequently rinsed with dH2O and air dried (lightproof). 
The hybridized area was mounted in vectashield, covered with a coverslip 
whose edges were sealed with nail polish. For 3D FISH the slide was briefly 
rinsed in 4x SSC, mounted in vectashield and placed on a microscope slide by 
sealing the edges with nail polish. 
3.10.6 RNA FISH 
RNA FISH was used to visualize actively transcribed HIV RNA. The major difference 
between RNA and DNA FISH is that in the latter case only the probe is denatured but 
not the nuclear DNA. Hence, only the single stranded RNA in the nucleus is 
hybridized by the probe. The protocol was adapted and modified after 
(http://www.singerlab.org/protocols). For this purpose cells were fixed in a special 
kind of way and stored in 70% EtOH (see  3.2.5). 
 First the cells were rehydrated by incubating in 50% FA/2x SSC for at least 30 
min. (not longer than 2h) 
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 The composition of the HM was the same as for DNA FISH (see  3.10.3) 
except for the addition of VRC (Vanadyl ribonucleoside complex) to a final 
concentration of 10 mM. 
 After denaturing (5 min. at 80°C in water bath) the HM was incubated 30 min. 
at 37°C in the water bath. 
 An adequate amount HM was put on a slide, the coverslip carrying the 
rehydrated cells was placed on it and the edges were sealed with fixogum. 
 Hybridization was ensured by incubatiing the slide in a metal box swimming in 
a 37°C water bath for 48h. 
 Stringent washing steps: 
- 2x 3 min. 2x SSC (37°C) 
- 3x 5 min. 50% FA/2x SSC (42°C) 
- 2x 5 min. 4x SSC (37°C) 
 Blocking: 10 min. 4% BSA/4x SSC (37°C) 
 Antibody detection see  3.10.5 except for the addition of VRC to a final 
concentration of 10 mM in each antibody dilution. 
 
3.11  Immunocytochemistry in combination with FISH 
This method was used to visualize distinct DNA or RNA FISH signals together with 
SC35 splicing speckles. The SC35 antibody had to be diluted in PBS buffer whereas 
the antibodies for FISH signal detection were diluted in SSC buffer. Therefore, the 
buffer had to be changed which was the only crucial step in the protocol. When the 
cells were in 4x SSC washing buffer after the last (in principle the second) antibody 
incubation for FISH signal detection, the protocol was continued as follows (in case 
of RNA FISH VRC was added to a final concentration of 10 mM in each antibody 
dilution): 
 Washing step from FISH detection: 
- 2x 5 min. 2x SSC (37°C) 
 Change buffer: 
- 2x 5 min. 1x PBS (37°C) 
 Blocking: 10 min. 4% BSA/1x PBS (37°C) 
 1. antibody: MαSC35 diluted 1:100 in 1x PBS (37°C, 1h) 
 Washing step: 
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- 3x 5 min. 1x PBS 
 2. antibody: diluted in 1x PBS (37°C, 1h) 
 Washing step 
- 3x 5 min. 1x PBS (37°C) 
 Counterstaining: DAPI (500 µg/ml) diluted 1:100 in 1x PBS (37°C, 10 min.) 
 
3.12  Microscopy 
3.12.1 Phase contrast microscope 
The phase contrast microscope was used in the cell culture for checking the cell 
growth and density to estimate in which dilution they have to be seeded on 
coverslips. For 2D FISH experiments metaphase slides where checked under the 
phase contrast microscope for suitable areas for hybridization. For technical 
properties see  6.13. 
3.12.2 Epifluorescence microscope 
Results of 2D FISH, 3D FISH and of other fluorescence labeling experiments were 
checked under the epifluorescence microscope. Images were recorded using the 
Metaview software with a CCD camera and the 63x oil objective in adequate zoom. 
For technical properties see  6.13. 
3.12.3 Confocal laser scanning microscope (CLSM) 
The confocal microscope was used to record nuclei for 3D reconstructions and 
investigations on nuclear architecture. The scanning process was accomplished in 
the sequential scan mode to avoid Bleed-through. 
The table below displays the main scanning parameters. 
Voxel size (x,y,z) 80 nm x 80 nm x 240 nm 
Line Average 3 
Image size 256 x 256 (TLy, HeLa)  / 
512 x 512 (astro) pixels 
Pinhole 1 airy unit 
 
The filter ranges were adjusted to avoid light emitted from other channels. The 
photomultiplier settings (gain and offset) were chosen such that both over- and 
underexposure was prevented, covering the whole grey value scale of 0-255 (8-bit 
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image format). The laser excitation power was adjusted to highest possible value not 
causing obvious photobleaching. For technical properties see  6.13. 
 
3.13  Image processing, evaluation and statistics 
3.13.1 Chromatic shift correction 
For each scanning process, microscopic files were exported as 8-bit tiff-series. 
Additionally the info files which contain all scanning parameters (e.g. voxel size, laser 
settings, microscope settings, etc.) were saved in the same main folder (folder name 
“raw series”). The program ImageJ 1.37c was used for image processing. The first 
processing that had to be accomplished was the correction of the chromatic shift. 
Chromatic aberration is a distortion in optical systems and arises from the different 
refraction properties of light with different wavelengths. Shift correction was 
performed with a special plugin (Shift corrector by Boris Joffe, LMU München, 
Germany) while synchronistically in this process the tiff-series were converted into 
image stacks resulting in one stack for each channel. The outcoming images were 
saved in an extra folder (“shifted stacks”). 
3.13.2 Deconvolution 
Only in case of splicing speckle experiments the images were deconvolved directly 
after shift correction and prior to further processing such as threshold defining. 
Because of the optical properties of a microscopic system out-of-focus light from 
above and below causes blur and creates a distorted image. In case of heavy blur 
fine structures are hardly illustrated. A possibility to reduce blur is the mathematical 
process of deconvolution by which the blurred light is calculated back to its origin 
resulting in a sharper image. Deconvolution was helpful to improve illustration of 
SC35 splicing speckles. Images of experiments, where the distance of BAC signals 
to the nuclear surface was measured, were not deconvolved. Threshold for both BAC 
and DAPI signal, which represents the nuclear surface, can be defined appropriately 
in “raw” images without deconvolution. In SC35 experiments all images including 
BAC, HIV and DAPI channel were deconvolved. Deconvolution was implemented 
using the Huygens Essential 3.3.0p0 program running under Linux. The 
deconvolution parameters were generated from a measured point spread function 
(PSF). More details concerning the deconvolution process see (Albiez, 2007). The 
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deconvolved images were treated further as described in the following three 
chapters. 
3.13.3 Preliminary work on image files 
The images of the BAC channel showed two (or three; depending on the number of 
chromosomes) distinct signals: one that co-localizes with the HIV signal and one (or 
two, respectively) on the homologous chromosome(s). In advance to further image 
analysis one had to distinguish between BAC signal co-localizing with HIV and not. 
Therefore the following steps were proceeded with the BAC channel images in 
ImageJ: First the whole image stack was duplicated (image -> duplicate). In one of 
the images the BAC signal that co-localizes with the HIV was cut out, in the other 
image the BAC signal(s) on the homologous chromosome(s) was (were) cut out 
resulting in one image stack for each BAC signal. Both images were saved 
separately. 
3.13.4 Threshold defining 
For subsequent image analysis one has to define signal and background for each 
stack by setting a threshold. In advance all images were modified with the Gaussian 
blur filter (process -> filters -> Gaussian blur; sigma(radius) was set on 1) to reduce 
pixel irritations and to create a slight soft-focus effect. Afterwards all images were 
normalized with the plugin stack normalizer (available on ImageJ homepage) 
assuring that the whole grey value range from 0-255 was covered. The modified 
shifted image stacks were again saved in an extra folder (“bearbeitet”). Finally the 
thresholds for each image stack could be defined and inscribed. It is important to 
note that now only true signals should be found in the images. All background signals 
whose grey values were above the threshold had to be cut out otherwise it would 
irritate the measurement and give false positive results 
3.13.5 Enhanced absolute distance to surface (eADS) 
The 3D measurement program was eADS developed by T. Thormeyer (Thormeyer, 
2005; Albiez et al., 2006) who enhanced and improved the existing ADS program 
(absolute distance to surface) developed by Dr. J. von Hase (Kirchhoff Institut, 
Heidelberg). With the new eADS program (which is by now an application in EDMT: 
enhanced distance measurement tool) it is possible to define, voxel by voxel, the 
shortest distance in 3 dimensions from a signal to a reference signal. If the nuclear 
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position of a BAC signal, i.e. the distance to the nuclear surface, was determined, the 
counterstain was used as reference channel. Figure 6 illustrates the measurement 
procedure. Green and red circles indicate BAC signals for which the shortest 
distance to the nuclear surface in 3D should be determined. It is now measured from 
the respective BAC signal, voxel by voxel, in defined shells in 3 dimensions until the 
first contact with any voxel of the reference channel. In principle, as reference 
channel almost any signal can be chosen such as centromeres, telomeres or 
nucleoli. In this thesis besides the radial nuclear location of BAC signals also the 
relation to the BAC harboring chromosome territory and to splicing speckles was 
determined. In these cases either the chromosome territory or SC35 splicing 
speckles were used as reference channels. The resulting evaluation file can be 
opened in Excel by using the function “import external data”. For illustration adequate 
graphs can be generated. 
 
 
 
Figure 6: eADS performance illustration 
a – 3D Amira reconstruction; view inside a nucleus; nuclear surface in blue, BAC signals in red and 
green; white arrows indicate shortest distance to nuclear surface. 
b – corresponding excel evaluation graph from eADS measurements; with a quarter of the nucleus the 
scale of the x-axis is exemplified; shortest distance of the BAC signals (red, green) to the nuclear 
surface is indicated by arrows; negative values indicate location within the reference signal, here the 
nucleus; positive values indicate location outside reference signal. 
 
Creating the mask (using ImageJ): 
The DAPI counterstain reveals less and also not stained areas like nucleoli or 
accumulations of open chromatin. If a threshold is set it may happen that these areas 
is omitted. So, if now a signal is positioned nearer to such an internal nuclear relief 
than to the nuclear surface, eADS measures the wrong distance leading to a false 
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positive result. By using a nuclear mask as reference channel the addressed 
scenario can be avoided: 
- A threshold for the counterstain channel was defined and applied (Image -> 
Adjust -> Threshold (set threshold) -> Apply). In doing so one had to mind that 
in the ImageJ options background color is white and foreground color is black. 
- The omitted holes were filled (Process -> Binary -> Fill Holes). 
- The image was inverted (Edit -> invert). 
- The resulting mask was saved as “m_Kern(n).tif” in the same folder as the 
modified shifted image stacks (folder name “bearbeitet”). 
The folder “bearbeitet” now contained all processed shifted stacks and the masks for 
each nucleus. 
Generating the parameter file (using EDMT filemaker): 
eADS needs a parameter file that caries all important information like for example the 
thresholds for each image stack, the storage paths for the input and output files or 
the voxel size. Here, one also defines the reference channel and which channels are 
measured against that. To receive the chromatin distribution, the DAPI channel as 
well was measured against the reference channel (mask). 
Running the eADS program: 
EDMT was started, Ultra Rapid Distance Measurement was chosen and the 
parameter file was loaded. The output file with the results was imported in Microsoft 
Office Excel, where graphs with the BAC signal and DAPI distribution were created. 
For further details and troubleshooting see (Thormeyer, 2005; Albiez, 2007; Kupper, 
2007; Kupper et al., 2007). 
3.13.6 Determination of surface area with ImageJ 
The surface area of BAC signals was measured with the object counter 3D described 
in (Bolte and Cordelieres, 2006) and downloaded from 
http://imagejdocu.tudor.lu/doku.php?id=plugin:analysis:3d_object_counter:start. Blur 
in images was reduced using the Gaussian filter (Sigma (radius)=1) in advance. 
Subjective influence was minimized by normalizing the BAC signals with the stack 
normalizer plugin and by applying a constant threshold of 50 (Astrocytes, HeLa 
cells), 100 (T-lymphocytes) or 130 (cloneB cells). The number of surface pixels was 
plotted in Excel graphs. 
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3.13.7 Statistical evaluation 
A putative statistical significance was ascertained by using an appropriate significant 
test. Generally, the paired t-test was used, a pair consisting of the values for the 
integration site and the homologous site (averaged when two were present: 
HeLa18q22.3, Astro18q22.1) from the same nucleus. For radial nuclear positioning, 
the median values were used. Some distributions were not normally distributed, thus 
the Wilcoxon signed rank (WSR) test for paired samples instead had to be applied 
(radial distributions of MMUXA1.1, HeLa18q22.3, HeLaXq22.1, Astro18q22.1, 
surface pixels HeLa18q22.3). Distributions in untreated and sodium butyrate treated 
cells were compared with the Mann–Whitney rank sum test. All calculations were 
performed with SigmaStat 3.5. 
 
3.14  Determination of gene density, GC content and other genomic 
properties 
Except for GC content the genomic properties were directly read of the map viewer 
on the NCBI homepage (http://www.ncbi.nlm.nih.gov/) after having blasted the 
respective integration site sequences. From there the sequences surrounding the 
integration sites were downloaded and submitted to the Repeatmasker homepage 
(http://www.repeatmasker.org/) to obtain the GC content. The maximum sequence 
length possible to upload to the Repeatmasker homepage is approximately 5 Mb. 
Hence, properties of the 10 Mb window were computed by two uploading steps. Total 
genomic GC content was taken from (Venter et al., 2001) (human genome) and from 
(Waterston et al., 2002) (mouse genome). Genomic properties were determined in a 
0.5, 2 and 10 Mb window around each integration site. 
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4. RESULTS 
4.1 HIV Integration site mapping and karyotype analysis 
HIV integration sites were investigated in astrocytes, HeLa cells and T-lymphocytes 
(for details about cell types and infection see  3.1). The first step was to identify the 
genomic position of the integrated provirus via LM-PCR (see  3.4). For each identified 
integration site a BAC clone was ordered that covers the respective integration site. 
After testing the BAC clones for correct chromosomal position on metaphase 
spreads, 3D FISH experiments were performed. 
4.1.1 Mapping of the HIV integration sites via LM-PCR 
The extracted DNA from each cell type was digested using varying restriction 
enzymes (see  3.4). After linker ligation distinct DNA fragments were amplified. One 
primer binds in the 5´LTR of the provirus, the other primer in the linker. The amplified 
DNA fragment in between revealed the genomic host DNA adjacent to the proviral 
5´LTR. The analytic gels of the LM-PCR products revealed distinct and bright bands 
(e.g. both lanes in Figure 7c), weak bands with DNA smear (e.g. Figure 7e lane four 
and six) or lanes with DNA smear (e.g. Figure 7a lane one). 
To allow sequencing of the PCR product, bands had to be distinct and 
separate from each other and contain a certain amount of DNA. Therefore, only the 
assays from lanes which satisfy these parameters were subsequently put on a 
preparative gel (method see  3.5.2). In such a case the complete remaining volume 
(approximately 45µl) was applied. Bands of interest were cut out and sent for 
sequencing (see  3.6). An example of a preparative gel before and after extraction of 
bands is given in Figure 8. 
Sequencing results were blasted on NCBI web page. In case of no blast hit the 
sequence was either internal of the provirus (see Figure 5) or not assignable (red 
rectangled bands in Figure 7). For the investigated astrocytes, HeLa cells and T-
lymphocytes nine HIV integration sites were identified, seven of them were located 
within a gene (Table 1). It has to be noted here, that the T-lymphocytes harbor more 
than the two identified integration sites since in subsequent FISH experiments HIV 
signals were visible, that did not co-localize with one of the BAC signals (see Figure 
23). 
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Figure 7: Analytic agarose gel examples of LM-PCR products 
M – marker (numbers in bp); K- - negative control (without DNA); K+ - positive control (contain human 
genomic DNA provided by the Genome Walker Universal Kit; in brackets each used restriction 
enzyme; Rectangle indicated bands were cut out after a subsequent preparative gel run and 
sequenced; green rectangles mark bands which revealed integration sites, red rectangles indicate 
bands with no results in terms of integration site position; 5µl of each PCR product was analysed on 
the agarose gel. 
 
 
 
Figure 8: Preparative gel of LM-PCR products 
Restriction enzyme assays of astrocyte DNA with HindIII (lane one), NlaIII (lane two) and SacI (lane 
four), respectively; lane three is empty; a – before bands marked by asterisks were extracted, b – 
afterwards; M – marker (numbers in bp) 
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Integration 
site 
Astro 
18q22.1 
HeLa 
6p12.3 
HeLa 
11q22.3 
HeLa 
15q21.3 
HeLa 
16p13.3 
HeLa 
18q22.3 
HeLa 
Xq22.1 
TLy 
2q11.2 
TLy 
2q14.2 
Nearest 
gene 
CDH19 SUPT3H PDGFD ZNF 
280D 
AXIN1 NETO1 CSTF2 KIAA 
1310 
PTPN4 
Distance 
to nearest 
gene 
0 0 250kb 0 0 700kb 0 0 0 
Gene ID 28513 8464 80310 54816 8312 81832 1478 55683 5775 
sequence ATAACA
ATATTG
TATAAT
ATATGA
AGAAAT 
GCAAGT
TTTCAGT
TACTGTG
CTTGATA
GGC 
AAATC
ATTAA
GTTGTT
AATGG
AATTTT
AAG 
CAGAA
AAATG
CAAAT
AGGGT
CATTTT
AGTC 
GGGCTTT
CCCTAG
GTTCTGT
TCATCAG
GTG 
CATAGA
GCAAG
GGGCC
AACAGA
CCCCCT
TA 
ACAG
CACA
ACTG
GATA
CCAC
TGAA
TTAAT
C 
GGTGG
GTCTG
GACCA
CTCCT
GGATT
CTGGG 
TGCCT
TCCTC
AGACT
TTGTT
ACAGC
ATAGG 
Table 1: Genomic positions of HIV integration sites 
Overview of HIV integration sites in three different human cell types. HeLa – HeLa cells; TLy – T 
lymphocytes; Astro – astrocytes. Description behind the cell type defines the chromosomal region of 
the integration site. A distance of 0 to the nearest gene means the integration is inside the gene; gene 
ID from NCBI human genome database; sequence – start of sequenced host genome from LM-PCR 
directly adjacent to 5´LTR of integrated provirus. 
 
4.1.2 Control PCRs confirmed integration site mapping results and absence 
of tandem copies 
To better characterize HIV in general and to confirm mapping results, integration 
sites were subjected to control PCRs. For this purpose, specific primers were 
designed, one binding within the provirus 5´LTR and the other 1 kb away within the 
genomic host DNA (sequence see  6.5). In case of a correct mapping result a distinct 
band with 1 kb in size should be visible on the gel. As candidates the integration sites 
HeLa 11q22.3, HeLa 18q22.3, HeLa Xq22.1 and Astro 18q22.1 were chosen. In all 
lanes, except for the negative controls, the expected 1 kb bands appeared indicating 
the correct mapping result (Figure 9). It has to be noted, that PCRs were performed 
in a S1 lab. Therefore, digested DNA assays had to be used and not genomic DNA 
(see  3.2.1). Correct mapping of integration sites can also be confirmed in subsequent 
FISH experiments by co-localization of HIV signal and BAC signal, which marks the 
integration site region. Thus further PCRs were not necessary. 
To test whether multiple integrations were arranged consecutively, PCR with 
specific primers was performed. For this purpose, the primer “GSP2” binding within 
the 5´LTR from the LM-PCR experiments (see  3.4.2) and a primer binding within the 
3´LTR (“GSP3LTR_100”) were used. In case of two proviruses integrated directly 
next to each other with the same orientation, a fragment of approximately 150 bp in 
size should be amplified as indicated in Figure 10. For each cell type two digestion 
assays (EcoRI and SacI) of the extracted genomic DNA were tested (Figure 11). 
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Figure 9: Control PCRs to confirm LM-PCR results 
M – marker (numbers in bp); negative controls (K-) contain PCR assay from respective left lane 
without primers; for each integration site the EcoRI and the SacI restriction enzyme assay were 
analyzed; a – integration sites HeLa 11q22.3 and HeLa 18q22.3, b – integration site HeLa Xq22.1, c – 
integration site Astro 18q22.1. 
 
 
Figure 10: Primer position illustration for control PCRs 
Two consecutively into host genome (black bars) integrated proviruses (green bars) flanked by their 
LTR regions (red bars) are shown; due to identical sequences of the LTRs both primers GSP2 (light 
blue) and GSP3LTR_100 (dark blue) bind, opposedly orientated, within the 3´LTR and the 5´LTR; 
primer binding sites indicated by horizontal light blue (GSP2) and dark blue (GSP3LTR_100) arrows; 
primer sequences see  6.5; putative amplifiable fragment lengths, delineated by vertical black lines, are 
displayed; restriction enzyme recognition sites indicated by vertical black (SacI) and gray (EcoRI) 
arrows. 
 
 
 
 
Figure 11: Control PCRs to test multiple integration sites arranged consecutively 
1.5% agarose gel; M – marker (numbers in bp); Astro – astrocytes; TLy – T-lymphocytes; HeLa – 
HeLa cells; EcoRI, SacI – restriction enzymes; asterisks mark bands; 5µl of probe was applied. 
 
Contrary to the EcoRI digestion assay, the SacI assay should never reveal an 
amplified fragment of 150 bp, since SacI has a recognition site within the LTR region 
(see vertical black arrows in Figure 10. The predicted bands at approximately 150 bp 
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did not appear in one the EcoRI assays, but in lane 3 (T-lymphocytes) at 250 bp and 
in lane 5 (HeLa cells) at 600 bp weak bands were visible (Figure 11). This means that 
both in T-lymphocytes and in HeLa two HIV integrations could be in immediate 
vicinity (250 bp and 600 bp far away from each other, respectively). It cannot be said 
here which integration sites were concerned. For this, PCRs with specific primers are 
necessary. It should be taken into account that two neighboring proviruses might be 
orientated in opposite directions which was not considered in the primer design here. 
The blurry bands shorter than 100 kb in each lane of Figure 11  apparently derive 
from the primer. 
 Both EcoRI and SacI have recognition sites within the provirus (perpendicular 
arrows in Figure 10). The amplification of an additional fragment of ~9 kb in size that 
covers the whole integrated provirus is consequently not possible and was also never 
found in one of the lanes in Figure 11. 
 
4.1.3 BAC clones were tested for correct chromosomal position 
For each identified integration site appropriate BAC clones were selected which 
cover the respective genomic region. All BAC clones were tested for correct 
chromosomal binding by FISH on metaphase spreads. If the provided BAC clones 
were loacetd differently as expected, allternative clones were selected, which was 
once the case (HeLa 18q22.3). Finally, the following BAC clones were used for 
further FISH experiments: 
 
Integration 
site 
Astro 
18q22.1 
HeLa 
6p12.3 
HeLa 
11q22.3 
HeLa 
15q21.3 
HeLa 
16p13.3 
HeLa 
18q22.3 
HeLa 
Xq22.1 
TLy 
2q11.2 
TLy 
2q14.2 
BAC clone RP11-
831H17 
RP11-
818O21 
RP11-
63H12 
RP11-
566D24 
RP11-
517F15 
RP11-
693I21 
RP11-
255J06 
RP11-
67L23 
RP11-
132N24 
Table 2: BAC clones covering HIV integration sites 
Overview of BACs which were used for further FISH experiments; HeLa – HeLa cells; TLy – T 
lymphocytes; Astro – astrocytes. Description behind the cell type defines the chromosomal region of 
the integration site 
 
4.1.4 Due to chromosomal rearrangements, not all identified integration sites 
could be evaluated 
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An essential condition for detecting possible changes in the nuclear position with and 
without viral integration is the same genomic constitution for the harboring 
chromosome and its homolog. Since all used cell types are immortalized or cancer 
derived, chromosomal aberrations are to be expected. Putative chromosomal 
RESULTS 
aberrations were investigated in 2D FISH experiments with chromosomal paint 
probes and respective BAC probes for each cell type and integration site. 
The results of the 2D FISH mapping revealed several chromosomal 
abnormalities summarized in Table 3. Only integration site harboring chromosomes 
were analyzed. HSA18 in astrocytes, HSA2 in T-lymphocytes and HSA18 in HeLa 
cells were of normal appearance (see Figure 11a,b and Figure 13e). Thus, the 
respective integration sites 18q22.1 in astrocytes, 2q11.2 and 2q14.2 in T-
lymphocytes and 18q22.3 in HeLa cells could be evaluated in 3D FISH experiments 
with regard to their nuclear architecture. In HeLa cells, among the integration site 
harboring chromosomes HSA6, HSA11, HSA15 and HSA16 an abnormal constitution 
was determined. Of each of these chromosomes three or four copies of different 
sizes were found, often including translocations (see Figure 13a,b,c,d). 
 
 
 
Figure 12: Chromosomal analysis of astrocytes and T-lymphocytes 
Overlay of widefield microscopic images (a - astrocytes) and z-projections of confocal image stacks (b 
- T-lymphocytes); FISH on metaphase spreads; blue – DAPI; red – chromosome paint probe (HSA18 
and HSA2); green – BAC probe marking respective HIV integration site (18q22.1 on astrocyte 
metaphases and 2q11.1 on T-lymphocyte metaphases); yellow – BAC probe marking HIV integration 
site 2q14.2 on T-lymphocyte metaphases. 
 60 
RESULTS 
 
 
 61
RESULTS 
Figure 13 (previous page): chromosomal analysis of HeLa cells 
Overlay of widefield microscopic images of FISH on metaphase spreads; blue – DAPI; red – 
chromosome paint probe (HSA6, HSA11, HSA15, HSA16, HSA18, HSAX); green – BAC probe 
marking respective HIV integration site (6p12.3, 11q22.3, 15q21.3, 16p13.3, 18q22.3, Xq22.1); red 
mark in each ideogram indicates respective integration site position; karyotypes are not 
unconditionally complemented since each image does not show all chromosomes of a metaphase 
spread or ideogram covers some chromosomes in the image. 
 
Taken together, only for five of the nine integration sites the relevant chromosomes 
were of normal appearance. Compared to the ideograms, BAC signals showed the 
correct chromosomal positions in all cases. The integration site HeLa Xq22.1 showed 
a special situation (see  4.1.5). Results were verified by at least ten metaphase 
spreads per BAC. When performing 3D FISH experiments, for each batch of cells the 
chromosomal constitution was controlled by FISH on metaphases, since further 
chromosomal aberrations during cell culture cannot be excluded. 
 
Cell type Integration 
site 
Chromosomal constitution Evaluable
? 
HeLa 6p12.3 Four chromosomes 6 of 3 different sizes no 
HeLa 11q22.3 Three different chromosomes 11 no 
HeLa 15q21.3 Three different chromosomes 15 (two 
“homologous”, one larger); additionally one 
translocated region 
no 
HeLa 16p13.3 Translocation of one of the two BAC binding 
regions 
no 
HeLa 18q22.3 All three chromosomes 18 show normal 
constitution 
yes 
HeLa Xq22.1 Both X chromosomes show normal constitution; 
additionally two small translocations 
? 
(see  4.1.5) 
T-
lymphocytes 
2q11.2 Both chromosomes 2 show normal constitution yes 
T-
lymphocytes 
2q14.2 Both chromosomes 2 show normal constitution yes 
Astrocytes 18q22.1 All 3 chromosomes 18 show normal constitution yes 
Table 3: Evaluation of FISH on metaphase spreads 
 
4.1.5 LC5-HIV HeLa cells have no inactive X chromosome 
One of the mapped integration sites in the female HeLa cell line was located on the X 
chromosome. In normal female human cells, one of the two X chromosomes is 
inactived resulting in a condensed heterochromatic structure, the Barr body, 
frequently located at the nuclear rim (Barr and Bertram, 1949). Shape and gene 
positioning of active and inactive X chromosome can differ significantly (Eils et al., 
1996; Dietzel et al., 1999). Hence, it had to be clarified whether one of the two X 
chromosomes in the HIV infected HeLa cell line was inactive. The inactive X 
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chromosome can be distinguished from the active by specific epigenetic properties, 
such as accumulation of the histone variants macroH2A or 3meH3K27 (Chow and 
Heard, 2009). 
Figure 14 shows, that the LC5-HIV HeLa cell line does not carry an inactive X 
chromosome, since neither an accumulation of 3meH3K27 nor of macroH2A histone 
modifications was detectable. Neither did the cells display a Barr body.  In the female 
control cells an accumulation of both histone modifications and therefore an inactive 
X chromosome was found (HFb images in Figure 14). Thus, all X chromosomes in 
this cell line were active. 
 
 
Figure 14: Immunostaining to ckeck for inactivated X chromosome 
Z-projections of confocal image stacks; arrow indicates inactivated X chromosome in HFb (human 
fibroblasts) cells; arrowhead indicates the Barr body in the DAPI channel; arrow in overlay image 
indicates the inactive X chromosome; of the HeLa cell population 50 cells were checked. 
 
4.1.6 Gene density and GC content in the integration site environment 
For further characterization of the genomic environment of the integration sites, gene 
density and GC content in 0.5, 2 and 10 Mb windows around each integration was 
determined (Figure 15). An obvious tendency of integration sites towards gene dense 
or GC-rich regions was not detectable. Integration sites were found both in gene 
dense regions (HeLa 16q13.3, HeLa Xq22.1, TLy 2q11.2) and in gene poor regions 
(HeLa 11q22.3, HeLa 18q22.3, Astro 18q22.1). Integration sites also located in 
regions with both high and low GC content. 
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Figure 15: Gene density and GC content of integration site regions in HIV infected cells 
Method see  3.14; evaluable integration sites indicated by asterisks. 
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4.1.7 2D FISH experiments revealed co-localization of BAC and HIV signal 
FISH on metaphase spreads of HeLa cells with BAC marking integration site Xq22.1 
and HIV probes showed co-localization of both signals (Figure 16). This was a very 
challenging experiment, since only in less than 5% of the recorded metaphase 
spreads a HIV signal was distinctly visible. During recording at the microscope, the 
HIV signal was not identifiable at the screen. Only after images were normalized 
concerning the grey value range, the HIV signal could be localized by co-localization 
with the BAC signal that marks the integration site. 
Comparing the BAC and HIV signal in Figure 16b, the difference in size (BAC 
~150 kb, HIV ~10 kb) becomes apparent. In consideration of the fact that the putative 
co-localization of HIV signal and its corresponding BAC signal was finally obvious in 
3D FISH experiments, no further 2D FISH experiments of this kind were performed. 
 
 
Figure 16: FISH on metaphase spreads of HeLa cells 
Projection of three confocal sections; b – Zoom of region marked by square in a; a, b: blue – DAPI, red 
– BAC marking integration site Xq22.1, green - HIV; homologous X chromosome without HIV 
integration marked by arrow in a; scale bar 0.5 µm. 
 
 
 
 
 
 65
RESULTS 
4.2 FISH on intact HIV infected interphase nuclei 
FISH with probes for HIV, BACs marking the integration sites and chromosomal paint 
probes was performed on structurally preserved nuclei. Depending on the cell type, 
nuclei with different counts of HIV FISH signals were found. 
The HIV infected astrocytes, HeLa cells and T-lymphocytes were 
characterized in advance with regard to the number of integrations per nucleus via 
LightCycler qPCR (Manja Meggendorfer, Helmholtz Zentrum München, personal 
communication). The results predicted one provirus copy per astrocyte, six copies 
per T-lymphocyte and 0.6 copies per HeLa cell nucleus. 
 
4.2.1 T-lymphocyte nuclei showed diverse morphologies 
As mentioned above HIV infected astrocytes, HeLa cells and T-lymphocytes were 
investigated in this thesis. The first two show rather uniform fibroblast-like nuclear 
morphologies throughout a cell population. However, T-lymphocytes showed large 
variation in nuclear shape from round to strechted or asymmetric (Figure 17). Hence, 
for objective 3D measurements, nuclei had to be selected. Only the ones were 
chosen for scanning that show the average morphology of the cell population. An 
example for such a nucleus is indicated by arrow in Figure 17. 
 
 
Figure 17: nuclear morphologies of KE37/1-IIIB T-lymphocytes 
Three widefield microscopic images; DAPI staining; the three images exemplify the variety of nuclear 
morphologies among the T-lymphocyte population; the difference in brightness due to different DAPI 
staining intensities can be neglected, only the nuclear shape and morphology are crucial; arrow marks 
a nucleus with averaged morphology. 
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4.2.2 The HIV FISH probe detected HIV DNA and RNA 
With a target size of 9.7 kb the HIV provirus is at the lowest detection limit for FISH 
probes. The HIV signal after 3D FISH on interphase nuclei of all three cell types was 
surprisingly strong (Figure 18). One would expect an at least 10 times larger BAC 
signal compared to the HIV signal, due to the lengths of sequences detected by both 
probes (~150 kb and 9.7 kb, respectively). A potential explanation for the strong HIV 
signal was that the HIV probe also detects HIV RNA. This assumption was verified by 
RNase A digest (Figure 19). The HIV signal was clearly smaller after RNase digest 
(compare HIV signal -RNase and +RNase in Figure 19) indicating the loss of RNA, 
which otherwise contributed to the FISH signal. DAPI staining and BAC signal quality 
were not influenced by the treatment. The smaller HIV signal (indicated by arrow in 
Figure 19) is hardly identifiable without the co-localizing BAC signal which marks the 
integration site. HIV FISH signal comparison with and without RNase A digest was 
performed with all three HIV infected cell types. In all cases the HIV signal was 
smaller with treatment.  
An RNA FISH experiment with HeLa cells and T-lymphocytes gives 
information about the transcriptional levels of the HIV provirus. Probes for HIV and 
the house-keeping gene β-actin were co-hybridized. β-actin is known to be involved 
in cell motility, structure and integrity and should therefore be expressed at 
microscopic detectable levels. Comparing the HIV and β-actin RNA signals in HeLa 
cells in Figure 20 the strength of the HIV RNA signal and therefore the grade of HIV 
transcription becomes obvious. In T-lymphocytes a β-actin RNA signal was hardly 
visible. In summary, it can be concluded that the five investigated HIV integration 
sites were strongly transcribed. 
 
Figure 18: 3D FISH on interphase nucleus 
Mid confocal sections; 3D FISH on HeLa cell nucleus with BAC probe (Xq22.1) marking the respective 
integration site and HIV probe; nuclear DNA stained with DAPI; all images are normalized with the 
stack normalizer plugin in ImageJ so that the whole gray value range from 0 – 255 in each image is 
used; scale bar 5 µm. 
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Figure 19: RNase A digest 
Mid confocal sections; 3D FISH on HeLa cells with BAC probe (Xq22.1) marking the respective 
integration site and HIV probe; nuclear DNA stained with DAPI; control (-RNase; upper panel) and 
RNase treated (+RNase; lower panel); arrow indicates HIV signal; all images are normalized with the 
stack normalizer plugin in ImageJ so that the whole gray value range from 0 – 255 is used; this 
increases background signal in the HIV channel after RNase digest; for each cell type (HeLa cells, 
astrocytes and T-lymphocytes) approximately 30 cells were compared; scale bar 5 µm for both panels. 
 
 
Figure 20: RNA FISH with probes for HIV and β-actin 
Z-projections of three mid confocal sections; two different HeLa cell nuclei after RNA FISH with probes 
for HIV and β-actin; arrows in β-actin images indicate RNA signals; all images are normalized as 
described for Figure 19; scale bar 5 µm. 
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4.2.3 Some cell types showed multiple integration sites 
To investigate the nuclear architecture of HIV integration sites, 3D FISH on 
interphase nuclei was applied. HIV and a BAC marking the respective integration site 
were used as probes. In some cases the integration site harboring chromosome 
territory was also stained. Figure 21 and Figure 23 show examples for each 
investigated integration site.  
 
 
Figure 21: 3D FISH on astrocyte interphase nucleus 
Z-projections of confocal image stacks; Overlay image: light blue – chromosome territory 18 (CT18), 
green – BAC marking integration site (18q22.1), red – HIV signal, blue – DAPI counterstain. Co-
localization of HIV and BAC signals indicated by arrow; scale bar 5 µm. To benefit HIV FISH signal 
quality and to reduce background signal, the brightness/contrast tool in ImageJ was applied for the 
HIV channel. 
 
 
Figure 22: line scan of HIV and co-localizing BAC signal 
a: microscopic image; magnification from overlay of HIV (red) and BAC (18q22.1, green) signals from 
Figure 21; b: line scan analysis from microscopic image in a; red curve – HIV signal intensity, green 
curve – BAC (18q22.1) signal intensity; value – gray value (0-255); distance in pixel. 
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Figure 23: 3D FISH on interphase nuclei of HeLa cells and T-lymphocytes 
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Figure 23 (previous page): Z-projections of confocal image stacks; 
a,b: HeLa cell nuclei; green – BAC signals (18q22.3; Xq22.1); light blue – chromosome territories 18 
and X (CT18, CTX); red – HIV signal; Co-localizing BAC and HIV signals are indicated by arrows. 
c: T-lymphocyte nucleus; BAC signals marking integration sites in yellow (2q14.2) and green (2q11.2); 
red – HIV signal; Co-localizing BAC and HIV signals are indicated by arrows; the T-lymphocyte 
nucleus (c) harbors multiple HIV integration sites (four HIV signals are visible); scale bars 5 µm. 
For each nucleus the co-localization of HIV with one of the BAC signals is indicated by arrow in the 
overlay images; to benefit HIV FISH signal quality and to reduce background signal, the 
brightness/contrast tool in ImageJ was applied for the HIV channel. 
 
The overlay image in Figure 21 clearly shows the co-localizing HIV and BAC signals 
(indicated by arrow). This observation was finally confirmed by a line scan analysis of 
the fluorescence intensities of both signals (Figure 22). 
Interestingly, in some T-lymphocyte nuclei up to four HIV FISH signals were 
visible, indicating multiple integration sites (Figure 23c gives an example for this 
observation). The two integration sites 2q11.2 and 2q14.2 in the T-lymphocytes were 
located both on same chromosome 2. This was confirmed by an additional FISH 
experiment with probes for HIV, both BACs marking the integration sites and a paint 
probe for chromosome 2 (data not shown). On which chromosome the additional 
integration sites were located remained undetermined. 
Cell populations of astrocytes, HeLa cells and T-lymphocytes were 
investigated with regard to the number of HIV FISH signals per nucleus. For this 
purpose only nuclei came into consideration, which were, based on the DAPI staining 
and nuclear morphology, convenient to be potentially evaluated for 3D 
measurements. This means the selected nuclei had to show the average morphology 
of the respective cell population. Of each population between 70 and 80 nuclei were 
investigated. The BACs for the evaluable integration sites were co-hybridized. In 
case of the HeLa cells additionally BAC 11q22.3 was co-hybridized. Although this 
integration site could not be evaluated, due to chromosomal aberrations ( 4.1.4), it 
should account for further characterization of the HeLa cells (see next chapter). 
Some HIV FISH signals did not co-localize with one of the BAC signals; however, 
they were taken as distinct signals if shape and fluorescence intensity was 
comparable to those that did co-localize. 
Astrocytes never harbored more than one HIV FISH signal. This always co-
localized with the BAC signal marking integration site region 18q22.1 (Figure 24a). In 
the majority of HeLa cell nuclei one HIV signal was found (74%, Figure 24b), very 
rarely two (3%). In the latter case none HIV signal co-localized with one of the three 
BAC signals (18q22.3, Xq22.1 and 11q22.3). In T-lymphocytes up to four HIV signals 
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per nucleus were found, in most cases one or two (33% and 34%, respectively, 
Figure 24c). This observation is in accordance with results from qPCR experiments 
mentioned at the beginning of this chapter, whereupon the T-lymphocytes harbor up 
to six HIV provirus copies and are therefore multiple infected. If two or more HIV 
signals were visible, they mostly (69%) co-localized with both integration site marking 
BACs 2q11.2 and 2q14.2. 
The qPCR result, which determined one HIV provirus copy per astrocyte 
nucleus, was also confirmed by the count of HIV FISH signals (Figure 24a). Since the 
qPCR experiment determined 0.6 provirus copies per nucleus in the HeLa cells, they 
were characterized in details (see following chapter  4.2.4). 
In a certain amount of nuclei (between 5% and 23%, Figure 24) of all three cell 
populations no HIV signal was found. It was not verifiable whether this was due to 
nuclei without integrated HIV provirus or due to an insufficient hybridization because 
of the critical size of  the target sequence (<10 kb). 
 
 
Figure 24: Count of HIV FISH signals per nucleus 
Overview of number of HIV signals per nucleus among the cell population of astrocytes (a), HeLa cells 
(b) and T-lymphocytes (c); between 70 and 80 cells for each population were investigated; nuclei were 
selected according to their nuclear morphology, which should represent the average of the respective 
cell population. 
 
4.2.4 The HeLa cell line LC5-HIV is a pool of clones 
The cell line LC5-HIV was established by HIV-1 infection of a HeLa-derived cell line 
followed by sub-cloning via limiting dilution (Mellert et al., 1990). qPCR results 
revealed 0.6 provirus copies per nucleus (Manja Meggendorfer, Helmholtz Zentrum 
München, personal communication). Six integration sites were mapped via LM-PCR 
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(see  4.1.1). Among the HeLa cell population most nuclei harbored one HIV signal 
(74%, Figure 24b). In nearly one fourth (23%, Figure 24b) no HIV signal was visible. 
To characterize the HeLa cell population further, in nuclei with one HIV signal, the 
frequency was determined how often the HIV signal co-localizes with one of the 
BACs marking the integration sites 18q22.3, Xq22.1 and 11q22.3 (see Figure 25). 
For this purpose the 74% of the cell population with one HIV signal per nucleus 
indicated in Figure 24b was evaluated. 
 
 
Figure 25: HIV integration site distribution among the HeLa cell population in nuclei with one 
HIV signal 
Evaluation of the 74% of the cell population indicated in Figure 24b with one HIV signal per nucleus. 
Percentage indicates how often the HIV signal did not (no coloc) or co-localized with one of the BAC 
signals marking the integration sites Xq22.1, 11q22.3 and 18q22.3; n=80. 
 
Interestingly, in the majority of evaluated nuclei, the HIV signal co-localized with the 
BAC signal marking integration site region Xq22.1 (52%, Figure 25). Only in 9% the 
HIV signal co-localized with the BAC 18q22.3, in 26% with the BAC 11q22.3 (Figure 
25). In 13% of nuclei the HIV signal did not co-localize with one of the co-hybridized 
BACs Figure 25. This is explainable with overall six mapped integration sites in the 
HeLa cells. 
 Apparently, the LC5-HIV HeLa cells are a pool of different clones, although the 
cells were supposed to be sub-cloned (Mellert et al., 1990). There is a domination of 
the integration locus Xq22.1 harboring clone of 40% among the population (52% of 
cells with one HIV signal per nucleus in Figure 25 equates to 40% of the whole 
population). Multiple infections can be excluded at least for integration site regions 
18q22.3, 11q22.3 and Xq22.1. In 2D FISH experiments as described and shown in 
 4.1.7 with probes for these regions never more than one HIV signal per metaphase 
spread was found. Furthermore, qPCR experiments revealed only 0.6 HIV provirus 
copies per nucleus, although six integration sites were mapped in the HeLa cells 
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( 4.1.1). In 23% of the HeLa cells no HIV signals was found, which suggests that a 
certain amount of cells are not infected. As mentioned before, this could also be due 
to the critical target size of the HIV provirus. This seems to be unlikely in case of 
HeLa cells, since the percentage of HeLa nuclei without HIV signal exceeds the 
respective percentages determined in astrocytes and T-lymphocytes by far (23% 
compared to 5%, respectively 7%, Figure 24).  
4.2.5 HIV integration sites within a nucleus differed in their transcriptional 
activities 
To characterize further the transcriptional activity of the integration sites, RNA FISH 
experiments were applied for T-lymphocytes and HeLa cells (method see  3.10.6). 
Briefly, without denaturing nuclear DNA, FISH with a probe for HIV was performed. 
Generally, in both cell types the HIV RNA signals were surprisingly strong and 
distinct indicating high HIV transcription (Figure 28 and Figure 27). This was already 
determined before by comparing HIV and β-actin RNA signals (see Figure 20). HeLa 
cells and T-lymphocytes varied in the HIV signal count per nucleus (Figure 26), 
whereas the determination of the exact number of HIV RNA signals per nucleus was 
sometimes difficult (exemplified in Figure 28f). A BAC signal, which could validate the 
HIV signal by co-localization as in DNA FISH experiments, would not have been 
visible due to the procedure of RNA FISH. Hence, BAC probes were not used here. 
 Among HeLa cells, one HIV RNA signal was visible in 67% of nuclei, two 
signals in 4% of nuclei (Figure 26a). In nearly one third (29%) no HIV RNA signal 
could be detected, which supports the assumption in the previous, that not all HeLa 
cells are HIV infected. T-lymphocyte nuclei habrored mostly four or more signals 
(48%Figure 26b), whereas, as mentioned before, in nuclei with more than four 
signals the exact count is hardly identifiable without a co-localizing BAC signal. In 
Figure 28f for example case five RNA signals were counted (indicated by 
arrowheads). 
The HIV RNA signals in HeLa cells generally seem to be larger, even though 
slightly, than in T-lymphocytes, suggesting stronger HIV transcription in HeLa cells. 
Noteworthy, both in HeLa cells and T-lymphocytes HIV RNA signals within the same 
nucleus frequently differed in their sizes and intensities (compare HIV signals marked 
by arrows and asterisks in Figure 27 and Figure 28). This indicates different 
transcriptional activities of HIV proviruses within the same nucleus. The possibility of 
several proviruses being integrated consecutively cannot be fully excluded since final 
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control experiments are missing. This should therefore be taken into account for 
higher local transcriptional potential. 
 
 
 
 
Figure 26: Percentage of different counts of HIV signals per nucleus in HeLa cells (a) and T-
lymphocytes (b) after RNA FISH 
Of each cell type 100 nuclei were evaluated 
 
 
Figure 27: HIV RNA FISH signals in HeLa cell nuclei 
Z-projection of confocal image stacks; RNA FISH with HIV probe; red – DAPI, green – HIV RNA; e,f: 
arrows mark stronger HIV RNA signal, asterisks weaker signals; scale bar 5 µm. 
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Figure 28: HIV RNA FISH signals in T-lymphocyte nuclei 
Z-projections of confocal image stacks; RNA FISH with HIV probe; red – DAPI, green – HIV RNA; a-e: 
arrows mark strong HIV RNA signals, asterisks mark weaker signals; f: putative HIV RNA signals are 
indicated by arrowheads; scale bar 5 µm. 
 
4.3 Radial nuclear positioning of HIV integration sites 
To determine the 3D nuclear distribution of HIV integration sites, FISH with probes for 
HIV and BAC probes marking the respective integration site regions was applied. 
Nuclei were selected according to their morphology and co-localization of HIV and 
BAC signal. Only nuclei that showed the average morphology of each cell type 
population were selected. Images were processed as described (see  3.13). Briefly, 
DAPI and BAC images were normalized, blur was carefully reduced and a threshold 
was defined. Signals of integration sites and homologous control sites were 
separated and analyzed independently. For both signals the shortest distance in 3D 
to the nuclear surface was determined as described (see  3.13). Possible 
repositioning of the HIV integration locus was investigated by comparing the nuclear 
distribution of the BAC signal co-localizing with the HIV signal and the respective 
BAC signal on the homologous chromosome. 
In HeLa cells both integration loci (18q22.3 and Xq22.1, green curves; Figure 
29) were highly significant (p<0.001 and p=0.002, respectively) located more internal 
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than their respective regions on the homologous chromosomes. The integration loci 
in T-lymphocytes (TLy 2q22.2 and TLy 2q14.2) and astrocytes (Astro 18q22.1) did 
not show significant positional changes (p>0.05). Comparing the mean values of their 
medians, differences between the distribution curves in Figure 29 become even more 
obvious (Figure 30). In HeLa cells, the mean value of the medians of the integration 
locus 18q22.3 distribution is 0.24 µm more internal compared to the control region, in 
case of integration locus Xq22.1 0.12 µm. The differences for all other integration loci 
distributions and respective control regions are marginal (between 0 and 0.04 µm, 
Figure 30).  
 
 
 
Figure 29: nuclear distribution of HIV integration loci 
distance to nuclear surface: negative values – inside nucleus, positive values – outside nucleus; red 
curves – nuclear distribution of BAC signal co-localizing with HIV signal; green curves – nuclear 
distribution of BAC signal on homologous chromosome; blue – DNA distribution; HeLa – HeLa cells; 
TLy – T-lymphocytes; Astro – astrocytes; statistics was performed with medians of green and red 
curves; n – number of evaluated nuclei. 
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Figure 30: mean values of medians, same dataset as in Figure 29 
Mean values of medians of distribution curves of BAC signals co-localizing with HIV (red squares) and 
respective BAC signals on homologous chromosomes (green circles); differences between values for 
each integration locus in brackets. 
 
To characterize both repositioned integration loci in HeLa cells (18q22.3 and Xq22.1) 
further, their distribution within their respective chromosome territories 18 and X was 
determined. Both integration loci show the same distribution within their harboring 
chromosome territories as their respective regions on the homologous chromosomes 
(p>0.05; comparing the medians of red and green curves in Figure 31a and b). A 
significant difference in the nuclear distribution of the integration site harboring 
chromosome territories and the homologous ones was not determined (p>0.05; 
comparing the medians of red and green curves in Figure 31c and d).  
Taken together, repositioning of integration loci 18q22.3 and Xq22.1 in HeLa 
cells was only with regard to the nuclear surface. The distance to the surface of the 
respective chromosome territory did not change. Neither chanced the integration site 
harboring chromosome territories 18 and X their nuclear positions compared to their 
homologues. 
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Figure 31: BAC distributions within their respective chromosome territories (a,b) and nuclear 
distribution of chromosome territories 18 and X (c,d) 
Distances of BACs to the chromosome territory surface and distanes of the chromosome territories to 
the nuclear surface was determined as described in  3.13.  
a,b: distribution of BAC signals with regard to the surface of their harboring chromosome territory 
(CT18 and CTX, respectively); red curves – BAC signals (18q22.3 and Xq22.1) co-localizing with HIV 
signals; green curves – respective BAC signals on homologous chromosomes; 
c,d: nuclear distribution of CT18 and CTX discriminating between integration site harboring (red 
curves) and homologous chromosome territory (green curves). 
x-axis: negative values – inside chromosome territory (a,b) or nucleus (c,d), positive values – outside 
chromosome territory (a,b) or nucleus (c,d). 
 
4.4 Repositioning was accompanied by chromatin decondensation 
Upon visual inspection of BAC signals, in some cases signals of integration sites 
appeared more decondensed than the BAC signals on the homologous 
chromosomes. In 2D z-projections of three different HeLa nuclei in Figure 32, the 
BAC signals co-localizing with the HIV signals (indicated by arrows in the overlay, 
Figure 32 lower panel) occupy larger areas than their homologues. 
This impression was confirmed by 3D surface measurements of the BAC 
signals (Figure 33) as described in  3.13.6. Briefly, using the 3D object counter plugin 
in ImageJ the surface area of the BAC signals was determined. To avoid personal 
bias a fixed threshold was used. In HeLa cells, the BAC signal covering integration 
site region 18q22.3 showed on average a 1.49 times larger surface (p<0.001, Figure 
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33) than the respective BAC on the homologous chromosome. For the BAC marking 
integration site region Xq22.1, the surface difference was smaller (1.14x) but still 
highly significant (p<0.001, Figure 33). In T-lymphocytes and astrocytes no significant 
difference in the surface areas could be determined. Interestingly, these observations 
correspond to the extent of repositioning (Figure 29 and Figure 30). The strongest 
difference in the surface area was determined for the most repositioned integration 
site region 18q22.3 in HeLa cells. Less difference in the surface area was found for 
integration site region Xq22.1 in HeLa cells corresponding to a less pronounced 
repositioning. 
 
 
Figure 32: BAC signals in HeLa cell nuclei demonstrating Chromatin decondensation 
Z-projections of confocal image stacks; 3D FISH on three different HeLa nuclei with HIV probe and 
BAC marking integration site region 18q22.3; 
upper panel: BAC (18q22.3) signals; lower panel: respective overlay images of BAC (18q22.1, green) 
and HIV signals (red); counterstain with DAPI (blue); arrows indicate BAC signals co-localizing with 
HIV signals. 
 
 80 
RESULTS 
 
Figure 33: Surface area of BAC signals 
Dots – surface area in pixels (px) of each BAC signal; bars – mean values of respective BAC surface 
pixels co-localizing (red) or not co-localizing (green) with HIV signal, respectively. 
 
4.5 Treatment with sodium butyrate increased HIV transcriptional 
activity, but did not significantly affect the proviral nuclear position 
Sodium butyrate (NaBut) acting as a deacetylase inhibitor has been shown to 
markedly increase HIV-1 transcription via the transcription factor NF-kB (Quivy et al., 
2002). Repositioning towards the nuclear interior upon transcriptional activation was 
described for transgenes (Tumbar and Belmont, 2001; Dietzel et al., 2004) and 
several genes or chromosomal subregions (Zink et al., 2004; Chuang et al., 2006; 
Williams et al., 2006). Whether transcriptional upregulation of the HIV provirus results 
in an analog repositioning, was tested by treating the cells with NaBut as described in 
 3.2.3. For HeLa cells, T-lymphocytes and astrocytes both HIV transcription and virus 
production was measured, in each case with and without NaBut treatment. HIV 
transcriptional activity was determined via qPCR by comparing to RNA polymerase II 
RNA levels (described in  3.2.3). Virus production was measured by the amount of 
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p24 (described in  3.2.3), which is a HIV core protein and therefore correlates with the 
virus particle count. 
In all three cell types HIV transcription was induced upon NaBut treatment 
(Figure 34a). The highest HIV transcription rate compared to RNA polymerase II RNA 
levels, with and without NaBut treatment, was determined in T-lymphocytes, whereas 
in HeLa cells and astrocytes lower amounts of HIV transcripts were found. Except for 
untreated HeLa cells, the amounts of HIV transcripts exceeded the amounts of RNA 
polymerase II transcripts, which can be read off the ratio values in Figure 34a. 
Among the three investigated cell types, the highest virus production, 
respectively the virus particle concentration in the cell supernatant was measured in 
HeLa cells (Figure 34b). In T-lymphocytes and astrocytes virus production was 
comparatively low. As HIV transcription levels, in HeLa cells, T-lymphocytes and 
astrocytes virus production was increased upon NaBut treatment. In summary, NaBut 
treatment increased both HIV transcription and virus production (Figure 34c). HeLa 
cells showed the highest increase in HIV transcription (~10-fold) compared to T-
lymphocytes (~2-fold) and astrocytes (~3-fold). HIV production in astrocytes was 
increased nearly 7-fold, in HeLa cells and T-lymphocytes virus production was 
increased only marginally (1.3-fold and 1.1-fold, respectively). 
 Possible changes in the positioning of the integration loci upon NaBut 
treatment were determined as described for untreated cells (see  4.3). While 
transcription of the HIV provirus was increased, the NaBut evaluation revealed very 
similar distributions for integration loci as well as for control loci (same locus in 
treated versus untreated cells: p>0.05 for all integration loci). The only noticeable 
difference is that astrocyte nuclei have become smaller which can be read off the 
DAPI curve for Astro 18q22.1 (in Figure 29 the curve reaches the x-axes at -3 µm, in 
Figure 35 at -2 µm indicating a nuclear radius of 3 µm or 2 µm, respectively). 
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Figure 34 (previous page): Effect of sodium butyrate (NaBut) treatment 
A: Ratio of HIV transcripts to RNA polymerase II transcripts in HeLa cells (HeLa), T-lymphocytes (TLy) 
and astrocytes (Astro) compared to NaBut treated cells (+NaBut); numbers above columns display 
measured values (data adapted from measurements performed by Manja Meggendorfer, Helmholtz 
Zentrum München). 
B: p24 concentration in supernatant in HeLa cells (HeLa), T-lymphocytes (TLy) and astrocytes (Astro) 
compared to NaBut treated cells (+NaBut); numbers above columns display measured values (data 
adapted from measurements performed by Manja Meggendorfer, Helmholtz Zentrum München). 
C: x-fold increase of p24 levels an HIV RNA by NaBut treatment in HeLa cells (HeLa), T-lymphocytes 
(TLy) and astrocytes (Astro) compared to untreated cells. 
 
 
 
 
 
 
Figure 35: nuclear distribution of HIV integration loci in NaBut treated cells 
distance to nuclear surface: negative values – inside nucleus, positive values – outside nucleus; red 
curves – nuclear distribution of BAC signal co-localizing with HIV signal; green curves – nuclear 
distribution of BAC signal on homologous chromosome; blue – DNA distribution; HeLa – HeLa cells; 
TLy – T-lymphocytes; Astro – astrocytes; n – number of evaluated nuclei. 
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4.6 Integration of HIV had no influence on the positioning of the 
integration locus relative to SC35 splicing speckles 
Since HIV does not have own splicing factors the virus is dependent on the host 
splicing machinery. To investigate the spatial relation of HIV integration sites towards 
splicing speckles, the distance of the BAC signals co-localizing with the HIV signal 
and the respective BAC signals on the homologous chromosomes to SC35 splicing 
speckles was determined as described in  3.13.5. Therefore 3D FISH in combination 
with immunocytochemistry was performed (see  3.11). In advance to threshold 
defining for measurement procedure, the microscopic images were deconvolved as 
described in  3.13.2. Escpecially for threshold defining, blur hinderes the specification 
of FISH signals emanating from fine structures such as splicing speckles. The 
mathematical process of deconvolution reduces blur caused by out of focus light. In 
(Albiez, 2007) the gain in signal quality and enhancement in contrast were proven by 
comparing deconvolved confocal images with electron microscope images, the latter 
providing much higher resolution. 
As illustrated in Figure 36 the raw image without deconvolution is much more 
blurry and noisy compared to the deconvolved image. Hence, deconvolution 
facilitates proper threshold defining by improved delineating of SC35 signal. 
Neither BAC signals co-localizing with HIV signals nor BAC signals of the 
homologous regions contacted SC35 signals, with the exception of HeLa 18q22.3 
where 15 -20% of BAC signals co-localized with or were found adjacent to SC35 
Figure 38). Significant differences between the distribution of integration loci and 
homologous control regions relative to SC35 splicing speckles were not determined 
(p>0.05; Figure 38). The distribution of the HIV FISH signal towards splicing speckles 
of the same experiment was determined separately, but revealed similar results as 
the co-localizing BAC signal (red curves in Figure 38). 
Since splicing of the HIV transcripts is mandatory, the question arises whether 
HIV RNA signals contact SC35 speckles. Therefore, RNA FISH in combination with 
immunocytochemistry was performed (described in  3.11). In HeLa cells and T-
lymphocytes, ~30% of the HIV RNA signals co-localized with or contacted splicing 
speckles (Figure 39b). BAC probes were not used since RNA signals were not 
expected, which was proven in preliminary RNA FISH test experiments. Hence, it 
could not be identified from which integration site the RNA signals derived. 
 
 85
RESULTS 
 
 
Figure 36: Effect of deconvolution on SC35 signal in an astrocyte nucleus 
Z-projection of three mid confocal sections of the same SC35 splicing speckles image; before (raw 
image) and after deconvolution (deconvolved image); scale bar 5 µm. 
 
 
 
 
 
Figure 37: SC35 antibody staining in combination with 3D FISH 
Z-projection of three mid confocal sections of the respective astrocyte nucleus from Figure 36; FISH 
probes for BAC covering integratiuon site region 18q22.1 (green) and HIV (red); counterstain with 
DAPI (blue); antibody against SC35 splicing speckles (light blue); Images are deconvolved; arrow in 
overlay indicates BAC signal co-localizing with HIV; to benefit HIV FISH signal quality and to reduce 
background signal, the brightness/contrast tool in ImageJ was applied for the HIV channel; scale bar 5 
µm. 
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Figure 38: Distribution of BAC signals with regard to SC35 splicing speckles 
Distribution of BAC signal co-localizing with HIV signal (red) and on homologous chromosome (green) 
towards surface of SC35 splicing speckles; x-axis: negative values – inside SC35 signals, positive 
values – outside SC35 signals; n – number of evaluated nuclei. 
 
 
 
Figure 39: RNA FISH in combination with SC35 antibody staining and according eADS 
evaluation 
a: z-projection of mid confocal sections, HeLa cell nucleus; green - SC35 splicing speckles, red – HIV 
RNA (indicated by arrow), blue - counterstain with DAPI; image is deconvolved; scale bar 5 µm. 
b: distribution of HIV RNA with regard to the surface of SC35 splicing speckles in T-lymphocytes (TLy, 
(brown) and HeLa cells (HeLa, orange); negative values on x-axis – inside SC35 signal; positive 
values – outside SC35 signal; n – number of evaluated nuclei. 
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4.7 Karyotype analysis and genomic properties of the integration 
sites in the mouse cell line cloneB 
The mouse hematopoietic precursor cell line cloneB was transduced with the LTR-
driven gamma-retroviral gene transfer vector pSF91-GFP (Modlich et al., 2006). In 
this publication, five integration sites are described. Four additional integration sites 
were identified in the lab of Manuel Grez (Georg-Speyer-Haus, Frankfurt), who kindly 
provided the cell line (for overview of identified integration sites see Table 4). 
 FISH on metaphases and karyotype determination of the cell line, test for 
correct chromosomal position of the BAC clones and gene density, GC content and 
chromatin condensation analysis of the integration loci were part of this thesis, while 
3D FISH experiments and data evaluation (see  4.8.2) were part of the supervised 
diploma thesis of Birgit Groß (Groß, 2009). 
 
Integration site MMU 
3A3+ 
MMU 
5G1+ 
MMU 
9A3 
MMU 
11B5 
MMU 
11E1+ 
MMU 
12B3+ 
MMU 
12D2 
MMU 
16B2 
MMU 
XA1.1+ 
Nearest 
gene 
Evi1 Mad1like1 Dnm2 Lig3 Gm885 Akap6 Batf AI480653 Wdr45 
Distance to  
nearest gene 
121 kb 0 0 0.5 kb 0 0.4 kb 13.5 kb 0 0.4 kb 
Gene ID 14013 17120 13430 16882 380732 238161 53314 268880 54636 
Table 4: gene transfer vector integration sites in cloneB 
Overview of gene vector integration sites in mouse hematopoietic cell line cloneB. Integration site 
description defines the chromosomal region; Integration site mapping was performed in the lab of 
Manuel Grez (Georg-Speyer-Haus, Frankfurt); integration sites marked by + have been described in 
(Modlich et al., 2006); gene ID from NCBI mouse genome database. 
 
 
4.7.1 The cloneB cell line has a normal karyotype 
To verify the chromosomal position of BAC clones, each clone was co-hybridzed with 
the integration site harboring chromosome paint probe. Karyotype analysis of cloneB 
revealed a normal female mouse karyotype (40,XX). As exemplified for integration 
sites MMU11B5, MMU11E1, MMU3A3 and MMU5G2 in Figure 40a,c, no 
chromosomal aberrations of the integration site harboring chromosomes were 
determined. Hence, all nine integration loci could be evaluated in terms of their 3D 
nuclear position. The used BAC clones are summarized in Table 5. 
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Figure 40: BAC test and karyotype anaysis of cloneB 
a, c: FISH on cloneB metaphase spreads; paint probes for chromosome 11 (a, MMU11, blue), 
chromosome 3 (c, MMU3, red) and chromosome 5 (c, MMU5, blue); BAC probes covering integration 
site regions 11B5 (a, red), 11E1 (a, green), 3A3 (c, yellow) and 5G2 (c, green); counterstain with DAPI 
(grey). 
b, d, e: ideograms for respective chromosomes stained in metaphase spreads on the left; red marks 
indicate respective integration loci. 
 
 
 
Integration 
site 
MMU 
3A3 
MMU 
5G1 
MMU 
9A3 
MMU 
11B5 
MMU 
11E1 
MMU 
12B3 
MMU 
12D2 
MMU 
16B2 
MMU 
XA1.1 
BAC name RP23-
439N22 
RP23-
217N11 
RP23-
317E10 
RP23-
316C11 
RP23-
247J12 
RP24-
267H3 
RP23-
369N11 
RP24-
206H1 
RP23-
54C14 
Table 5: BAC clones for integration sites in cloneB 
 
 
 89
RESULTS 
4.7.2 Gene density and GC content of integration sites 
 
Figure 41: CloneB gene density and GC content of gene vector integration site regions 
Gene density was read off the NCBI homepage; the sequences were submitted to the Repeatmasker 
homepage to obtain the GC content. Chromosomal averages were taken from NCBI homepage (gene 
density) and from (Waterston et al., 2002) (GC content). 
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The chromosomal neighborhoods in 0.5 Mb, 2 Mb and 10 Mb windows around the 
integration sites vary both in gene density levels and GC content. MMU3A3, 
MMU12B3 and MMU16B2 for example locate in gene poor, whereas MMU9A3, 
MMU12D2 and MMUXA1.1 are found in rather gene dense regions (Figure 41). 
Concerning the GC content similar observations can be made, whereby again no 
preferences are obvious. 
 
4.8 FISH on intact mouse hematopoietic precursor nuclei and data 
evaluation 
All nine integration sites were investigated in terms of their radial nuclear distribution. 
To investigate possible repositioning upon gene transfer vector integration, the 
position in 3D of BACs covering the integration sites were compared to the position of 
the homologous BACs. This chapter summarizes data from the diploma thesis of 
Birgit Groß (Groß, 2009). However, these data are essential to understand the 
following chapter and parts of discussion and were therefore included here. 
 
4.8.1 No more than four integration sites were visualized in one nucleus 
In 3D FISH experiments with the gene transfer vector probe and different BAC 
probes marking the integration loci (Figure 42), a varying number of vector signals 
per nucleus were found. The maximum count was never more than four. The target 
sequence of the vector probe is 3.2 kb and therefore even smaller than the HIV 
provirus. It is most probably that, just like in case of HIV, RNA contributed to the 
enlargement of the FISH signal and thus to its visualization. This suggestion was 
supported by 2D FISH experiments on metaphases, where only DNA for 
hybridization is available. Here, it was not possible to visualize the gene transfer 
vector signal. 
In summary, a maximum of four integrations per nucleus were transcriptionally 
active simultanously or at least active at detectable levels. Combinations of certain 
actively transcribed integration sites were not found, but all integration sites were 
transcriptionally active at any time. 
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Figure 42: 3D FISH on mouse hematopoietic precursor cell line cloneB nucleus 
Z-projections of confocal image stacks; Overlay image: green – BAC signal marking integration site 
region (MMU12B3), red – gene transfer vector signal (pSF91-GFP), blue – DAPI counterstain, co-
localization of gene transfer vector and BAC signal indicated by arrow, scale bar 3 µm; Zoom image: 
magnification of co-loacalization of BAC and gene transfer vector signal from overlay image; 
arrowheads in pSF91-GFP image indicate gene transfer vector signals; image adapted and modified 
from (Groß, 2009). 
 
 
4.8.2 All nine integration loci in the mouse cell line cloneB tend to locate 
more internal in the nucleus than their homologous regions 
Integration site region MMU3A3 showed a highly significant shift towards the nuclear 
interior when compared to its corresponding site on the homologous chromosome 
(p<0.001, Figure 43a,j). Notably, MMU3A3 is in the immediate vicinity of the 
protooncogene Evi1 (ecotropic virus integration site 1), a region with frequently 
observed viral and gene transfer vector integrations (Modlich et al., 2006; Ott et al., 
2006; Wieser, 2007; Metais and Dunbar, 2008). MMU5G1 showed a less pronounced 
but still significant difference (p=0.033, Figure 43b). 
 Although no significant difference in the radial nuclear distribution in case of 
the other seven integration sites was determined (p>0.05, Figure 43c-i), interestingly, 
they were all located more internal than their homologous regions (Figure 43j). 
However, for a random radial distribution of nine integration site regions, the 
probability that all nine are localized more interior than their homologues is only 
(0.5)9, corresponding to p<0.002. For all nine sites combined, the deviation from a 
random distribution towards more internal positions of integration sites is thus highly 
significant. Even if the integration site regions with the smallest differences, 
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MMU11E2 and MMU12D2, would be excluded from the calculation, the p value still 
would be highly significant with (0.5)7=0.008. 
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Figure 43 (previous page): Nuclear distribution of BAC signals in cloneB cells 
a-i: red – nuclear distribution of BAC signal co-localizing with gene vector integration site; green – 
nuclear distribution of respective BAC on homologous chromosome; blue – chromatin distribution; n – 
number of evaluated nuclei in each case; 
j: mean values of medians for each respective integration site evaluation;  
a-j: data and graphs adapted  and modified from (Groß, 2009). 
 
 
4.8.3 Chromatin condensation at integration sites was altered 
Since repositioning in HIV infected cells was accompanied by chromatin 
decondensation (Figure 33), the gene transfer vector integration sites were also 
investigated in this regard (described in  3.13.6). A significant difference in chromatin 
condensation between integration loci and homologous regions was determined for 
MMU11B5 and the repositioned integration site region MMU3A3. In both cases 
chromatin of the homologous regions was less condensed, in principle the opposite 
effect as observed in HIV infected cells. For all other integration sites no significant 
difference was detectable (p>0.05). 
 
Figure 44: Surface area of BAC signals in the cloneB cell line 
Blue dots indicate the surface area of each single BAC signal; red (BAC signal co-localizing with gene 
vector signal) and green (respective BAC signals on homologous chromosomes) bars indicate the 
mean values in the respective columns; for method of determination of BAC surface area see  3.13.6. 
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5. DISCUSSION 
5.1 Development of a protocol to visualize small FISH targets 
The first experimental challenge in this thesis was the visualization of a fluorescence 
signal for a <10 kb target sequence with FISH methods. The probe is conventionally 
labeled with fluorochromes or haptens and in the latter case subsequently detected 
by a fluorochrome labeled antibody. Hybridization ought to be carried out on 
structurally preserved nuclei. The HIV provirus, i.e. the integrated HIV genome within 
the host genome, is about 9.7 kb in size (Ratner et al., 1985). The integrated gene 
transfer vector in the mouse hematopoietic precursor cell line cloneB with a size of 
3.2 kb was even three times smaller. 
Alternative FISH techniques for critical target signal sizes have also been 
described. A dramatic increase of sensitivity can be achieved by enzymatic-mediated 
signal amplification such as catalyzed reporter deposition (CARD)-FISH (Schönhuber 
et al., 1997; Zwirglmaier, 2005). Following this method, either the probe nucleotides 
or the antibody detecting the probe are conjugated to horseradish peroxidase (HRP). 
HRP activates its substrate tyramide by oxidization which than covalently binds to 
tyrosine residues in close vicinity to HRP. The accumulation of tyramides conjugated 
to fluorochromes results in signal intensities up to 12 times stronger than with 
conventional labeled FISH probes (Schönhuber et al., 1997; Zwirglmaier, 2005). This 
techinique has already been used to visualize the integrated HIV provirus 
(Dieudonne et al., 2009). The drawback of this technique is the HRP molecule size of 
44 KDa.  To assure cell access lysozyme or proteinase treatment is required, which 
concomitantly affects cell morphology. Hence, this might be a useful tool for studies 
on metaphases, which was already shown (Deichmann et al., 1997), but possibly 
limited for 3D analysis on structurally preserved interphase nuclei. Additionally, the 
precise position of the target sequence gets delocated by the covalently binding of 
tyramides in the vicinity. 
Integrated HIV DNA was already visualized with FISH techniques in (Bell et 
al., 2001). There, cells were denatured together with the probe by heating at 94°C for 
4 min. This robust denaturing process normally should severely irritate if not destroy 
the 3D nuclear structure. The difference in (Bell et al., 2001) was that the cells were 
dehydrated in an ethanol series and air dried in advance to hybridization. This 
process flattens the nucleus and impedes reliable 3D analysis. 
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So, for the purposes in this thesis, FISH technique for structurally preserved 
nuclei as described in (Hepperger et al., 2007; Müller et al., 2007; Cremer et al., 
2008) had to be used, whereas standard protocols had to be costumized. As FISH 
probe template for HIV, the whole pNL4-3 plasmid was used, which contains the HIV 
proviral genome framed by the LTR sequences (Adachi et al., 1986). For the gene 
transfer vector in the mouse cell line, the whole pSF91-eGFP plasmid was used.  
The first question was how to label the FISH probe. The variety of hapten and 
fluorophore labeled nucleotides offers plenty possibilities. Using hapten labeled 
probes depends on antibody detection, which may account for worsening 
background signal due to unspecific antibody binding. Therefore, directly labeled 
probes were tested first. During recording nuclei at the confocal microscope faster 
bleaching compared to hapten labeled probes was observed. The best results were 
achieved by digoxigenin and directly Texas Red labeled probes in repeated 
experiments. Digoxigenin was detected with the antibody combination mouse α dig-
Cy5 and goat α mouse-Cy5 leading to less background signal and marginal 
bleaching. Directly Texas red labeled HIV probes resulted in less background signal, 
but bleaching was worse, even though acceptable, compared to hapten labeled 
probes. Taken together, the digoxigenin labeled HIV probe detected with mouse α 
dig-Cy5 and goat α mouse-Cy5 was the first choice in this thesis and is most 
advisable. The gene transfer vector probe  
The next modification was made with the composition of the hybridization 
mixture. For non-repetitive probes it is recommended to use 20-100 ng DNA/µl 
hybridization mixture and additionally unlabeled Cot-1 competitor DNA, representing 
10-50-fold the concentration of probe DNA (Müller et al., 2007). Although the HIV 
genome does not harbor larger repetitive sequences, adding the 50-fold 
concentration of Cot-1 DNA increased markedly the FISH signal quality, so did high 
amounts of probe (100-150 ng DNA/µl hybridization mixture). FISH control 
experiments revealed that the HIV probe detected HIV DNA and RNA which 
extended the fluorescence signal (see Figure 18 and Figure 19). Since RNA is prone 
to degradation it was important not to store the fixed cells too long until use. Finally, 
denaturation time and temperature were reduced. The cells were placed for 100 sec. 
at 72°C instead of the recommended 3 min. at 76°C on the hotblock. 
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In summary, higher amounts of probe DNA in the hybridization mixture, freshly 
fixed cells and gentle denaturation were pivotal criteria for visualizing a FISH signal 
derived from a <10 kb target sequence. 
 
5.2 Gene transfer vector integrations show preferences for gene 
dense and GC rich regions 
The mouse hematopoietic precursor cell line cloneB was transduced with the 
gamma-retroviral gene transfer vector pSF91-eGFP (Schambach et al., 2000; 
Modlich et al., 2006). Four of the nine identified integration sites were located within 
genes (see Table 7 page 114). Since in gene therapy insertional mutagenesis 
caused by gene vector integration within host genes is a major concern, integration 
between genes may be an advantage. Depending on the chromosomal location of 
the integration site gene function might be irritated by activation or inactivation 
potentially provoking leukemia (Bokhoven et al., 2009; Kustikova et al., 2009). The 
frequency of severe phenotypic alterations evoked from gene vector integration, 
however, is extremely low. This was shown both in animal models and clinical studies 
(Baum et al., 2003; Kohn et al., 2003). This may be underlined by the fact that the 
vast majority of the human genome is occupied by non-coding sequences although 
these DNA areas provide regulatory elements with essential functions in regulating 
gene expression. Hence, variations of these sequences by inserting genetic material 
may also have serious consequences. 
In the mouse cell line cloneB gene dense areas were slightly favored for 
integration site selection compared to gene poor areas. Six (MMU 5G1, MMU 9A3, 
MMU 11B5, MMU 11E1, MMU 12D2, MMU XA1.1) of the nine integration sites were 
in more gene dense regions compared to the respective chromosomal average, three 
of them (MMU 9A3, MMU 12D2, MMU XA1.1) in very gene dense regions (>30 
genes/Mb in a 0.5 Mb window) (see Figure 41 and Table 9). The highest gene 
density with more than 50 genes/Mb in a 0.5 Mb window was found for integration 
site on the X chromosome. A more obvious preference seems to exist for the GC 
content. Five of the nine integration sites are in regions with GC content higher than 
45%. The lowest GC content in a 0.5 Mb window was determined for integration sites 
MMU 3A3, MMU 12B3 and MMU XA1.1, but in these cases it was still in the range of 
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the respective chromosomal average. The highest percentage was found for the 
integration on chromosome five with more than 50% GC content. 
In contrast to HIV integrations, a preference for gene transfer vector 
integrations within genes was not found here, as only five of nine were within genes 
(Table 4 page 88). On the other hand, a tendency of gene transfer vector integrations 
towards rather gene dense and GC rich regions was determined. These results show 
that the risk of insertional mutagenesis is low, although cannot be excluded, since the 
probability to hit a gene for integration in gene dense regions is given. 
 
5.3 All gene transfer vector integration loci tend to locate more 
internal of the nucleus than their homologous regions 
In the mouse hematopoietic precursor cell line cloneB transduced with a gamma-
retroviral gene transfer vector all nine mapped and investigated integration sites 
located more internal than their respective loci on the homologous chromosomes 
(see Figure 43). Notwithstanding only two integration sites were repositioned 
significantly (MMU3A3 and MMU5G1, whereas MMU3A3 revealed higher 
significance; Figure 43), taking all nine integration sites together, the result is highly 
significant. For a random radial nuclear distribution of nine integration sites the 
probability that all nine are localized more interior than their homologues is only 
(0.5)9, corresponding to p<0.002. Even if integration site regions MMU11E1 and 
MMU12D2, which showed the least change, are excluded from the calculation, the p 
value still would be highly significant with (0.5)7=0.008. 
In (Williams et al., 2006) a scenario is described that the upregulation of the 
Mash1 gene was accompanied by repositioning of the respective gene locus towards 
the center. Several neighboring genes were activated upon this process. If 
oncogenes would be affected by this activation, repositioning of gene transfer vector 
integration sites may have severe consequences in the context of gene therapy. 
Interestingly, the higher significantly repositioned integration locus MMU3A3 
was in the immediate vicinity of Evi1 (ecotropic virus integration site 1), a region with 
frequently observed viral and gene vector integrations, whereas in most cases the 
integration leads to overexpression of Evi1 (Buonamici et al., 2004; Modlich et al., 
2006; Ott et al., 2006; Wieser, 2007; Metais and Dunbar, 2008). In murine 
hematopoietic precursor (lineage negative) cells, Evi11 overexpression was shown to 
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enhance the self-renewal capacity and clonal dominance resulting from Evi1 
upregulation was reported in several animal studies and human clinical trials (Li et 
al., 2002; Du et al., 2005; Kustikova et al., 2005; Ott et al., 2006; Laricchia-Robbio 
and Nucifora, 2008; Bosticardo et al., 2009; Komeno et al., 2009; Stein et al., 2010). 
It was shown that in the cell line cloneB the Evi1 gene was up-regulated upon the 
upstream gene transfer vector integration, which was essential for immortalization 
and cell survival (Modlich et al., 2006). Increased transcription of Evi 1 and potentially 
of the gene transfer vector may have taken influence on the nuclear position of the 
affected chromosomal region. Taken together, the nuclear repositioning of the 
MMU3A3 integration locus is linked to activation of Evi1 and clonal viability. 
In 3D FISH experiments never more than four gene transfer vector signals per 
nucleus were found. The small size of 3.2 kbp and results from HIV experiments 
suggest, that the gene vector is only visualized when it is sufficiently transcriptionally 
active. On metaphase spreads, where only DNA is detected, a distinctive signal for 
the 3.2 kbp gene transfer vector was never visible. Apparently, there is a 
transcriptional limitation for four integration sites per nucleus. Whether the other 
integration sites are transcriptionally silent or transcribed at undetectable levels 
remains elusive. It seems to be random which integration sites are transcribed 
simultaneously, since no preferences for certain combinations were identified. 
 
5.4 In the mouse cell line cloneB alterations in chromatin 
condensation upon gene vector integrations were determined 
Of the nine investigated gene transfer vector integration sites in the mouse cell line 
cloneB two differed significantly (MMU3A3, MMU11B5; p<0.05) in chromatin 
condensation compared to their respective regions on the homologous 
chromosomes. The next largest change was determined for integration locus 
MMUXA1.1 and reached a p-value of 0.07. Contrary to the observations made in HIV 
infected cells, in all three cases of the mouse cells the surface area of the integration 
site regions was less than on the homologous chromosomes, suggesting more 
condensed chromatin in the integration site region. This was also the case for the 
repositioned integration site (MMU3A3). That means if any changes in chromatin 
condensation occurred, gene vector integrations induced the opposite effect than 
observed for HIV integrations in this thesis. The gene transfer vector pSF91-eGFP 
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contains the spleen focus-forming virus (SFFV) LTR as promoter element (Modlich et 
al., 2006). Comparisons concerning the strength of the SFFV and HIV LTR promoter 
are not described in the literature. It is assumed here that transcription of the HIV 
provirus exceeded the transcription of the pSF91-eGFP vector since the HIV Tat 
protein boosts transcription of the integrated provirus (Easley et al., 2010). 
 In the previous chapter was suggested that the increased transcription of the 
Evi1 gene in integration site region MMU3A3 may have taken influence on the radial 
position of this locus. The surrounding chromatin, in contrast, was more condensed 
than at the respective region on the homologous chromosome, which was also the 
case for integration sites MMU11B5 and MMUXA1.1. Several studies have described 
transcription in condensed chromatin and offer possible explanations. In (Hu et al., 
2009) transcription of a condensed transgene was linked to a local chromatin 
decondensation, which was not visible with the applied imaging approaches. 
Reorganization within the histone octamere resulting in a locally small open 
transcriptionally permissive configuration is also an option as described in (Becavin et 
al., 2010). 
 
5.5 HIV integration sites were preferentially found within genes, but 
independent of splicing speckles location 
Generally, HIV proviruses in the human genome are predominantly found within 
active transcription units (Wang et al., 2007; Brady et al., 2009). In this thesis seven 
of nine identified HIV integration sites were located within genes, in line with these 
reports (see Table 3 page 62 and Table 6 page 113). Due to their predicted functions 
it is most likely that they are transcriptionally active (see Table 6). In (Mack et al., 
2003) genes adjacent to HIV integration sites frequently encode receptor-, signal 
transduction- and transcription-associated proteins. Such preferences were also 
observed in this thesis. Proteins with known functions are amongst others a cadherin 
(Astro 18q22.1), a zinc finger protein (HeLa 15q21.3), a protein tyrosine phosphatase 
family member (TLy 2q14.2) and a RNA processing protein (HeLa Xq22.1). 
 Consistent with (Schröder et al., 2002) all seven integration sites within genes 
were located in intron sequences (Table 1 page 57). Concerning the gene density of 
the surrounding environment, integration sites were found in gene poor (HeLa 
11q22.3, HeLa 18q22.3, Astro 18q22.1) as well as in gene dense regions (HeLa 
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16p13.3, HeLa Xq22.1, TLy 2q11.2) (see Figure 15, Table 8). The GC content varies 
too. Taken together, the only preference of HIV integration site selection noticed here 
was integration within genes. Both the gene density and GC content of the 
surrounding environment did not seem to be pivotal or cannot be brought in a 
considerable relationship. Neither did other genomic properties such as CpG islands 
or LTR content seem to play an important role (see Table 8 page 115). 
 Since HIV has to rely on the host cell transcription machinery and therefore 
makes use of host splicing components, integration sites were investigated in terms 
of their position towards SC35 splicing speckles. One might expect that integration 
and strong transcription in a gene poor area such as 18q22.3 in HeLa cells could 
lead to accumulation of splicing factors to this site. A significant difference between 
integration sites and respective regions on the homologous chromosomes with 
respect to splicing speckles, however, was not detected here (see Figure 38). 
Moreover, none of the BAC signals covering the integration sites were located 
adjacent to splicing speckles, except for HeLa 18q22.3 where 15 - 20% contacted or 
co-localized with SC35 signals (see Figure 38). This is consistent with (Bell et al., 
2001), where HIV integration site location towards splicing speckles was observed to 
be random. By contrast 30% of HIV RNA signals in HeLa cells and T-lymphocytes 
contacted SC35 signals (see Figure 39). However, this can be explained with the 
larger volume of RNA signals compared to BAC signals. 
 On the molecular level of the linear genome HIV preferentially integrates within 
active transcription units (Wang et al., 2007). Whether preferences with regard to the 
3D nuclear space exist, however, has not been reported yet. The distribution curves 
of the BAC signals not co-localizing with the HIV signals (Figure 29, green curves) 
should in principle reflect the nuclear radial location for integration site selection. 
Even though comparing results determined in nuclei of different shapes is critical and 
should not be taken exclusively, in the five scenarios in Figure 29 no obvious 
preferences or tendencies were apparent. The peaks of the distribution curves in 
Figure 29 show both peripheral (HeLa 18q22.3, Astro 18q22.1) and more internal 
(TLy 2q11.2) positions. Furthermore the mean values of the medians (Figure 30, 
green circles) range from -1.42 µm (TLy 2q11.2) to -0.75 µm (Astro 18q22.1). 
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5.6 HeLa cells and T-lymphocytes harbored multiple HIV 
integration sites 
Target cells of HIV were generally considered to bear only one single infection per 
cell. During the last decade this prevalent assumption was questioned by several 
counterexamples based on experiments both in in vitro infected and in patient cells. 
Spleen cells of HIV infected individuals, for example, were averaging three or four 
proviruses, up to eight (Jung et al., 2002). In a T cell line infected with a HIV-1-
derived virus double infections were found significantly more often than expected 
from random events (Dang et al., 2004). The probability of multiple infections was 
based on calculations from the multiplicity of infection value. The findings in this 
thesis join these counterexamples, since in two of three cell types in vitro infected 
with HIV-1 more than one provirus per nucleus was detected (see  4.2.3). Only 
astrocytes had constantly one integration site per nucleus. In the T-lymphocyte cell 
type KE37/1-IIIB up to four integrations per nucleus were microscopically visualized, 
with one or two integrations on average. In the HIV infected HeLa cells rarely two 
integration sites per nucleus were visualized, mostly only one. 
In advance, a quantification via LightCycler qPCR revealed statistically for the 
astrocytes one provirus copy per nucleus, for the T-lymphocytes six and for the HeLa 
cells 0.6 (Manja Meggendorfer, Helmholtz Zentrum München, personal 
communication). Thus, among the HeLa cell population not all cells were infected. 
Determining the number of integration sites via FISH methods is based on single cell 
observations. Since the provirus was detected with a probe that subsequently was 
visualized by antibody detection, this method of analysis is indirect and might be 
affected by various factors. As described in the previous chapter detecting 
sequences of critical sizes less than 10 kb with conventionally labeled FISH probes is 
challenging. Hence, the number of visualized integration sites can vary. Never the 
less, results from both 3D FISH (Figure 23) and RNA FISH (Figure 27 and Figure 28) 
experiments support the assumption that HIV is capable of multiple infections. 
As mentioned, in most HeLa cells one integration site was visualized, rarely 
two (Figure 24). Integration sites 18q22.3 and Xq22.1 were never detected within the 
same nucleus. Possible explanations would be that in HeLa cells either multiple HIV 
integrations are a rare event or selectively disadvantageous. In the KE37/1-IIIB T-
lymphocytes both mapped integration sites were located on chromosome two. 
Microscopic Images revealed that they were located on the same chromosome, not 
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on different homologs. Frequently two additional integration sites were visible 
simultaneously. 
Besides direct infection, HIV is able to choose a cell mediated entry pathway. 
Dendritic cells are known to capture several virions of HIV and transport them to their 
target T-cells (Grouard and Clark, 1997; Geijtenbeek et al., 2000; McDonald et al., 
2003). In case of multiple integrations a certain importance is assigned to this cell 
mediated entry pathway (McDonald et al., 2003; Chen et al., 2005). The observations 
made in this thesis, however, offer an example of multiple HIV integrations in in vitro 
infected cells. 
 
5.7 The integration locus Xq22.1 harboring clone was the most 
dominant among the LC5-HIV HeLa cell population 
In  4.2.4 it was determined that the LC5-HIV HeLa cells are a pool of clones with 
different integration sites. The cell line was obtained by infection of LC5 cells with the 
HIV-1 isolate HTLV-IIIB and subsequent end-point dilution technique (Mellert et al., 
1990). qPCR experiments revealed 0.6 HIV integrations per nucleus. In this thesis six 
integration sites were mapped but never more than two were microscopically visible, 
in most cases one (Figure 24). As described in  4.2.2 the HIV probe detected DNA 
and RNA, which increased the signal size and facilitated the visualization of the HIV 
provirus in FISH experiments. If an integration site is insufficiently transcribed or 
inactive, it is possible that due to the lack of RNA it is not visible. In FISH experiments 
on metaphases with the HIV probe and BACs marking integration site regions 
11q22.3, 18q22.3 and Xq22.1, only one provirus per metaphase spread was found 
(see  4.2.4). Hence, these three integration sites are found in different clones. 
 Interestingly, clones with different integration sites were resented among the 
HeLa cell population with variable frequency (Figure 25). The most prominent 
member was the clone harboring integration site Xq22.1 with 40%, whereas 
integration site clone 18q22.3 accounted only for 7% of the population. Obviously, 
some clones have selective advantages over others, which might be traced back to 
different genomic positions of integration sites. An in vivo clonal selection upon 
retroviral integrations has been described earlier for blood cells (Deichmann et al., 
2007). There, in an X-linked SCID (severe combined immunodeficiency) gene 
therapy trial CD34+ cells of patients were transduced and retransplanted. In post-
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transplanted cells (4 – 41 months after retransplantation) integration site distribution 
among the population was different indicating selective or growth advantages for 
clones harboring distinct integration sites. Gene activation upon integration in gene 
loci that govern growth or survival of the affected cells was suggested to account for 
this observation. In another gene therapy trial, where X-linked chronic granulomatous 
disease (CGD) was treated, similar in vivo expansion of distinct clones was observed 
(Ott et al., 2006). There, clones showing gene vector integration sites in or near the 
genetic loci MDS1-EVI1, PRDM16 or SETBP1 became predominant approximately 
five months after reinfusion of CD34+ cells. Transcriptional levels of the affected 
genes increased upon integration. A relation between gene vector integrations in the 
MDS1-EVI1 region and an in vivo clonal dominance has also been described before 
for mouse bone marrow cells (Kustikova et al., 2005). It was frequently observed that 
expression of genes in the vicinity of retroviral integration sites can be altered upon 
integration (see  5.9). 
 The HeLa cell clone with integration in region Xq22.1 accounted for 40% and 
therefore dominated the cell population. The provirus in Xq22.1 was located within 
the CSTF2 gene (Table 1 page 57) which encodes a protein involved in RNA 
processing. Genes at integration sites in less represented clones encode for a 
transcription initiation protein (integration locus 6p12.3), a zinc finger protein 
(integration locus 15q21.3) and a protein of the Wnt signalling pathway (integration 
locus 16p13.3). These clones together made up 10% of the HeLa cell population. 
Whether transcription of these genes was upregulated or affected somehow by HIV 
integration, which might influence growth behaviour of the cell, was not investigated, 
since it was not in the focus of this thesis. Only the gene AXIN1 in close vicinity to 
integration locus 16p13.3 with its ability to induce apoptosis allows drawing an 
obvious connection to cell survival. How exactly the HeLa cell sub-clone population 
arose, is not clear. 
 For the KE37/1-IIIB T-lymphocytes results from qPCR experiments suggested 
up to six integrations per nucleus, with the LM-PCR technique two of them were 
mapped in this thesis. In the subsequent FISH experiments between one and four 
HIV signals per nucleus were visible (see Figure 24), the count of HIV RNA signals 
varied too (see Figure 26). It is not clear whether the T-lymphocytes were also a 
population of subclones, which would explain the non-constant number of DNA FISH 
signals. The qPCR results and the varying number of HIV RNA signals rather 
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suggest that the T-lymphocytes harbor four or more integration sites, which might 
have different transcriptional activities. Therefore, the T-lymphocytes might be an 
example for latent HIV infections within a population. It remains elusive on which 
mechanism this putative latency was based. High levels of CpG methylation of the 
viral promoter have been shown to result in viral latency (Blazkova et al., 2009) as 
well as distinct epigenetic modifications like hypoacetylation (Coull et al., 2000). 
 
5.8 Radial nuclear repositioning was determined for two HIV 
integration loci 
Five of the nine mapped HIV integration sites could be investigated in terms of their 
3D nuclear position ( 4.1.4). Two of them (HeLa 18q22.3 and HeLa Xq22.1) were 
significantly located more internal than their respective regions on the homologous 
chromosomes (see Figure 29).  The change was more pronounced for 18q22.3 than 
for Xq22.1 (0.24 µm compared to 0.12 µm mean values of median in Figure 30).  
Peripheral chromatin is in molecular contact with the nuclear lamina (Kind and 
van Steensel, 2010). These chromatin properties might constrain repositioning of 
distinct genetic loci. Repositioning in a flat astrocyte nucleus, where more chromatin 
is in closer proximity of the lamina, might be more limited than in round nuclei like T-
lymphocytes. Here, in neither of them repositioning of the investigated integration loci 
was observed. The repositioned integration locus 18q22.3 was in hemispherical 
HeLa nuclei and in close vicinity to the nuclear surface (HeLa 18q22.3, peak of green 
curve at -0.125 µm, Figure 29). Within that distance away from the nuclear lamina, 
attachment did not seem to prevent repositioning. Independent from lamina 
attachment, due to its absence, would be repositioning during mitosis. At which 
particular time after integration repositioning took place and at which cell cycle stage 
could not be determined. 
The repositioned integration loci HeLa 18q22.3 and HeLa Xq22.1 differed both 
in gene density and GC content. Integration site in region 18q22.3 was between 
genes and in a very gene poor region (no genes within a 0.5 Mb window). On the 
other hand, integration site in region HeLa Xq22.1 was located within a gene and in a 
gene dense region. The grade of gene density seemed not to elicit repositioning. 
Taking all five integration loci into account, a high variation in gene density, GC 
content and LTR content was found (Figure 15 and Table 8). 
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Repositioning is often implicated in transcriptional alterations. Several 
publications report gene activation upon movements towards the nuclear interior (see 
introduction  2.3.2). In (Gierman et al., 2007) a scenario of an integrated transgene 
acquiring the expression level of the surrounding chromosomal area is described. In 
particular, epigenetic properties at HIV integration sites and the surrounding genomic 
regions can influence the degree of provirus expression (Jordan et al., 2001; Wang et 
al., 2007). Notwithstanding its preference for active transcription units, HIV integration 
sites might be surrounded by transcriptional environment not satisfying for viral 
purposes. Since gene expression is proposed ot be affected by the nuclear location 
(Zhao et al., 2009), repositioning towards more suitable regions offers a solution to 
improve transcriptional competence. In (Zink et al., 2004) transcriptional activation is 
proposed to be the driving force for repositioning. Transcriptional activity affects its 
nuclear position rather than vice versa. This theory would provoke repositioning of 
the HIV integration sites as a result of increased transcription. 
In (Lilley et al., 2009) viral interactions in advance to integration with host 
chromatin modifications such as histone methylations, phosphorylations or 
acetylations and repair mechanisms induced by the virus are described. These 
events might lead to alterations in nuclear architecture which provoke repositioning. 
Actually, retrovirally caused changes in chromatin condensation were observed (see 
 4.4 and following chapter). 
Considering repositioning under the light of increasing transcription, it is not a 
must for the integration site to move to another nuclear location if transcriptional 
competence is already given or sufficient. Another suggestion to guarantee 
transcription could be a reorganization in the chromatin environment around the 
integration site as described in (Dieudonne et al., 2009). In the silent state the HIV-1 
provirus was observed to be associated with pericentromeric chromatin regions, 
being transcriptional activated this association got lost, without taking influence on its 
nuclear location. In this thesis all investigated integration sites were transcriptionally 
active, because the HIV probe always detected certain amounts of RNA (see  4.2.2). 
Having that in mind one can guess that the integration sites that did not reposition 
either were already convenient for transcription or became so by modification of the 
neighboring chromatin. 
A hint for that is given by the results of the sodium butyrate (NaBut) 
experiments (see Figure 35). NaBut treatment verifiably increased HIV transcription 
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(see Figure 34c), whereas the strongest effect was measured for the HeLa cells with 
a ten time higher amount of HIV transcripts than in untreated cells. An explanation for 
the quite minor increase in T-lymphocytes could be the already high transcriptional 
activity in untreated cells (Figure 34a), so a tremendous increase upon NaBut 
treatment might not be compulsorily expectable. Nuclear positions of HIV integration 
sites and their respective loci on the homologous chromosomes in NaBut treated 
cells did not differ significantly compared to untreated cells (compare Figure 29 and 
Figure 35). That could mean, although transcription was boosted, repositioning was 
not necessary as the current location seems probably transcriptionally satisfying. It 
has to be taken into account that the measured effect on transcription of the NaBut 
treatment is representative for the whole cell population of each cell type (astrocytes, 
HeLa cells and T-lymphocytes). This means, in case of the latter two cell types, 
increase in transcription was determined for all integration sites together and not for 
each single one. 
The observed repositioning was in both cases (HeLa 18q22.3 and HeLa 
Xq22.1) with regard to the nuclear surface. The integration site position did not 
change with regard to the surface of the respective chromosome territory (see Figure 
31c,d). Hence, it is no looping out scenario with an emanating chromatin fiber from its 
harboring chromosome territory as described in several studies for gene loci upon 
transcriptional activation (see introduction  2.3.2). There are several mechanistic 
explanations. The integration site changed its location within the chromosome 
territory but not the distance to its surface. The other possibility might be that a larger 
area or component within the chromosome territory around the integration site 
changed its position or the whole chromosome territory rotated. Both repositioned 
integration sites harboring chromosome territories X and 18 did not change their 
nuclear distribution (see Figure 31c,d). A contrary event is reported in (Szczerbal et 
al., 2009). There, adipogenesis genes were found to move towards the nuclear 
center upon transcriptional activation and the respective chromosome territories also 
altered their nuclear distribution. 
 The LC5-HIV HeLa cells were a population of sub-clones with several 
integration site clones. Transcription of genes in the integration site regions can 
therefore not be determined by qPCR since the results would display the properties 
of the whole population. It would be interesting to see whether repositioning 
correlates with an up-regulation of genes at the integration sites. Gene function and 
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expression levels can be tremendously affected by insertion of a provirus directly 
within or in the vicinity of a gene (Thomas et al., 2003; Bushman et al., 2005). 
 Among the HeLa cell population, the clone harboring the most repositioned 
integration site region 18q22.3 only accounted for 7%. The cell clone harboring the 
other repositioned integration site Xq22.1 dominated the population with 40%. 
Whether less repositioning contributes to this selective advantage or the genomic 
position of the provirus takes the main influence, remains elusive. 
 
5.9 Repositioning of HIV integration loci was accompanied by 
chromatin decondensation 
Depending on the grade of compaction and transcriptional competence, chromatin is 
classified in euchromatin and heterochromatin. Compared to euchromatin, 
heterochromatin is more condensed and transcriptionally less active (see introduction 
 2.3.1). In this thesis both upon HIV integration repositioned loci (HeLa 18q22.3 and 
HeLa Xq22.1) were significantly decondensed compared to their respective loci on 
the homologous chromosomes. This was determined by the different surface areas of 
BACs which marked the integration sites (Figure 33). Since the BAC probes did not 
detect the provirus but only the surrounding host genome, the measured increase in 
signal size clearly evolved from chromatin enlargement and not from the accretion of 
nucleotides. Obviously, neighboring host cell chromatin structure was influenced by 
the integrated HIV provirus. Chromatin decondensation accompanying transcriptional 
activation of a genetic locus has been observed earlier, e.g. for the Hoxb locus 
(Chambeyron and Bickmore, 2004) or an activated transgene (Dietzel et al., 2004). In 
the last case, repositioning was observed too. 
 HIV integrations as well as integrations of HIV based vectors are known to 
modulate expression levels of certain host genes, whereas both upregulation and 
downregulation was found (Mitchell et al., 2003; van 't Wout et al., 2003). 
Expressional alteration was described for several transcription factors (van 't Wout et 
al., 2003) or genes involved in the interferon response, DNA-damage response and 
apoptosis (Corbeil et al., 2001). Transcription of genes proximal to integration sites 
can be affected especially, when located downstream of the provirus. A read through 
the 3´LTR polyadenylation signal, by which subsequent host genes might be 
activated, was suggested in (Ashe et al., 1995). 
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 Whether the decondensation led to transcriptional up-regulation of adjacent 
genes remains elusive. At least for integration site HeLa 18q22.3, which was 700 kb 
away from the next gene, the BAC probe, due to its size of 146 kb (see Table 10 
page 117), was not capable of detecting RNA of possible transcribed genes in this 
region. The genomic region covered by the BAC probe at integration site region 
Xq22.3 in HeLa cells contains two genes (CSTF2 and NOX1) which possibly would 
allow by transcription certain amounts of RNA to be detected. This might result in a 
measurable increase in signal size. However, this assumption tends to be unlikely 
since in RNA FISH experiments using the BAC probes a distinct RNA signal was not 
visible (data not shown). For both repositioned integration site regions, HeLa 18q22.3 
and HeLa Xq22.1, the contribution of RNA to the increase in BAC signal size can 
thus be disregarded. 
Integration locus 18q22.3 in HeLa cells was repositioned and decondensed 
strongest. This locus is gene poor and 700 kb distant from the next gene. The less 
repositioned and decondensed integration locus Xq22.1 was located within a gene 
and in a gene dense region. A possible explanation for the different alterations in 
chromatin compaction might be that the gene blank chromatin was more compacted 
and therefore could be decondensed more than already less condensed, gene richer 
chromatin. This assumption is underlined by the signal sizes of the BACs that did not 
co-localize with the HIV signal (green bars in Figure 33). In principle, these BACs 
display the properties of the integration site before integration. The BACs marking 
integration loci 18q22.3 and Xq22.1 in HeLa cell feature approximately the same 
sizes (146 and 155 kb). At same chromatin compaction they should posses the same 
surface area. Apparently, the BAC signal for region 18q22.3 was smaller and 
therefore the chromatin was more condensed than the BAC for integration locus 
Xq22.1 (259 px to 316 px). 
The influence of surrounding chromosomal regions on the transcription level of 
a given inserted gene is exemplified in (Gierman et al., 2007). There, embryonic 
kidney cells were transduced with a lentiviral construct containing a GFP reporter 
gene. GFP expression gave information about the transcriptional level of the inserted 
construct. GFP expression of integration sites located in highly expressed domains 
called ridges was 4-fold higher than the identical gene integrated in anti-ridges. 
Furthermore FISH with BAC clones for the integration sites revealed a significantly 
larger diameter of the clones covering the highly expressed reporter gene region than 
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the respective region with low expression in anti-ridges. Transferred to HIV 
integrations, this would suggest that, depending on the genomic environment of 
integration sites, HIV may be transcribed at varying intensities and therefore provide 
different chromatin condensation states. 
APPENDIX 
6. APPENDIX 
6.1 Abbreviations 
3C chromosome conformation capture 
4C circular chromosome conformation capture 
2D, 3D 2-dimensional, 3-dimensional 
Astro astrocytes 
BAC bacterial artificial chromosome 
bp base pair 
CT chromosome territory 
DAPI 4’,6-diamidino-2-phenylindole 
dH2O distilled water 
ddH2O double-distilled water 
eGFP enhanced green fluorescent protein 
EtOH ethanol 
Evi-1 ecotropic virus integration site 1 
FISH fluorescence in situ hybridization 
gDNA genomic DNA 
h hour 
HM hybridization mixture 
HIV humane immunodeficiency virus 1 
HSA homo sapiens 
kb kilobase 
LTR long terminal repeat 
LM-PCR ligation (linker) mediated polymerase chain reaciton 
Mb megabase 
min minutes 
MMU mus musculus 
NaBut sodium butyrate 
ng, µg, mg nanogram, microgram, milligram 
µl, ml microliter, milliliter 
nm, µm nanometer, micrometer 
o/n over night 
pmol pico mol 
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PSF point spread function 
qPCR quantitative polymerase chain reaction 
RT room temperature 
sec seconds  
siRNA small interfering RNA 
SFFV spleen focus-forming virus 
TLy T-lymphocytes 
VRC Vanadyl ribonucleoside complex 
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6.2 Location of integration sites 
6.2.1 HIV integration sites 
Integration 
locus 
HeLa 
6p12.3 
HeLa 
11q22.3 
HeLa 
15q21.3 
HeLa 
16p13.3 
HeLa 
18q22.3 
HeLa 
Xq22.1 
TLy 
2q11.2 
TLy 
2q14.2 
Astro 
18q22.1 
Nearest 
gene 
SUPT3H PDFGD ZNF280
D 
AXIN1 LOC100
505817 
CSTF2 KIAA 
1310 
PTPN4 CDH19 
Gene ID 8464 80310 54816 8312 1005058
17 
1478 55683 5775 28513 
Distance to 
nearest 
gene 
0 250 kb 0 0 700kb 0 0 0 0 
Gene 
description 
Encodes 
Transcrip
tion 
initiation 
protein 
SPT3 
homolog 
platelet 
derived 
growth 
factor D 
zinc 
finger 
protein 
280D 
Cytoplas
mic 
protein;
Wnt 
signaling 
pathway;
can 
induce 
apoptosi
s 
misc. 
RNA 
cleavag
e 
stimulati
on 
factor, 3' 
pre-
RNA, 
subunit 
2 
 
hypotheti
cal 
protein 
protein 
tyrosine 
phosphat
ase, 
non-
receptor 
type 4 
(megaka
ryocyte) 
 
cadherin 
19, type 
2  
 
Chromosom
e integrity 
- - - - + + + + + 
sequence GCAAGT
TTTCAG
TTACTG
TGCTTG
ATAGGC 
AAATCA
TTAAGT
TGTTAA
TGGAAT
TTTAAG 
CAGAAA
AATGCA
AATAGG
GTCATT
TTAGTC 
GGGCT
TTCCCT
AGGTTC
TGTTCA
TCAGGT
G 
CATAGA
GCAAG
GGGCC
AACAGA
CCCCCT
TA 
ACAGC
ACAAC
TGGAT
ACCAC
TGAAT
TAATC 
GGTGG
GTCTG
GACCA
CTCCT
GGATT
CTGGG 
TGCCTT
CCTCA
GACTTT
GTTACA
GCATA
GG 
ATAACA
ATATTG
TATAAT
ATATGA
AGAAAT 
Table 6: Position of HIV integration sites 
Loci are identified by the chromosomal band in which they sit. A distance of 0 to the nearest gene 
means the integration is inside the gene. Gene ID and description are from the NCBI human genome 
database. Chromosome integrity was essential to compare the nuclear distribution to the homologous 
locus (see main text). ‘Sequence’ identifies the start of the sequenced host genome from LM-PCR 
directly adjacent to the 5´LTR of the integrated provirus. 
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6.2.2 Gene transfer vector integration sites in mouse cells 
Integratio
n locus 
MMU 
3A3+ 
MMU 
5G1+ 
MMU 
9A3 
MMU 
11B5 
MMU 
11E1+ 
MMU 
12B3+ 
MMU 
12D2 
MMU 
16B2 
MMU 
XA1.1+ 
Nearest 
gene 
Evi1 Mad1like1 Dnm2 Lig3 Gm885 Akap6 Batf AI48065
3 
Wdr45 
Gene ID 14013 17120 13430 16882 380732 238161 53314 268880 54636 
Distance 
to nearest 
gene 
121 kb 0 0 2.6 kb 0 0.4 kb 13.6 kb 0 0.4 kb 
Sequence AATTAGG
A 
GGAGG 
GCCTG 
AGGGG 
AAACT 
CCAAT 
AAATT 
TCACA 
GACAC 
TCTGT 
ATCTA 
TTTGC 
AAATT 
TGAGG 
GGTCA 
CTATA 
GTTGA 
AGCTG 
GTCAG 
GAAGT 
CAGAA 
GACAC 
TCTAT 
GGGAG 
TTGAT 
 GAGAA 
CGTGG 
TCTTG 
CGTGT 
CCTGA 
GCCTA 
GAGAT 
CCAAC 
TATAA 
GGCAT 
TTTTT 
CAATT 
GCTGG 
AATAA 
AAGAT 
CTTGA 
AAGTT 
GAGAT 
Start of 
sequence
d gDNA 
(Tsp5901 
cut) 
 14040420
9 
2120670
5 
8259694
8 
10657543
7 
5362048
0 
8656246
5 
3091311
5 
687924
5 
End of 
sequence
d gDNA 
(Begin of 
5'LTR) 
 14040408
1 
2120661
2 
8259676
9 
10657552
4 
5362044
0 
8656219
9 
3091277
0 
687879
3 
Table 7 Position of gene transfer vector integration sites 
Integration locus description defines the chromosomal band; Loci marked by + have been described 
before (Modlich et al., 2006); gene ID from NCBI mouse genome database; Sequences from LM-PCR 
performed in the lab of Manuel Grez: end of sequenced host genome adjacent to 5´LTR of integrated 
gene vector except for MMU11E1 where the sequence displays the start of the sequenced host 
genome adjacent to the 5´LTR; Start and end positions of gDNA state 02/07. 
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6.3  Genomic properties of integration site environment 
6.3.1 HIV integration sites 
 
Table 8: Genomic properties of HIV integration sites (state 08/09) 
HeLa – HeLa cells; Tly – T-lymphocytes; Astro – astrocytes; data taken from NCBI homepage by 
blasting respective sequences except for GC content and LTR content which were taken from 
Repeatmasker homepage; total GC content on chromosome from (Venter et al., 2001). Gene density 
is given as genes per megabase, calculated for 0.5, 2 and 10 megabase windows around the 
integration site, and for the whole chromosome. The GC content in percent is given for the same 
windows. 10 Mb window incomplete due to genomic position in case of HeLa 16p13.3 (telomeric) and 
Tly 2q11.2 (gap in sequenced contig). 
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6.3.2 Gene transfer vector integration sites in mouse cells 
 
Table 9: Genomic properties of gene transfer vector integration sites (state 11/10) 
Data taken from NCBI homepage by blasting respective sequences except for GC content and LTR 
content that were taken from Repeatmasker homepage; total GC content on chromosome from 
(Waterston et al., 2002). Gene density is given as genes per megabase, calculated for 0.5, 2 and 10 
megabase windows around the integration site, and for the whole chromosome. The GC content in 
percent is given for the same windows. 
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6.4 BAC properties 
6.4.1 BACs covering HIV integration sites 
Integration 
Site 
HeLa 
6p12.3 
HeLa 
11q22.3 
HeLa 
15q21.3 
HeLa 
16p13.3 
HeLa 
18q22.3 
HeLa 
Xq22.1 
TLy 
2q11.2 
TLy 
2q14.2 
Astro 
18q22.1 
BAC 
name 
RP11-
818O21 
RP11- 
63H12 
RP11-
566D24 
RP11-
517F15 
RP11-
693I21 
RP11-
255J06 
RP11-
67L23 
RP11-
132N24 
RP11-
831H17 
Start [Mb] 45.10 103.66 54.60 0.23 96.38 99.88 97.23 120.34 - 
Stop [Mb] 45.28 103.85 54.79 0.38 96.53 100.03 97.33 120.48 - 
Length 
[kb] 
182 194 189 150 146 155 100 139 - 
State 06/09 01/08 06/09 06/09 01/08 01/08 07/09 07/09 07/07 
Database 
version 
54 49 54 54 49 49 55 36.3 - 
Table 10: HIV integration sites – BAC properties 
BACs were chosen from Ensembl database except RP11-132N24, which was chosen from NCBI 
database and RP11-831H17, which was kindly provided by Mariano Rocchi, University of Bari, Italy. 
 
6.4.2 BACs covering gene transfer vector integration sites 
Integration 
Site 
MMU 
3A3 
MMU 
5G1 
MMU 
9A3 
MMU 
11B5 
MMU 
11E1 
MMU 
12B3 
MMU 
12D2 
MMU 
16B2 
MMU 
XA1.1 
BAC 
name 
RP23-
439N22 
RP23-
217N11 
RP23-
317E10 
RP23-
316C11 
RP23-
247J12 
RP24-
267H3 
RP23-
369N11 
RP24-
206H1 
RP23-
54C14 
Start [Mb] 30.15 140.32 21.13 82.50 106.46 53.56 86.49 30.81 6.69 
Stop [Mb] 30.37 140.52 21.31 82.68 106.67 53.67 86.64 31.02 6.90 
Length 
[kb] 
220 200 175 180 210 113 144 
 
212 215 
State 10/06 12/07 07/08 02/07 02/07 02/07 02/07 02/07 02/07 
Database 
version 
41 48 50 43 43 43 43 43 43 
Table 11: Gene transfer vector integration sites – BAC properties 
All BACs were chosen from Ensembl database. 
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6.5 Linker and Primer sequences 
6.5.1 LM-PCR described in  3.4.2: 
Linker +: 5’-GACCCGGGAGATCTGAATTCAGTGGCACAGCAGTTAGGT -3` 
Linker -: 5’-Pho-CCTAACTGCTGTGCCACTGAATTCAGATCTCCCG - 3’ 
Linker specific primers for nested PCRs: 
LSP1 (outer): 5’ - GACCCGGGAGATCTGAATTC - 3’  
LSP2 (inner): 5’ - AGTGGCACAGCAGTTAGG - 3’ 
HIV provirus specific primers: 
Bio-LMPCR-1: 5´- TAACTTCTCTGGCTCAACTGGTAC - 3´ 
LMPCR-2 (outer): 5´ - TGGCCCTGGTGTGTAGTTCTG - 3´ 
LMPCR-3 (inner): 5´- AGGATATCTTGTCTTCGTTGGGAG - 3´ 
 
6.5.2 Control PCRs described in  4.1.2: 
Primer within 3´LTR (25 bp before end of provirus) towards host genome: 
GSP3LTR: 5´- AACTAGAGATCCCTCAGACCCTTTTAGTCAG -3´ 
 
Primers within host genome towards provirus 3´LTR (approx. 1 kb away); specific for 
each integration site (indicated in brackets): 
LC5_#11 (HeLa 11q22.3): 5´-AGACGTCTAGCTAAAAGAAAATTCTGATAT-3´ 
LC5_#18 (HeLa 18q22.3): 5´-GTATGGCAAAGATGGAAAATCTCCACAAATC-3´ 
LC5_#X (HeLa Xq22.1): 5´-AGCTACTGTAGTGGGATATGAAGCAAAATGGA-3´ 
 
Primer within 3´LTR (100 bp away from provirus end) towards host genome: 
GSP3LTR_100: 5´-AACTAGGGAACCCACTGCTTAAGCCTCAAT-3´ 
 
6.5.3 Universal Genome Walker Kit described in  3.4.3: 
HIV provirus specific primers: 
GSP1 (outer): 5´- AAAGGTCAGTGGATATCTGATCCCTGGCCC-3´ 
GSP2 (inner): 5´ - CAGGGAAGTAGCCTTGTGTGTGGTAGATCC-3´ 
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Linker (adaptor) sequence and adaptor primers: 
 
Image taken from Genome Walker Universal Kit User Manuel (Clontech Laboratories) 
 
6.5.4 qPCR described in  3.2.3: 
RNA Pol II (s): 5´-GCACCACGTCCAATGACAT-3´ 
RNA Pol II (as): 5´-GTGCGGCTGCTTCCATAA-3´ 
HIV-transcripts F: 5´-CCAGTCACACCTCAGGTACCTTTAAGACC-3´ 
HIV-transcripts R: 5´-GTGTGTGGTAGATCCACAGATCAAGG-3´ 
 
6.6 pNL4-3 (HIV) plasmid map 
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6.7  pSF91-eGFP (gene transfer vector) plasmid map 
 
 
 
 
 
Linear structure of the pSF91-eGFP gene transfer vector (3.188 kb in size): 
 
LTRSF – long terminal repeat from friend spleen focus-forming virus; SD – splice donor site; SA – 
splice acceptor site; θ – primer binding site; ψ – packaging signal; eGFP – reportergene; PRE – 
posttranscriptional regulatory element from Woodchuck Hepatitis virus; image taken from (Modlich et 
al., 2006). 
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6.8 Antibodies 
Antibody Dilution Company, Distributor 
Mouse-α-Ki67 1:100 Roche, Mannheim, Germany 
Mouse-α-DIG-Cy3 1:100 Dianova, Hamburg, Germany 
Mouse-α-DIG-Cy5 1:75 Dianova 
Mouse-α-SC35 1:100 Sigma-Aldrich, Deisenhofen, Germany
Mouse-α-DIG 1:500 Sigma-Aldrich 
Avidin Alexa488 1:200 Molecular Probes (Invitrogen), 
Karlsruhe, Germany 
Streptavidin-Cy5 1:200 Rockland, Gilbertsville, PA, USA 
Rabbit-α-DNP 1:200 Sigma-Aldrich 
Rabbit-α-triH3K4* 1:500 Abcam, Cambridge, UK 
Rabbit-α-triH3K9* 1:400 T. Jenuwein, IMP, Wien, Austria 
Rabbit-α-triH3K27* 1:400 Upstate, Lake Placid, NY, USA 
Mouse-α-macroH2A* 1:5 Kindly provided by A. Ladurner, EMBL, 
Heidelberg, Germany 
Sheep-α-DIG-FITC 1:100 Roche 
Goat-α-Avidin-FITC 1:200 Vector, Burlingame, CA, USA 
Goat-α-Mouse-Cy5 1:100 Dianova 
Goat-α-Mouse-Alexa488 (hca) 1:400 Molecular Probes (Invitrogen) 
Goat-α-Mouse-Alexa350 1:100 Molecular Probes (Invitrogen) 
Goat-α-Rabbit-Alexa488 (hca) 1:200 Molecular Probes (Invitrogen) 
Goat-α-Rabbit TexasRed 1:50 Dianova 
Goat-α-Rabbit-Cy3 (Fab) 1:200 Dianova 
Antibodies marked by “*” diluted in PBS buffer; others work both in PBS and SSC buffered solutions. 
6.9 Buffers, media and solutions 
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Buffer/solution/medium Ingredients Constitution 
Agarose gel Agarose, 
TAE-buffer 
Appropriate amount of 
agarose dissolved in 
respective amount of TAE-
buffer by heating-up in 
microwave 
4% BSA in PBS/Tween 
blocking solution 
BSA, 
1x PBS/Tween 
4 g BSA dissolved in  
100 ml 1x PBS/Tween 
4% BSA in 4x SSC/Tween 
blocking solution 
BSA, 
4x SSC/Tween 
4 g BSA dissolved in 
100 ml 4x SSC/Tween 
CSK buffer NaCl, Sucrose, Pipes, 
MgCl2, PMSF 
Diluted in DEPC-treated 
water; final conc.: 
100 mM NaCl 
300 mM Sucrose 
10 mM Pipes 
3 mM MgCl2 
1.2 mM PMSF 
DEPC-treated water ddH2O, DEPC 0.1 ml DEPC are added to 
100 ml ddH2O, incubated 
12 h at 37°C and 
autoclaved for 15 min.; 
APPENDIX 
stored at 4°C for months
until use 
Dulbeccos MEM- 
medium (10% FCS) 
Dulbeccos MEM-Medium 
FCS 
Penicillin/Streptomycin 
500 ml Dulbeccos MEM 
50 ml FCS 
5 ml 
Penicillin/Streptomycin 
Fixative (fixing metaphases) Methanol, Acetic Acid Methanol:Acetic Acid = 3:1
50 % formamide solution Formamide, 
4x SSC 
500 ml formamide, 
500 ml 4X SSC; pH 
adjusted on 7.0 
20% glycerol Glycerol, 
ddH2O 
20 ml glycerol diluted in  
80 ml H2O bidest. 
0.1 N HCl solution 1N HCl, 
H2O bidest 
10 ml 1N HCl diluted in 
90 ml H2O bidest 
Hybridization mastermix 20% dextran sulfate, 
2x SSC 
8g dextran sulfate 
dissolved in 40 ml 2xSSC 
(vortex) and filtrated  
(0.45 µm filter) 
50 mM MgCl2 solution 1 M MgCl2, 
1x PBS 
10 ml MgCl2 diluted in 190 
ml 1x PBS 
10x NT buffer 0.5 M Tris-HCl (pH 7,5) 
50 mM MgCl2 
0.05% BSA 
50 ml 1M Tris-HCl (pH7.5) 
5 ml 1M MgCl2 
50 mg BSA 
45 ml H2O 
4 % paraformaldehyde 
fixation solution 
Paraformaldehyd, 
1x CMF-PBS 
4 g PFA dissolved in  
100 ml 1x CMF-PBS (or 
0.3x CMF-PBS for fixing in 
suspension growing cells) 
by heating-up to approx.
70°C (transparent 
solution); cooling down to 
RT before use 
20x PBS 140 mM NaCl 
2.7 mM KCl 
6.5 mM Na2HPO4 
1.5 mM KH2PO4 
320 g NaCl 
8g KCl 
57.6g Na2HPO4 
9.6g KH2PO4 
ad 2l H2O bidest.; 
adjust pH to 7.4 by adding 
HCl; autoclaved if used for 
cell culture 
1x PBS 20x PBS 
H2O bidest. 
20x PBS diluted 1:20 in 
H2O bidest. 
1x PBST Tween 20 
1xPBS  
100µl Tween 20 ad 1l 
1xPBS 
Pepsin solution (50µg/ml) Pepsin stocksolution 
(100mg/ml) 
10mM HCl solution 
50µl Pepsin stock solution 
diluted in 100ml 10mM 
HCl prewarmed to 37°C 
Poly L lysin solution Poly L lysine, ddH2O Poly L lysine diluted 1:7 in
ddH2O 
RNase solution (20mg/ml) RNase, 
1M Tris-HCl 
200mg RNase dissolved in 
100µl Tris-HCl, 30µl NaCl, 
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5 M NaCl 
ddH2O 
ad 10ml ddH2O; heat for 
15 min. at 90°C 
RPMI 1640 medium (10% 
FCS) 
RPMI 1640 Medium 
10% FCS 
Penicillin/Streptomycin 
500ml RPMI 1640 
50ml FCS 
5ml Penicillin/Streptomycin
20x SSC (pH 7,0) 150mM NaCl 
15mM Na-Citrat 
175.3g NaCl 
88.2g Na-Citrat 
ad 1l H2O bidest.; 
adjust pH to 7.0 by adding 
NaOH 
4x/2x/0.1x SSC 20x SSC 
H2O bidest. 
20x SSC diluted 
1:5/1:10/1:200 with H2O 
bidest. 
4x SSCT Tween 20 
4x SSC 
2ml Tween 20 in 1l 4x 
SSC 
Nicktranslation stopping mix 0.1% bromophenol blue 
0.5% dextran blue 
0.1 M NaCl 
20 mM EDTA 
20 mM Tris-HCl pH7.5 
40 mg bromophenol blue 
200 mg dextran blue 
800 µl 5 M NaCl 
1600 µl 0.5 M EDTA 
800 µl 1 M Tris-HCl pH7.5 
ad 40 ml H2O bidest. 
50x TAE-Puffer (pH 8.0) 40 mM Tris acetic acid 
1 mM EDTA 
242g Tris 
18,6 g EDTA 
57,1 ml acetic acid 
ad 1l H2o bidest. 
0.5% Triton solution Triton X-100 
1x PBS 
5ml Triton X-100 ad 1l
1xPBS 
Trypsin / EDTA solution 0.5% trypsin 
CMF-PBS 
0.5% trypsin diluted 1:10 
in CMF-PBS; warming-up 
to 37°C before use 
 
6.10  Chemicals and reagents 
Chemical / reagent Company, Distributor 
Acetic acid Sigma-Aldrich, Deisenhofen, Germany 
Agarose Seakem ME Cambrex, Rockland, Maine,USA 
Biotin succinimidyl ester (bio) Molecular Probes (Invitrogen), Karlsruhe, 
Germany 
Bovine serumalbumin (BSA) dissolved in 
SSC 
ICN Biomedicals, Eschwege, Germany 
Bovine serumalbumin (BSA) dissolved in 
PBS 
Sigma-Aldrich 
Bromophenol blue Sigma-Aldrich 
Calcium chloride Merck, Darmstadt, Germany 
Cetus II buffer Applied Biosystems 
Chloroform Roth, Karlsruhe, Germany 
Colcemide Biochrom, Berlin; Germany 
Cy3 mono NHS ester (Cy3) Amersham Biosciences, Freiburg, Germany 
Cy5 mono NHS ester (Cy5) Amersham Biosciences, Freiburg, Germany 
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DAPI (4,6 diamino-2-phenylindole) Sigma-Aldrich 
Dextran blue Sigma-Aldrich 
Dextran sulfate Amersham Biosciences, Freiburg, Germany 
Digoxigenin succinimidyl ester (dig) Molecular Probes 
Dinitrophenyl aminohexanoid acid 
succinimidyl ester (dnp) 
Molecular Probes 
DMEM medium Biochrom, Berlin, Germany 
DMSO (Dimethyl sulphoxide) Sigma-Aldrich 
EDTA Merck 
Ethanol absolute p.a. Merck 
Ethidium bromide Sigma-Aldrich 
Fetal calf serum (FCS) Biochrom 
FITC succinimidyl ester (FITC) Molecular Probes 
Formamide Merck 
Gel loading buffer Sigma-Aldrich 
Glycerol Merck 
Glycine Amersham Biosciences 
Iscove medium (incl stable glutamine) Biochrom 
Isopropanol Merck 
Potassium chloride (KCl) Merck 
Potassium phosphate (KH2PO4) Calbiochem, Darmstadt, Germany 
Magnesium chloride Merck 
MgCl2 solution (25 mM) PCR Perkin Elmer, Wellesley, MA, USA 
β-mercaptoethanol Merck 
m-IL3 (murine Interleukin-3) Biochrom 
m-SCF (murine stem cell factor) Biochrom 
NaHCO3 Sigma-Aldrich 
Nick translation buffer (10×) Roche, Mannheim, Germany 
Sodium acetate Merck 
Sodium azide Merck 
Sodium chloride Merck 
Sodium citrate Calbiochem 
Sodium hydrogen phosphate (Na2HPO4) Merck 
Paraformaldehyde Merck 
PCR buffer D (5×) Invitrogen 
PCR buffer I (10×) without MgCl2 Perkin Elmer, Jugesheim, Germany 
Penicillin/Streptomycin Biochrom 
Phenol Roth 
Poly-L-lysine Sigma-Aldrich 
Buffer D (5x) Invitrogen 
RPMI 1640 Medium Biochrom 
Hydrochloric acid Merck 
Nitrogen (liquid) Provided by LMU 
TAMRA succinimidyl ester (TAMRA) Molecular Probes 
Texas Red succinimidyl ester (Texas 
Red) 
Molecular Probes 
Tris-HCl Sigma-Aldrich 
Triton X-100 Sigma-Aldrich 
Tween 20 Calbiochem 
 124 
APPENDIX 
Vectashield Vector Laboratories Inc., Burlingame, CA, 
USA 
VRC (Ribonucleoside-Vanadyl complex) New England Biolabs, Frankfurt, Germany 
W1 (Polyoxyethylene ether W1) Sigma-Aldrich 
 
6.11  Enzymes and nucleotides 
Enzyme Company, Distributor 
DNase I Roche, Mannheim, Germany 
Pepsin Sigma-Aldrich, Deisenhofen, Germany 
DNA polymerase I (Kornberg Pol) Roche 
Rnase A Roche 
Taq polymerase GE Healthcare, München, Germany 
All restriction enzymes, according buffers 
and BSA used in  3.4.2 
New England Biolabs, Frankfurt, Germany 
 
Nucleotide(s) Company, Distributor 
6MW-Primer MWG-Biotech, Ebersberg, Germany 
Aminoallyl-dUTP Sigma-Aldrich, Deisenhofen, Germany 
Biotin-16-dUTP home labeled 
Cot-1 DNA Invitrogen, Karlsruhe, Germany 
Cy3-dUTP home labeled 
Digoxigenin-11-dUTP home labeled 
DNP-11-dUTP home labeled 
dNTPs (each 2,5 mM) Invitrogen 
dTTP (1mM) Invitrogen 
Lambda/Hind III marker  Fermentas, St. Leon-Rot, Germany 
1kb ladder Fermentas 
Salmonsperm-DNA Invitrogen 
humane Cot-1 DNA Invitrogen 
Tamra-6-dUTP home labeled 
TexasRed-12-dUTP home labeled 
All primers, Linker+ and Linker- used in 
 3.4.2 
Metabion, Martinsried, Germany 
 
 Further information about solutions, chemicals and protocols see (Cremer et al., 
2008). 
6.12  Kits 
Kit Company, Distributor 
Advantage 2 PCR Kit Clontech, CA, USA 
DNeasy Blood & Tissue Kit Qiagen, Hilden, Germany 
Dynabeads kilobase BINDER Kit Invitrogen, Karlsruhe, Germany 
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First Strand Synthesis System for RT-
PCR 
Invitrogen 
GenomiPhiTM V2 DNA Amplification Kit GE Healthcare, München, Germany 
HIV-1 p24-Antigen Capture ELISA Advanced BioScience Lab Inc., CA, USA 
Light Cycler 480 SYBR Green I Master Roche, Mannheim, Germany 
NucleoBond Xtra Midi/Maxi Kit Macherey-Nagel, Düren, Germany 
peqGOLD Plasmid Miniprep Kit II Peqlab, Erlangen, Germany 
Qiaquick Gel Extraction Kit Qiagen 
Qiaquick PCR Purification Kit Qiagen 
Rapid DNA Ligation Kit Roche, Mannheim, Germany 
RNeasy RNA Mini Kit Qiagen 
Universal Genome Walker Kit Clontech, CA, USA 
 
6.13  Consumables, technical equipment and microscopes 
Consumables Company, Distributor 
Cryotubes (1.5 ml) Greiner Bio One, Frickenhausen 
Coverslip (15x15/76x26mm) Superior 
Glass pipette (1/5/10/25ml) Costar, Fernwald 
Tubes (1.5/2ml) Schubert & Weiss, München 
Cell culture flasks (25/75cm2) Greiner Bio One, Frickenhausen 
Tubes (15/50ml) Greiner Bio One, Frickenhausen 
Fixogum Marabuwerke, Tamm 
Glass flasks (50/100/250/500/1000ml) Schott 
Cuvettes (50/100ml) Schubert & Weiss, München 
Microscopic slides (76x26mm) R.Langenbrink 
PCR tubes (0.5ml) Molecular Bio Products TM, San Diego, 
USA 
Petri dishes (35x10mm) Greiner Bio One, Frickenhausen 
Pipette tips (white) Molekular Bio Produkts 
Pipette tips (yellow, blue) Greiner Labortechnik 
Pipette aid (Accu-jet® BRAND) Schubert & Weiss, München 
Quadri PERM® plus (4x 76x26mm) Heraeus, Hanau 
Sterile filter (pore size 20/40 µm) Satorius, Göttingen 
6 well plates (6x 35x10mm) Greiner Bio One, Frickenhausen 
 
Technical equipment Company, Distributor 
Incubator (B 5060) Haraeus, Hanau 
Autoclav H+P Labortechnik GmbH 
Gel electrophoresis apparatus Owl, Portsmouth, USA 
Centrifuge (1,5 ml, Biofuge pico) Heraeus, Hanau 
Centrifuge (15/50ml, Rotanta/S) Hettich, Tuttlingen 
Hot block (Dri Block DB-2D) Techne Progene, Cambridge, UK 
Laminar flow (Airflow) Biohit 
Pipette aid (Accu-jet® BRAND) Schubert & Weiss, München 
Thermal cycler (TC312, TC3000) Techne Progene, Cambridge, UK 
Thermal cycler (Thermomixer 5436) Eppendorf 
Transilluminator (Gel Imager) MWG Biotech, Ebersberg 
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Vacuum centrifuge (Vacuum Concentrator) Bachhofer, Reutlingen 
pH-meter WTW, Weilheim 
Vortex (VF2) Janke & Kunkel 
Liquid nitrogen tank (Apollo) Cryotherm 
Icemachine (Scotsman AF-10) Masare, München 
Freezer -20°C Bosch 
Freezer -80°C Sanyo 
Water baths Jukabo (small), GFL (large) 
Parafilm Pechiney, Menasha, USA 
Paper wipes Kimberly-Clark / Roth 
forceps Dumont, Montiguez 
Pipette (10/20/200/1000µl) Gilson 
 
 
Phase contrast microscope: Axiovert 25C (Zeiss, Jena) 
Objectives: 
CP Achromat 5x / 0.12 
CP Achromat 10x / 0.25 Ph1 
LD Achrostigmat 20x /0.3 Ph1 
LD Achrostigmat 40x / 0.55 Ph2 
 
Epifluorescence microscope: Axiophot 2 (Zeiss, Jena) 
Objectives: 
Plan Neofluar 16x / 0.5 
Plan Neofluar 40x / 1.3 oil 
Plan Neofluar 63x / 1.4 oil 
Plan Neofluar 100x / 1.3 oil 
Filter: 
DAPI (BP 365, FT 395, LP 450-490 nm) 
FITC (BP 450-490, FT 510, LP 515-565 nm) 
Cy3 (BP 546, FT 580, LP 590 nm) 
Cy5 (BP 575-625, FT 645, LP 660-710 nm) 
Camera: 
Coolview CCD (Applied Imaging) 
Software: 
Metavue 
 
Confocal laser scanning microscope: Leica TCS-SP5 (Leica , Heidelberg) 
Objectives: 
Objektiv: 
Plan-Achromat 63x oil / 1.4 
Lasers: 
Ar 100 mW 485, 476, 488, 496, 512 nm 
HeNe 2 mW 594 nm 
HeNe 10 mW 633 nm 
DPSS 10 mW 561 nm 
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5 photomultiplier with continuously adjustable bandwidth 
Software: 
Leica Application Suite AF Version: 2.0.0 build 1934 
 
6.14  Software 
Software Company, Distributor 
Amira TGS Europe, Düsseldorf, Germany 
Endnote X3 Thomson Reuters, NY, USA 
Enhanced Distance to Surface (eADS) 
v3.00a 
T. Thormeyer (Thormeyer, 2005; Albiez et 
al., 2006) 
Gene Construction Kit 2.5.13 Textco Inc., NH, USA 
ImageJ 1.37c Wayne Rasband, NIH, USA 
Leica confocal software Leica Microsystems, Wetzlar, Germany 
Metavue 6.2r2 Universial Imaging Corp. 
Microsoft Office 2003 Microsoft Corporation, WA, USA 
Photoshop CS2 Adobe Corporation, CA, USA 
Sigma Stat 3.5 SPSS Inc. (IBM), IL, USA 
 
6.15  Homepages / Databases 
Ncbi: http://www.ncbi.nlm.nih.gov/ 
Ensemble: http://www.ensembl.org/index.html 
Repeatmasker: http://www.repeatmasker.org/ 
BAC Pac Resources: http://bacpac.chori.org/ 
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6.16  List of publications 
Nagel J., Groß B., Meggendorfer M., Preiss C., Grez M., Brack-Werner R., Dietzel S. 
“Stably integrated and expressed retroviral sequences can influence nuclear location 
and chromatin condensation of the integraton locus “ 
Chromosoma, 2012 Mar; DOI: 10.1007/s00412-012-0366-9 
 
Rienzo M., Nagel J., Casamassimi A., Giovane A., Dietzel S., Napoli C. 
“Mediator subunits: gene expression pattern, a novel transcript identification and 
nuclear localization in human endothelial progenitor cells” 
Biochim Biophys Acta. 2010 Jul;1799(7):487-95 
 
Kim IH., Nagel J., Otten S., Knerr B., Eils R., Rohr K., Dietzel S. 
“Quantitative comparison of DNA detection by GFP-lac repressor tagging, 
fluorescence in situ hybridization and immunostaining” 
BMC Biotechnol. 2007 Dec 20;7:92 
6.17  Poster presentations and talks 
07/06: Düsseldorf, Germany (short talk): Kick-off Meeting of the DFG Schwerpunkt- 
 Programm (SPP)1230 („Mechanisms of gene vector entry and persistence“) in  
 line with the 13th Annual Meeting of the DG-GT (German Society of Gene  
 Therapy) 
09/06: Reimlingen, Germany (poster): 1st Chromatin Summer School,  
 SFB/Transregio 5 
03/07: München, Germany (talk): SPP1230 workshop 
11/07: Frankfurt, Germany (talk): SPP1230 Annual Meeting 
03/08: München, Germany (talk): SPP1230 workshop 
05/08: Madrid, Spain (poster): 2nd MC-GARD (Marie Curie: genome architecture in  
 relation to disease) conference: Interplay among genetics, epigenetics and 
non-coding RNA's. 
10/08: Berlin, Germany (talk): SPP1230 Annual Meeting 
04/09: Edinburgh, Scotland (poster): 3rd MC-GARD conference: Higher order genome  
 architecture 
10/10: München, Germany (poster): 3rd Transregio 5 Symposium, Chromatin:  
 Assembly and Inheritance of Functional States 
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6.18  Curriculum vitae 
 
Name: Jens Nagel 
Geburtsdatum: 19.12.1978 
Geburtsort: Heidelberg 
Familienstand: ledig 
Nationalität: deutsch 
 
Schulbildung 
1998 Allgemeine Hochschulreife, St.Raphael- 
 Gymnasium Heidelberg 
 
Zivildienst 
08/1998 – 09/1999 St.Elisabeth Klinik, Heidelberg  
 
Universitätslaufbahn 
10/1999 – 09/2000 Studium der Rechtswissenschaften, Ruprecht-Karls-
Universität, Heidelberg 
10/2000 – 10/2005 Studium der Biologie, Ruprecht-Karls-Universität, 
Heidelberg 
10/2005 – 06/2006 Diplomarbeit am Institut für Anthropologie und 
Humangenetik, Ludwig-Maximilians-Universität, 
München 
20.06.2006 Diplom 
seit 07/2006 Doktorarbeit am Institut für Anthropologie und 
Humangenetik, Ludwig-Maximilians-Universität, 
München 
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